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GLUCOSE INTOLERANCE
IN AN URBAN MALE COMMUNITY IN SAUDI ARABIA
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ABSTRACT
Most chronic non-communicable diseases result from a complex
interaction between heredity and environmental factors. With better living
conditions and adoption of western lifestyles in developing countries, there is an
increased incidence of these diseases, the most common of which is diabetes. This
study documents the prevalence of NIDDM, lOT, hypertension, obesity and
hyperlipidaemia in an urban male community [n= 125] in Jeddah, Saudi Arabia. It
also examines OGl'T reproducibility [n=35]; the influence of diet and physical
activity; the differences in these aspects between nationals and non-nationals and
the metabolic responses following the OGTT between the glucose tolerance
groups [n=43].
Glucose intolerance, NIDDM [14%] and ICiT [27%], were very common.
Overall, CVD risk factors such as smoking [43%], obesity [29%], hypertension
[5%], hypercholesterolaemia [7%], hypertriglyceridaemia [14%], occurring in
association with diabetes were high. Clustering of other risk factors such as
abdominal obesity, hyperinsulinaemia and hyperproinsulinaemia were also
shown. The OGTT is a poorly reproducible test in this community and a further
confirmatory test is always required to establish the diagnosis of glucose
intolerance. The dietary habit and food item record identified recognizable
features characteristic of this community, which were affected by both the cultural
and the social background. However, no differences were found between the
glucose tolerance groups. Physical inactivity was a major lifestyle problem and
the inactive group tended to have increased risk factors, although differences were
not significant. These environmental factors could not, however, be excluded as
possible causative factors in the high prevalence of glucose intolerance and CVD
risk factors in this community as the sample was small. Subjects with 101' tended
to have intermediate levels of risk factors and this study favours identifying IGT
as an independent category which lies between normal and NIDDM. Ethnic
differences should be considered whenever possible particularly in this
multinational community, since 40 % of this community were non-nationals.
Nationals differed in certain dietary aspects and they tended to be inactive,
otherwise no other significant differences existed between the groups.
As shown in different populations, those identified as ICT or NIDDM in
this community, were characterised by hyperfunction of the a-cell in IGT,
hypofunction of the a-cell in NIDDM and associated with immature secretion of
proinsulin. The insulin resistance which was profound in NIDDM and
intermediate in TOT was characterised by high glycerol and NEFA which were
suggestive of insulin insensitivity at the level of adipose tissue. Large-scale and
prospective studies are strongly recommended. Meanwhile, primary prevention
measures are urgently required as these findings pose a significant public health
problem.
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'NLDDM, to a large extent, is due to an unhealthy lifestyle.
The prevention of diabetes mellitus and its devastating complications
is the ultimate dream.
The prevention of NIDDM is closer to reality.
The WHO program 'Health for All by the year 2000' may well be a reality
for those people at risk of NIDDM".
Paul Zhnmet, 1992.
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SUMMARY
This chapter examines some aspects of diabetes with particular reference
to some epidemiological features in a world context. It will emphasise those areas
most relevant to the material discussed in this thesis.
CHAPTER ONE:	 DIABETES MELLITUS IN WORLD CONTEXT
1.1 HISTORY OF DIABETES
Knowledge of diabetes dates back to centuries before Christ. The
Egyptian Ebers Papyrus [ca. 1500 B.C.] described an illness associated with the
passage of much urine. Celsus [30 B.C. to 50 A.D.] recognised the disease but it
was not until two centuries later that another Greek physician, the renowned
Aretaeus of Cappadocia, gave the name diabetes [a siphon]. He made the first
complete clinical description, describing it as "a melting down of the flesh and
limbs into urine". In the 3rd to 6th centuries A.D., scholars in China, Japan and
India wrote of a condition with polyuria in which the urine was sweet and sticky.
However, although it had been known for centuries that diabetic urine tasted
sweet, it remained for Willis in 1674 to add the observation "as if imbued with
honey and sugar". The name diabetes mellitus [mellitus = honey] was thus
established. A century after Willis, Dobson demonstrated that the sweetness was,
indeed, due to sugar. From the time of the earliest recorded history of diabetes,
progress in the understanding of the disorder came slowly until the middle of the
19th century (MacFarland, 1991).
However, over these centuries gradually the course and complications of
the disease were recognised. Gangrene had been described by Avicenna, an Arab
physician, in about 1000 A.D. Its hereditary tendency was described ["Passed
with the seed"] as well as two general varieties, one with the classic acute
symptoms noted above [Type I or IDDM in today's terminology] and the other
with "torpor, indolence and corpulence" [Type II or NIDDM]. Within the past
century an association was established with a disturbance in the beta cells. These
islets were first noted in fish by Brockman early in thel9th century, but they bear
the name of Langerhans who described them in mammals in 1869. Soon after, the
German scientists, von Mering and Minkowski, found that surgical removal of the
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pancreas produced diabetes in the dog. At the turn of the century, an American,
Opie, noted the beta cells in the islets to be damaged in humans dying of the
disease. Finally in 1921 Banting and Best, Canadians, prepared active extracts of
pancreas which lowered the elevated glucose levels of diabetic dogs (Engelhardt,
1989).
1.2 DEFINITION
What is diabetes meffitus?. In generalisation, it is a grouping of anatomic
and chemical problems resulting from a number of factors in which an absolute or
relative deficiency of insulin and/or its function is present. It tends to run in
families; is associated with accelerated atherosclerosis, and predisposes to certain
specific microvascular abnormalities including retinopathy, nephropathy and
neuropathy. It doubles the risk of stroke, increases the risk for heart attacks 2- to
3-fold, and for peripheral vascular problems, particularly in the feet, 50-fold.
There are other problems, such as the lessening of resistance to infection,
especially if the diabetes is poorly controlled (Marble et al, 1985).
1.3 CLASSIFICATION AND TYPES
n mid-sixties a set of diagnostic criteria for diabetes was published
among others with wide variation both between and within countries (WHO,
1965). Since then and before 1978, a variety of descriptive terms were used to
classify diabetes, some based on the age of onset and others, the stage or the
degree of severity of the disease. Substantial differences in the diagnosis criteria
used by diabetes experts were also found (Wst, 1975) This leads to confusion
which hindered the assessment of data from studies of the natural history of the
disease and its complications. The NDDG [USA] then created a new
classification based on clinical or descriptive observations from epidemiologic
studies of large populations to provide uniform designations and a framework for
collecting investigative and epidemiological data on diabetes (NDDG, 1979). A
similar but more inclusive classification adopted by the WHO Expert Committee
on Diabetes Meffitus in 1980 (WHO, 1980) and modified in 1985 (WHO, 1985)
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has received general acceptance. Diabetes is subclassified as: Type I, insulin-
dependent diabetes mellitus [IDDM]; Type II, non-insulin dependent diabetes
mellitus [NTDDMI; malnutrition-related diabetes meffitus [MRDM]; and other
types of diabetes. Each category is described briefly below (Kareen et al. 1982).
IDDM or type I diabetes mellitus, which involves about 15 % of the
diabetic population, occurs primarily in young patients, but may be seen at any
age. It is usually characterised by an abrupt onset of symptoms, although present
evidence suggests that its evolution may involve an antecedent period of slowly
developing autoimmune damage to the pancreatic B cells (Leslie et al, 1989).
NTDDM or type II diabetes mellitus, which occurs in 80 to 85 % of the
diabetic population, is usually encountered in adults, but may occur in young
patients. NIDDM is recognised as having a strong genetic basis, as evidenced by
studies of identical twins and by familial transmission of diabetes in an autosomal
dominant inheritance pattern (Taylor, 1989).
Malnutrition-related diabetes mellitus is a clinical subgroup that included
in the WHO classification but not in that of the NDDG. It occurs predominantly
among young adults in tropical, developing countries. Distinctive clinical
features and course, and the great number of cases in certain regions, led to the
creation of this new major class of diabetes. Clinical studies have suggested the
existence of at least two subclasses: FCPD and PDPD (Abu-Bakare, 1986).
There were other types of diabetes mellitus which was formerly termed
secondary diabetes. This is a heterogeneous subclass that includes many specific
disorders that induce diabetes including pancreatic disease, hormones, drugs or
chemicals, certain genetic syndromes and insulin receptor abnormalities (Keen et
a!, 1982).
The designation of impaired glucose tolerance [1(11'] applies to individuals
whose plasma glucose concentrations after an oral glucose load lie between
normal and values diagnostic of diabetes (Albert!, 1980. The term iar avoids
the social, economic, and psychologic disadvantages associated with such
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formerly used designations as chemical, latent or subclinical diabetes. A detailed
account of IGT is found in Chapter two below.
Gestational diabetes mellitus occurs in approximately 2 % of pregnancies.
It is a consequence of the diabetogenicity of the gravid state in women with
marginal insulinogenic capacity; it generally reverts to normal following
parturition. If unrecognised or untreated, gestational diabetes may increase the
risk of perinatal morbidity and mortality (Hadden, 1986).
To identify the statistical risk classes for glucose intolerance, two
additional terms are used. These are not part of the diagnostic identifications for
patient records but are useful in research studies.
The term previous abnormality of glucose tolerance refers to individuals
with previous diabetes or ICT who regained normal glucose tolerance (.NDDG,
1979). Most frequently, individuals in this class include patients with former
gestational diabetes or acute hyperglycemia whose metabolic status has returned
to normal following appropriate treatment. These individuals are at increased risk
for developing diabetes with stress or weight gain.
The potential abnormality of glucose tolerance was formerly termed
prediabetes or potential diabetes and applies to individuals at substantially greater
risk for diabetes than the general population (WHO, 1980). The category includes
first-degree relatives of patients with diabetes, an identical co-twin of a patient
with IDDM or NIDDM, HLA-identical siblings, or islet-cell antibody positive
individuals. Also included are obese individuals and individuals who have
delivered a large infant.
1.4 DIAGNOSIS
Classic symptoms, fasting plasma glucose, elevated postprandial or
postglucose values and OGTT are the four diagnostic areas that will be
considered here. Criteria for the diagnosis of diabetes mellitus have been
developed by both the NDDG and the World Health Organisation based on data
from epidemiologic surveys in different parts of the world. These diagnostic
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standards provide a basis for uniformity in research and data collection. Further,
the plasma glucose concentrations now considered diagnostic of diabetes provide
better prediction for subsequent development of the specific complications of
diabetes than those in the previously recommended criteria (Shuman, 1988).
In clinical practice, suspicion of diabetes is gleaned from history and
physical findings. Symptoms such as fatigue, thirst, polyuria, weight loss, and
recurrent infection are frequent clues. A family history of diabetes, obesity,
unfavourable obstetrical experiences, premature atherosclerosis, neuropathic
disorders are indicators of probable diabetes mellitus. Urine glucose testing is
frequently performed as a screening test, but is not acceptable for diagnostic
purposes. A positive urine test can be a helpful indicator, but may give
misleading results during pregnancy because of increased renal blood flow or in
the presence of renal glycosuria. Patients with high renal glucose thresholds or
elderly patients with decreased renal blood flow may not have glycosuria in spite
of elevated blood glucose concentrations (Shuman, 1988).
In normal subjects, the upper normal limit of fasting plasma glucose is 6.4
mmol/l 115 mg/dl. Diabetes can be diagnosed reliably when fasting plasma
glucose concentrations are 7.8 mmolll [^ 140 mg/dl]. Immediate confirmation of
the diagnosis can be obtained by determining the glycated haemoglobin
concentrations simultaneously. If the glycated haemoglobin concentration is
greater than normal, the diagnosis is confirmed by an elevated ambient glucose
concentration preceding the fasting plasma glucose determination Otherwise, a
second diagnostic plasma/blood glucose is required on a second occasion in
asymptomatic subjects. With few exceptions, fasting plasma glucose values
correlate well with the rise in plasma glucose concentrations observed after a meal
or glucose load, although it is less sensitive and less specific for the diagnosis of
diabetes than the post-glucose load glucose (Shuman, 1988).
A two-hour postprandial plasma glucose concentration of '1 L. 1 mmol/l [ ^
200 mg/dl] or 10 mmol/l [^ 180 mg/dl] for whole blood may be indicative of
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diabetes if certain precautions have been observed. Because glucose utilisation is
impaired in persons consuming low-carbohydrate or weight-reduction diets, the
postprandial glucose test should be performed in those consuming unrestricted
diets providing greater than 150 g of carbohydrate daily for at least 3 days.
Additional precautionary measures include eliminating drugs that reduce glucose
tolerance, having individuals maintain normal physical activity, and avoiding the
test in ill or stressed persons. The test is most reliably performed using a standard
oral glucose load. In patients with liver or kidney disease, partial gastrectomy, or
thyrotoxicosis, an elevated postprandial plasma glucose may also be observed.
Diabetes can also be found in subjects with normal fasting values, although this is
unusual in clinical practice (Shuman, 1988).
The oral glucose tolerance test [OCilT] is the most sensitive test for the
diagnosis of diabetes. Without scrupulous care in standardising the test and
preparing the patient, however, the OGTT can be misleading since some factors
can interfere with normal glucose tolerance and result in a hyperglycemic curve.
This test is not required for diagnostic purposes when the fasting plasma glucose
is unequivocally elevated. The OGTT as adopted by the WHO requires two
plasma glucose values; fasting and 2-h after a 75 g glucose load. The intervening
samples at ½, 1, and 1½ hours are not used. The scheme provides a simple and
accurate method for obtaining a diagnosis criteria. There is insufficient evidence
from the available studies to justify the use of the more complicated NDDG
criteria. Both sets of diagnostic criteria specify that a fasting plasma glucose ^ 7.8
mmol.l [^ 140 mg/dl] and/or a 2-h of 11.1 mmol/l [^ 200 mg/dl] are diagnostic of
diabetes meffitus in the nonpregnant adult (WHO, 1985; Harris et al, 1985). If
only the 2-h value is elevated, then a second test is required for confirmation. The
latter value represents the concentration observed in the bimodal distribution of
two-hour plasma glucose in epidemiological studies, and is the glucose
concentration at which characteristic microvascular lesions such as diabetic
retinopathy appeared in such studies (Shwnan, 1988).
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1.5 PREVALENCE
The prevalence of NIDDM varies greatly between population and it is 6.6
in the USA in persons aged 18 ys and over which increases with age, and the
frequency in females slightly exceeds that in men( Harris et al. 1987) . The
highest prevalence (and incidence) of NTDDM in the world has been described
among the Pima Indians of Arizona where the age-adjusted prevalence rate is at
least 10 times as high as in the general US population. In contrast, other Native
Americans, such as Eskimos were reported to have the lowest prevalence rates in
the world (Bennett, 1990).
Large variations in the prevalence of NIDDM are also found in other
countries (Zinvnet, 1982). Very low rates occur among Melanesians from Papua
New Guinea and in Australia rates of 3.4% are reported among Caucasians aged
25 years and over. In a series of studies among Pacific Islanders using WHO
criteria, Zimmet and his colleagues have shown that the prevalence of NIDDM in
persons aged 2Oyears or over varies from 2.9% in Polynesians living in a very
traditional manner on the island of Wallis, to 12% in persons who had migrated
from Wallis to New Caledonia. Among Micronesians in the same age range,
rates vary from 3.6% among those living in a relatively traditional manner in the
Island of Kiribati to 9 % in those living in the most urbanised island of that
country (King et al, 1984). Immigrants from the India sub-continent show a
prevalence of 5 to 15% world-wide (Ekoe, 1988).
1.6 INCIDENCE OF NIDDM
Only a few studies of the incidence of NIDDM using standardised and
comparable methodology have been performed (Bennett, 1990). The most
satisfactory method to determine the incidence of NIDDM is to study a specific
population by testing glucose tolerance at two separate points in time and then
estimating the cumulative incidence within the period between the examinations.
Such studies have been performed in the Pima Indians of Arizona and among
Micronesians in the central Pacific Island of Nauru. The incidence of NIDDM in
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the Pima was compared to that of the predominantly Caucasian American
population in Rochester, Minnesota, 19 times that of the Caucasian population.
A high incidence of NIDDM has also been found in the population of Nauru.A
less desirable, but less difficult method of estimating the changes in the incidence
of NIDDM was used to examine whether there has been a secular increase in the
disease in the general population. The incidence of diabetes has risen
considerably in the USA and there are also indications that the prevalence of
NIDDM has increased in England during the last 20 years (Bennett, 1990).
1.7 MORTALiTY
Many studies of mortality in diabetes have made no distinction between
the major forms of the disease. Furthermore, underreporting makes accurate
assessment of the impact of diabetes on mortality and life expectancy impossible if
only death certificates are available. In spite of underreporting, diabetes ranks as
the seventh leading cause of death in USA (Finch et a!, 1988).
Several prospective studies have documented excessive risks of
cardiovascular death among diabetics compared to nondiabetic. In each instance
the incidence of cardiovascular death was increased among the diabetics, and in
each the relative risk for women exceeded that of men, but the absolute risk of
ischemic heart disease mortality among diabetic men was greater in several of
them. Overall mortality and cause-specific mortality were determined from a 9-
year follow-up of men and women aged 44-77 in U.S.A survey. All cause age-
adjusted mortality rates were more than twice as high in diabetic men and women
than in the corresponding nondiabetic groups, with most of the increase
attributable to cardiovascular disease. Ischemic heart disease was 2.8 times as
frequent in men and 2.5 times as frequent in women. Ischemic heart disease
counted for approximately one-half of the deaths among diabetic men and one-
third of those among diabetic women. Other cardiovascular disease (including
renal disease) deaths were 2.34 and 1.93 times as frequent in diabetic men and
women, respectively. Noncardiovascular causes accounted for 26% of the excess
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of deaths among diabetic men and 22% among women. The risk of death
increased with increasing duration of diabetes. Thus, each additional 10 years of
diabetes was associated with a 24% increase in risk for cardiovascular disease
death.
Excessive mortality among diabetics has also been found among the Pima
Indians among whom diabetic nephropathy accounted for about 25% of the deaths
among diabetic, whereas ischemic heart disease, while much more common
among the diabetics, accounted for a much lower proportion of the diabetic
deaths. In Nauru the age-standardised mortality among diabetic men and women
was increased approximately four-fold over that of the population with normal
glucose tolerance (Finch et al, 1988). Large variations in mortality among
diabetics from different countries have been found, with much higher mortality
rates in Western Europe (jredominantly cardiovascular disease) than in Hong
Kong and Japan (primarily renal disease). This study is notable insofar as
hypertension emerged as one of the most predictive factors for increased mortality
among diabetics after adjustment for age, sex, and duration of diabetes.
Proteinuria is a strong predictor of mortality in NTDDM. It was shown that
abnormal albumin excretion at levels below those normally detected by dipstick
predict higher mortality rates including higher rates of cardiovascular and renal
disease. Among the Pima Indians proteinuria is associated with virtually all of the
excess risk of mortality that is attributable to NTDDM (Finch et at, 1988).
1.8 MORBIDITY
Macroangiopathy:
Atherosclerosis is more severe and starts earlier than in non-diabetics.
Due to this accelerated atherosclerosis diabetics have a markedly increased risk of
myocardial infarction, cerebral stroke and gangrene of the legs. Thken together,
the various macrovascular complications account for about 75% of all deaths in
diabetes. How diabetes contributes to the complex process of atherogenesis is
unclear. Factors that may play a role are hypertension [one of every two adult
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diabetics is hypertensive], hyperlipidaemia and hypercholesterolaemia, sorbitol
accumulation in cells of the vessel walls and altered platelet aggregation (Marble,
1985).
Microangiopathy:
The most powerful risk factor for diabetic microangiopathy is degree and
duration of hyperglycaemia. Ethnic differences seem to play no role. Although
the exact biochemical mechanism linking sustained hyperglycemia, basement
membrane thickening and disturbed vascular function are not yet fully
understood, there is good evidence that an increased nonenzymatic glycation of
proteins induces diabetic microangiopathy (Marble, 1985).
Diabetic microangiopathy affects the glomerular and retinal capillaries in
particular, resulting in glomerular sclerosis and retinopathy. About 90% of all
adult diabetics show minor signs of diffuse and/or nodular (Kimmeistiel-Wilson)
glomerulosclerosis after 15-20 years duration of the disease without any
significant clinical symptoms, except slight proteinuria. In about 10% of the adult
diabetics and 50% of the juvenile diabetics an accelerated course of
glomeruloscierosis occurs, usually associated with hypertension, proteinuria and
renal insufficiency. Forty to 50% of Type I diabetics with an onset of their
disease before 15 years of age die of renal insufficiency. Among all diabetics
nephropathy accounts for about 9% of deaths and is thus the second leading cause
of death after myocardial infarction (Marble, 1985).
As with diabetic glomerulosclerosis the rate of diabetic retinopathy is
closely related to the severity and the duration of diabetes. Retinopathy starts
with the development of microaneurysms, macular oedema, periodic acid-Schiff
(PAS)-positive lipid exudates (hard waxy exudates), haemorrhages, and gray-
white microinfarcts (cotton wool spots). The nonproliferative stage is followed
by proliferation of new small vessels and fibrous tissue, probably due to retinal
anoxia, within and on the inner side of the retina. In the end stage of proliferative
retinopathy adhesions between the newly developed fibrovascular tissue on the
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retina and the vitreous body induce traction, retinal detachment, and ultimately
blindness. A similar process may concomitantly affect the iris resulting in
glaucoma. Cataract formation, on the other hand, is directly related to the
disturbed glucose metabolism in the lens that leads to sorbitol accumulation.
Diabetic polyneuropathy appears in different forms, the most common
being the bilateral distal sensorimotor syndrome (Symmetric peripheral
polyneuropathy) affecting symmetrically the nerves of the lower extremities.
Other forms of diabetic neuropathy include mononeuropathy, amyotropy, and
dysfunction of the autonomic nervous system (Marble, 1985).
Infections, which in the preinsulin era played a significant role in the
natural course of diabetes, are nowadays of minor significance for the diabetic.
Infections most often affect the skin [candida albicans], the urinary tract and the
kidney [pyelonephritis with and without necrotizing renal papiffitis]. Necrobiosis
lipoidica is a rare skin disease closely related to diabetes. It usually develops after
diabetes has been present for years, but in some patients it may precede clinical
diabetes (Marble, 1985).
1.9 NIDDM
NIDDM is one of the most important non-communicable diseases in the
world, with a prevalence ranging from less than 2% in rural India to as much as
30% in certain American Indian and Pacific Island populations (Zinvnet, 1982).
The disease generally presents in middle life and is diagnosed either as an
incidental finding or following presentation with thirst, polyuria and recurrent
infections. It is a cause of substantial morbidity and mortality, frequently due to
atherosclerotic complications, and in certain developing countries is assuming
equal importance to infectious diseases. It is widely assumed that NIDDM has a
multifactorial aetiology in which the role of environmental factors is to hasten the
progression of NIDDM in a genetically predisposed individual (Zimmet, 1982).
The next few paragraphs discuss these factors briefly.
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1.9.1 Role of genetics:
The genetics of diabetes is perhaps no longer a nightmare but still a
headache (Keen, 1987). The importance of the genetic contribution to NIDDM
has been established by the study of certain inbred populations, the almost 100%
concordance of disease in monozygotic twins and by familial clustering. The
study of inbred populations has suggested that the genetic component of NIDDM
is due to a single gene inherited in an autosomal dominant fashion (Hitman et al,
1991). Progress in identifying specific genetic factors involved in NIDDM has
been slow and no consistent evidence has emerged supporting a major aetiologcal
role for any of the genes so far studied. This may be due in part to
methodological problems encountered in the identification of such disease
susceptibility genes. Less well known is the mode of inheritance of NIDDM
genes, how many genes may contribute to the disease, and the way in which they
may interact. Further, not one of the genes that contributes to NIDDM has been
identified. This lack of knowledge is largely attributable to the nature of NIDDM.
Family studies suggest a strong genetic component in the aetiology of NTDDM,
with evidence for a major gene of co-dominant effect. A gene-dosage effect,
whereby diabetes develops earlier in people with two susceptibility genes than in
those with one susceptibility gene is likely (Serjeantson et a!, 1991). The search
for the diabetes gene has led to the cloning and characterisation of many genes
involved in controlling glucose homeostasis. These include the insulin, insulin
receptor, glucose transporter, amylin and glucokinase genes. Molecular
techniques have permitted rapid screening of these genes in NIDDM patients and
controls. Finally, there is now a rather contradictory genetic literature for
NIDDM, with weak disease associations reported and refuted for most candidate
genes (Serjeantson et a!, 1991).
1.9.2 Environment:
Environment has been described epidemiologically as 'all that which is
external to the individual human host' (Last, 1983). This definition encompasses
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not only such concepts as physical and biological agents but also less measurable
and direct-acting influences such as social and cultural forces and the behavioural
tendencies of individuals. It has also been traditional to consider certain
characteristics of the host, such an anthropometric indices, and also immutable
factors, most particularly subject's age, under the broad heading of environmental
influences (Wst, 1978; Zinvnet, 1982). The following factors are those which are
currently suspected of being precipitants of NIDDM.
1.9.3 Ethnicity:
The prevalence and incidence of NIDDM varies widely among different
ethnic groups (Bennett, 1990). American Indians are at particularly high risk,
although the rates vary widely according to tribe. Mexican Americans have rates
of NIDDM that are two to three times greater than those of USA population, an
increase that has been attributed in part to their heritage of American Indian
genes. In the USA the rates are also high in persons of Pacific Island origin,
particularly among Polynesians. Also in USA, persons of Japanese heritage have
rates of NIDDM that are appreciably greater than in the Caucasian population. In
many parts of the world Asiatic Indians have rates of NIDDM that exceed those
of the native population. High prevalence rates in Indians relative to those of the
majority population of the country have been described in Mauritius, Thnzania,
South Africa, the Carribean [Trinidad], Fiji, and the United Kingdom (Taylor et
a!, 1983). Furthermore, diabetes appears to be relatively frequent in Polynesians,
who now live in more westernised surroundings and the Australian aborigines
living in urban environments also have much higher rates of NIDDM than the
remainder of the Australian population (Bennett, 1990).
1.9.4 Obesity:
The association between obesity and NIDDM has long been recognised,
and while NIDDM is more frequent among obese persons, it is also clear that not
all the obese, even the very obese, develop NIDDM. Obesity may, therefore, be a
frequent precipitant of NIDDM among those who are otherwise susceptible to its
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development, and NIDDM may develop among persons who are not obese. Many
studies of the incidence of NIDDM have demonstrated a relation with obesity and
the risk is related to the duration, degree and distribution of obesity (Horton,
1990).
The risk of developing NIDDM in relation to obesity is a function of the
underlying susceptibility to the disease and the evidence of the interaction of
genetic susceptibility and obesity first came from one of the earliest follow-up
studies of diabetes epidemiology conducted in Oxford, Massachusetts (O'Sullivan
et al, 1965). They found that the appearance of NIDDM was more frequent
among the obese when there was a history of diabetes in a parent than when there
was no parental history. In addition, among Pima Indians who have at least one
parent with NIDDM the incidence is much more strongly related to obesity than
among persons of similar degrees of obesity in whom neither parent has NIDDM
(Zinvnet, 1982). In support to this observation, a recent report showed that the
duration of obesity increases the incidence of NIDDM in Pima Indians (Everhart
et al, 1992).
The late Dr Kelly West suggested that the maximum attained body weight
at age 25 years was one of the strongest predictors of the occurrence of NIDDM
in later years and those who became obese only in late middle age had a much
lower risk of developing the disease than those who had been of a similar degree
of obesity throughout their adult years (Vst, 1978). Thus, the risk of developing
diabetes appears to be a function of both the extent and duration of obesity.
Not only the presence of obesity, but its distribution within the body,
central or truncal, determines the incidence of diabetes. Data from Gothenberg,
Sweden, have shown among males that there is a striking relation between BMI
and the risk of developing diabetes. However, when BMI is subdivided according
to the ratio of WHC, those with larger WHR for a given BMI have a much higher
risk of NI1)DM (Migue, 1988). Thus, there is no question that obesity is a major
risk factor and perhaps, the most important factor that is amenable to change.
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1.9.5 Diet
Diet has long been believed to play a role in the development of diabetes
and the idea that excessive caloric intake could increase the frequency of the
disease and conversely that caloric deprivation could reduce it was reinforced
several times (West, 1978). Diabetes mortality rates decreased in countries that
experienced food shortages during World War I and World 'War II, whereas the
rates were relatively unchanged in countries where the food supply was
unaffected. However, cross-sectional or case-control studies have failed to
document any convincing relation between dietary intake and NIDDM (Ekoe,
1988). Based on studies of diabetes prevalence in several populations, West
showed that obesity was closely correlated with the prevalence of diabetes, but he
was unable to find any evidence that calorie intake or individual components of
the diet, independent of obesity, were implicated in its pathogenesis (1st, 1978).
Studies of migrant populations suggest that diet may play a role in the
development of the disease. Most of the studied populations, as in the Pacific,
that have migrated from a traditional environment who now have higher
prevalences of diabetes than are found in their countries of origin, consume diets
that are at least as high in calorie content and that contain much higher quantities
of refined carbohydrates, e.g., rice, flour, and sugar, than in the traditional
environment. Such populations, however, develop obesity and their level of
physical activity is usually decreased (Taylor et al, 1983). Similarly, among the
Japanese subjects residing in Hawaii, for example, the prevalence of N]DDM is
twice that found in Hiroshima, but the caloric consumption was no different, yet
the Hawaiian Japanese consume approximately twice as much fat, one-third less
complex carbohydrate, and almost three times as much simple carbohydrate as
their counterparts in Hiroshima.
Of the few attempts to perform prospective studies on the relationship
between the risk of developing NTDDM and dietary intake, in one there was no
effect of diet or its components on the incidence of men with diabetes. By
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contrast, a significantly increased carbohydrate and starch consumption was found
among 87 subjects who subsequently developed the disease and only total and
complex carbohydrates showed a significant relation to the incidence of the
disease (Ekoe, 1988). Total calorie intake is greater among persons who
subsequently develop diabetes, but whether the effect of dietary intake on the
incidence of diabetes are the result of obesity or diet is unknown. Although
sucrose intake has been suggested as a factor in the development of NIDDM,
based on the observation of higher sucrose intakes in some populations with high
rates of diabetes, there is no convincing epidemiological evidence at this time that
sucrose per se is a risk factor for the disease (Mann, 1987).
The effects of dietary intervention [reduction of total caloric and
carbohydrate intake] on the incidence of NIDDM among subjects with IGT
(Sartor et a!, 198G.), suggest that advice to moderate the diet may have an effect
on the incidence of diabetes. In view of this, additional prospective studies of
dietary intervention among groups of subjects at risk of developing NIDDM are
required.
1.9.6 Physical activity
Physical activity influences glucose metabolism, since well-trained
athletes, have less glycaemia after a glucose load and insulin responses are
diminished compared to untrained persons of similar weight. Conversely,
profound physical inactivity, eg, bedrest, is associated with the development of
abnormal glucose tolerance and higher insulin levels. These observations suggest
that physical activity influences insulin resistance (Horton et a!, 1988).
There are few epidemiological studies of the relation of NIDDM to
physical activity. The prevalence of diabetes, in Fiji, was twice as high in those
with the lower degrees of physical activity and, while suggestive of a protective
effect, the amount and degree of physical activity needed to achieve protection
from NIDDM is unknown (Taylor et a!, 1984). Similar results have been found
recently in the cross-sectional study from Mauritius (Dowse et a!, 1991) and in the
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prospective study from Malta (Schranz et al, 1991).
PATHOGENESIS
From the foregoing discussion it is clear that little can be stated definitely
about the aetiology of NIDDM except that it has a strong genetic basis. It is
therefore appropriate to consider the pathogenesis of the syndrome in order to
trace back the individual processes or mechanisms which must be initiated by
aetiologcal factors as yet unrecognised. It is clear that both impaired j3-cell
functions and insulin insensitivity are consistent features of NIDDM but the
question of which defect is primary in the aetiology of NIDDM has caused much
controversy (Feldman, 1988).
1.9.7 Insulin sensitivity:
NIDDM subjects increase glucose utilisation, during insulin infusion, by
only 30% compared with 300% in normal subjects, since, subjects in the earliest
detectable phases of NIDDM show, similar but less marked changes and
restoration of normoglycaemia has only a minor effect in ameliorating the insulin
insensitivity. Moreover, the insulin insensitivity is marked in muscle and adipose
tissue but is also present in liver (Taylor, 1989).
The mechanism of the insulin insensitivity has been intensively
investigated largely on insulin receptor number and affinity using blood cells and
careful study of a more appropriate cell type (adipocytes) from NIDDM subjects
has shown insulin receptor binding to be normal despite subnormal insulin
sensitivity. It is not appropriate to extrapolate findings from one cell type to
another such as muscle which plays a much greater role in vivo in the uptake of
glucose after an insulin stimulus, but these experimental data along with others,
are important in demonstrating that minor changes in insulin receptor number or
affinity are neither necessary nor sufficient to produce cellular insulin
insensitivity.
Transmission of the insulin signal across the insulin receptor, which is a
transmembrane glycoprotein approximately 80-fold larger than the insulin
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molecule, involves a series of unidentified steps. Similarly, transmission of the
message to the enzymes which mediate the actions of insulin is not yet
understood. The discovery of tyrosine kinase moieties on the intra-cellular
portion of the insulin receptor has raised hopes that this may represent a link in
the chain of events in signal transmission which could be subject to regulation,
control of kinase activity thus underlying changes in cellular insulin sensitivity.
Although there is a considerable evidence for this, anti-receptor antibodies may
initiate insulin action without affecting the kinase and, in some experimental
models of insulin resistance, insulin receptor kinase activity is unaltered. The
observation that insensitivity to insulin action is not exhibited by all insulin
responsive pathways within one cell type or by all metabolic effects of insulin in
vivo suggests that the insulin signal is transmitted via branching pathways after
insulin binds to its receptor (Taylor, 1989).
NTDDM is not merely a disorder of carbohydrate metabolism, since there
are prominent associated disorders of lipid metabolism. Several studies have
demonstrated that a part of the measured insulin insensitivity in NIDDM with
respect to glucose disposal results from metabolic competition between
nonesterified fatty acids and glucose. This increases the number of ways in which
insulin insensitivity may be influenced by genetic regulation, the used polygenic
effects being mediated not only by aspects of islet and insulin receptor function
but also by aspects of lipid metabolism (Erkelens, 1988).
1.9.8 Insulin secretion:
The normal human pancreas contains approximately 200 units of insulin,
and in patients with NIDDM diabetes, the pancreas has variable reductions in
insulin. Generally, postprandial insulin responses are decrease relative to
circulating glucose concentration, but absolute plasma insulin concentrations may
be decreased, normal, or even increased. Commonly, in patients with only
moderate or severe diabetes, sluggish insulin release immediately after a meal
leads to rapid increases in plasma glucose concentrations; later, with intense
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stimulation of insulin secretion from marked hyperglycaemia, circulating insulin
concentrations may be greater than normal. In general, however, patients with
advanced hyperglycaemia [fasting plasma glucose >300 mgldl (16.6 mmol/l)]
have reduced postprandial insulin secretion (Feldman, 1988).
The major feature of insulin secretion which characterises NIDDM is the
impaired or absent first phase insulin response. This appears to be closely related
to the loss of normal basal pulsatile insulin release, which may be produced in
normal subjects by infusing somatostatin. These abnormalities of dynamics of
stimulated insulin release must be distinguished from the day-long
hyperinsulinaemia that is seen in many NIDDM subjects. This may be a response
to the ambient hyperglycaemia or to insulin insensitivity or to both of these
factors. However, lowering of blood glucose by whatever means shows a partial
recovery in the ability of pancreas to respond to stimuli. Some sub-types of
NIDDM may never exhibit hyperinsulinaemia as evidenced by the observation of
low insulin response in the non-diabetic co-twin of identical twins discordant at
the time for diabetes. NIDDM, also characterised by a slow time course of
progression, insulin insensitivity and response to suiphonylureas for a period of
time, is not produced by a simple decrease in beta cell numbers alone.
The notion of 'pancreatic exhaustion' has been evoked in an attempt to
explain how insulin resistance may lead to secondary failure of insulin secretion.
There is no evidence that subjects without a genetic disposition to islet
malfunction ever exhibit such a phenomenon, and examination of subjects with
extreme insulin resistance due to insulin receptor blocking antibodies
demonstrates that the normal pancreas can sustain enormously elevated rates of
insulin production over many years (Taylor, 1989).
The pancreas may be smaller than normal in NIDDM and decreased
exocrine function is associated with fibrosis of the exocrine tissue. Within the
normal islet, cells producing insulin, glucagon, somatostatin and pancreatic
polypeptide are in close proximity and defined spatial relationships. This allows
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effective paracrine control of one cell type by another. In this respect the
approximate doubling of alpha cell numbers of NIDDM is of interest. The
histological finding is corroborated by hyperglucagonaemia in both established
NTDDM subjects and their offspring. The role of somatostatin within the islet is
unclear but changes in the relative proportions of the cell types or their position
within the islet could affect insulin secretion profoundly. Beta cell numbers are
only moderately decreased, perhaps up to 50 %, and this contrasts with the
requirement for a 90% pancreatectomy in animals or man to produce
hyperglycaemia (Taylor, 1989).
Amyloid deposition in the islets occurs in at least 50% of NTDDM subjects
and in some accounts for 90% of the islet volume. A novel peptide, islet amyloid
polypeptide has recently been identified which appears to be produced by beta
cells of normal and NIDDM subjects, but is incorporated into amyloid almost
entirely in the latter. This form of localised amyloidosis which occurs only in
relation to insulin producing cells may reflect a cellular dysfunction in NIDDM.
1.10 CONCLUSION
NTDDM has a strong genetic basis, autosomal dominant in some isolated
populations but more usually polygenic in nature. The major environmental
factors involved in the aetiology of NTDDM remain uncertain, and at the present
time, these cannot be regarded as primary factors. Disturbance of insulin
secretion and insulin action are necessary in the genesis of the syndrome, and
NIDDM cannot occur in the absence of /3-cell dysfunction. There is no evidence
that insulin insensitivity per se can initiate /3-cell damage although it is uniformly
present from very early in the development of the syndrome and is important in its
pathogenesis.
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SUMMARY
After almost 2000 years we are beginning to have some biochemical understanding of
diabetes and over the past 15 years it has become evident that diabetes is a heterogenous chronic
disease and both IDDM and NIDDM are real and increasing problems worldwide. Emerging from
this heterogenity is the recently recognised Impaired Glucose Tolerance [lOT] class, which lies
between normality and abnormality of the diabetic syndrome spectrum. This brief account
discusses JOT category from two main aspects; namely epidemiology and metabolism as far as
possible. The literature since 1980 usually refers to this group as IGT while before that it was
chemical, latent or borderline diabetes.
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CHAP'fER TWO:	 IMPAIRED GLUCOSE TOLERANCE
2.1 HISTORICAL BACKGROUND
Over 100 years ago it was recognised that at least two forms of diabetes
existed, clinically, in man, one characterised by obesity and the other occurring
usually in younger persons of even subnormal weight. Later on, attempts were
made to classify diabetes as either primary or secondary. Primary diabetes was
then subclassified according to the age of onset of the disease; to the therapeutic
response; to the stage in natural history of the disease; to insulin secretory status
or therapeutic requirement; to the predisposition to develop ketosis; or according
to the degree of glucose intolerance (Bennett, 1983). All of these are alternative
approaches that have been taken, but the most logical approach to classification of
the group of disorders which constitute diabetes mellitus would be a classification
based on the pathogenesis of the disease and, in most instances, however, this is
not known, and no classification until now is completely satisfactory (Ellenberg et
a!, 1983). Accordingly, wide disagreement and a confusing literature failed to
give rise to a single classification scheme or definition of terms.
To narrow this gap and to lessen this confusion the WHO Expert
Committee in their first report (WHO, 1965) introduced a classification of patients
according to age of recognised onset. Asymptomatic, sub-clinical or chemical
diabetes also appeared to define a person with a diabetic response to the OCTlT
whose fasting capillary blood sugar was below 130 mg/lOO ml. Since then, a
considerable growth in knowledge about the various forms of diabetes has
occurred, research had brought to light several pathogenic mechanisms leading to
diabetes and long-term follow up studies had provided evidence of differing
courses and outcomes.
This new information has led several international groups of EASD (Keen
et a!, 1979), NDDG (NDDG, 1979) and WHO (WHO, 1980, to review the
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classification of the disease and introduce valuable comments and suggestions.
The rationale for this new categorization was that there was a substantial group of
individuals who showed 'abnormal glucose tolerance' at a level that was
considered insufficient to classify them as diabetic. Even so, they were at high
risk of developing macrovascular disease and of progression to diabetes. This
category , also satisfied a need for defining a level of glucose intolerance that was
not clearly normal but that was also not sufficiently severe to predict
microvascular disease, particularly retinopathy, in prospective studies. In
December 1979 the NDDG declared the birthday of the term IGT as an
independent category which shortly thereafter was adopted by WHO.
Further justification for the consideration of IGF as a discrete entity has
come from the second US national Health and Nutrition Examination Survey
(Harris, 1989). Here individuals with IGT had rates of risk factors for NTDDM
[age, plasma glucose, past obesity, family history of diabetes, physical inactivity]
that were intermediate between those with NGT and those with diabetes, although
current obesity levels were similar for IGT and diabetes.
2.2 DEFINITION and TERMINOLOGY
The state of 1(11' is defined as "a glycaemic response to a standard glucose
challenge intermediate between normal and diabetic" (WHO, 1985). The
introduction of IG class in 1980 replaced the confusing terms of asymptomatic
diabetes, borderline diabetes, chemical diabetes, glucose tolerance test diabetics,
latent diabetes and subclinical diabetes; that had been used previously in the
literature to describe mild degrees of glucose intolerance. Moreover, this term,
unless a less ambiguous term found, would be strongly retained for the time being
to define the post 75g glucose levels, as in the WHO recommendations (Alberti,
198(1). Glucose intolerance implies both classes of abnormal glucose tolerance,
diabetes meffitus and IGI.
Recently, some studies however, have cast doubt on the concept of IIGT,
both because of its ephemeral nature (Riccardi et al, 1985; Glatthaar et al, 1985;
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Forrest et al, 1988) and as a consequence of doubts about whether it warrants
categorisation as a separate entity (Jarrett, 1987).
2.3 CLASSIFICATION and HETEROGENICITY of IGT
The IGT subclass remained in the most recent version of the WHO
classification (WHO, 1985), since its appearance, and formed with diabetes
meffitus and gestational diabetes the clinical class. The JUT category, similar to
diabetes mellitus, is further subdivided into primary, whether obese or non-obese,
and secondary, which is associated with certain conditions and syndromes. The
class of IGT is also heterogeneous because of both the distribution of patterns of
glucose intolerance in populations and the variability of the test employed to
characterise glucose intolerance in individual people.
Recently, the new concepts of JUT which was based on the phenomenon
of bimodality of plasma glucose distribution, suggests that JUT category consists
of three entities (Stern et a!, 1985). (i) 'JUT Normals' are subjects classified as
JUT but are normoglycaemic situated in the upper distribution of the normal
range; (ii) 'False Negative' are the subjects having diabetes but their OG1'T
values do not exceed the currently accepted NDDG or WHO cut-off points
because of the overlap between the normal and abnormal range; and (iii) 'JOT in
Transition' are the subjects who are truly in transition from normal to diabetic.
When a population is examined cross-sectionally, only a minority of lOT subjects
belong to the third category while in longitudinal studies, the cumulative
percentage of individuals passing through this stage would be much larger. These
three categories of JOT cannot be distinguished on the basis of their OUr!' values
and such a differentiation, however, will have to await the development of a
definitive marker(s) for the prediabetic state. Moreover, even "transient" 1(71' is
associated with an increased risk of deterioration to diabetes (Saad et al, 1988).
Bimodailty implies that the transition state between normal and diabetic is
relatively short. Decompensation occurs relatively rapidly over a period of two
years or less in Pima Indians (Knowler et a!, 1978) while other studies have
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reported lower cumulative decompensation rates (King et al, 1984; Keen et al,
1982; O'Sullivan et al, 1968). As seen in Fiji (Covently et al, 1986) and Kiribati
(Collins et al, 1984), the cut-off point defining diabetes in the distribution of
plasma glucose concentration may vary between populations of different ethnic
origins further supporting the theory of ICTF heterogeneity. It is therefore likely
that the IGT subjects who later develop cardiovascular disease are from the 'False
Negative' and 'IGT in Transition' categories and not from the ;IGT Normals;
(Stern et al, 1985).
2.4 BIMODALITY PHENOMENON
Biomodality of plasma glucose distributions has been reported in Pima
Indians (Bennett et al, 1976), Micronesians (Zimmet et a!, 1978) and Polynesians
(Raper et a!, 1984) who are relatively isolated genetically and have a high
prevalence of diabetes. Bimodality has also been reported in Mexican Americans
(Rosenthal et a!, 1985), a population which is more than 50% Caucasian, much
larger and genetically less isolated. These findings therefore suggest that
bimodality may be much more generalised to include other populations such as
Caucasians and Blacks (Motala et a!, 1987) but difficult to detect because of
much lower prevalence of diabetes and the second mode (Stern et a!, 1985).
Rushforth et al estimated that a prevalence of at least 10% was necessary
to see bimodal distribution (Rushforth et a!, 1971), though it has been found in a
population with a prevalence of diabetes of 6.7% (Raper et al, 1984). It was also
suggested that in the populations displaying bimodality the nadir between the two
modes may be higher than 11.1 mmol/l, the two hour blood glucose concentration
used to define diabetes mellitus (Stern et a!, 1988). Whether this is also the case
for the threshold for microangiopathy is not clear.
2.5 DIAGNOSIS and CRITERIA
The United States Public Health Service (USPHS), the Fajans and Conn
criteria, and the Mosenthal and Barry criteria were the three commonly accepted
diagnostic criteria by the year 1965. Since then, agreement and discrepancy in the
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evaluation of normal and diabetic OGfl has been hotly discussed. Subsequently
15 years later, another three sets of criteria were proposed, EASD, NDDG and
WHO in order to achieve a standardization in classification, methodology and
diagnostic criteria for the diagnosis of glucose intolerance. However there are
certain differences between the NDDG and the WHO recommendations. The
NDDG criteria for diabetes and for JUT require that the ½ hr, 1 hr or 1½ hr plasma
glucose value exceed 200 mg/dl. This is not a requirement of the WHO criteria.
This requirement creates a group of subjects with nondiagnostic OCTVl, many
of whom would be classified as IGT by the WHO criteria. The WHO
recommendations pointed out specifically against the overuse of the OGfF and
state that a fasting venous plasma glucose values of less than 100 mg/dl or random
glucose values of less than 140 mg/dl are sufficient to exclude the diagnosis.
Afterward, imprecision of these criteria for the OGTT had been
questioned when these were compared with 7 other previous sets (Massari et al,
1983). They found a major redistribution of a symptomatic subject in the 3
categories of glucose tolerance with a lower percentage of diabetesN and
normal subjects and a higher percentage of UICTF subjects. A third of their
population (33%) could not be classified into the three categories of glucose
tolerance using NDDQ criteria; 20% were 'Nondiagnositic and 13% could not be
classified. However, this does not occur when using the WHO criteria. Later, it
was shown that the omission of the mid-test value only makes a small difference
and of the 3.6% of persons who were diagnosed as having diabetes by WHO
criteria; 9.4% also had diabetes according to NDDG criteria (Harris et al, 1985).
However, the NDDU requirement for the mid-test value resulted in 11.3% of the
OUTTh being non-diagnostic, whereas all were classified according to WHO
criteria. This study supports the use of WHO criteria.
The NDDGIWHO difference have more relevance with respect to the
diagnosis and prevalence of JUT. The prevalence is generally lower with the
NDDG criteria due to a substantial proportion being non-diagnostic due to the
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lack of an elevated mid-test value. In the US population, if the intervening value
between 0 and 2-h is not imposed, the number of people with IGT is more than
doubled (Harris et al, 1987). Also the proportion of Nisei men with IGT is
increased by only 40% with the WHO criteria and the NDDG criteria led to a very
high prevalence of non-diagnostic class (Fujimoto et a!, 1987). Thus, the WHO
protocol is the most internationally accepted one (WHO, 1980)).
ICT category can only be defined by using the ocrr which is principally
used, nowadays for diagnosis when blood glucose levels are equivocal, during
pregnancy, or in an epidemiological setting to screen for diabetes and IGT. At
present IGT is rarely diagnosed in the clinical setting, perhaps because of its
recent introduction as a glucose tolerance class and lack of knowledge of its
clinical significance (Bennett, 1983). Moreover, both short-term (Riccardi et a!,
1985; Ganda et a!, 1978) and long-term (King et a!, 1984; Keen et a!, 1982)
studies have shown that IGT is an acutely unstable state and the OGrF is a test
with very poor reproducibility. In one of these studies (Riccardi et a!, 1985) only
56 % of the subjects with IGT at the start of the study showed persistent
intolerance 2-4 months later.
The values for diagnosis of IGT include a fasting blood glucose below a
cut-off level and two-hour post glucose blood values within a defined range. The
upper end of this range is defined by the lower level of the range for diabetes. It
is worth noting that the fasting glucose cut-off value was arbitrarily chosen and
recent work suggested that it was set too high (Saad et a!, 1988; Finch et al,
1990). For epidemiological studies, it is recommended that diagnosis be based on
the results of blood glucose 2-h after a 75g OGTT, since it is not possible to
ensure the fasting state in all subjects and the diagnosis of JOT cannot be made
without the glucose load (WHO, 1985). In addition the fasting value used to date
lacks sensitivity.
In epidemiological studies where the prevalence of lOT and diabetes are to
be assessed, WHO considers that a single elevated 2-h post OGrI' blood glucose
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is sufficient for the diagnosis of diabetes (WHO, 1985). In cross-sectional studies,
misclassification of people does not matter provided it occurs equally in both
directions so that the resulting prevalence is not changed (Fletcher et ci, 1982).
However, this has to be considered with caution. In longitudinal studies, the
different rates of progression from IGT to diabetes may, in part, be due to
different spectra of blood glucose distribution within the ICTF category (Jarrett,
1987).
For diagnostic screening, only the full diagnostic criteria i.e. two abnormal
tests in the absence of symptoms should apply. At least one of these values should
not be a fasting blood glucose level, given the possibility of abuse of the fasting
state. Even with the 2-h post OGTT blood glucose values, there was a within
subject coefficient variation of 32.4% when a single 2-h post OGTT capillary
blood glucose level (WHO, 1985) was compared with a fully supervised OGF
(Forrest et ci, 1988). The unsupervised drink and the timing of 2-hr sample did
not contribute substantially to the variability thus implying that the diagnosis of
diabetes should not be based in an asymptomatic subjects on the basis of a single
oarr. With the risk of developing diabetes being directly related to the degree
of glucose intolerance and cardiovascular disease morbidity/mortality being
associated with the upper 5 % of the blood glucose distribution, IGT is not a
clinical entity by itself. It is clearly impracticable to repeat an OCTrF several times
to define the severity of glucose intolerance, so other methods are necessary to
distinguish the three subgroups of JUT.
On the basis of studies in Bedford (Keen et ci, 1982) and in Pima Indians
(Bennett et ci, 1976); Jarrett et al (1976) suggested that a capillary blood glucose
concentration of 11.1 mmol/l (200 mg/dl) two hours after a 50g OGTT was a
reasonable cut-off point to divide those at risk of microvascular disease. A two-
hour post-glucose capillary whole blood glucose concentration of 7.5 mmol/l (135
mg/dl) had also been shown to be the value above which the risk of progression to
diabetes rose significantly (Jarrett et al, 1979), while below the value of 11
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mmoL'l (199 mgldl) spontaneous remission to normal glucose tolerance occurred in
some subjects (BDSWP, 1976).
At first glance, in view of this, assays of glycated haemoglobin or glycated
protein might offer potential advantages in classifying disorders of glucose
tolerance, their biological variability and dependence on nutritional state being far
lower than those for blood glucose concentrations (Pecoraro et al, 1986). These
benefits must, however, be set against the narrower biological range for these
variables. Glycated haemoglobin concentrations are not raised in people defmed as
having IGT in the GTT (Forrest et a!, 1988; Albutt et a!, 1985). In preliminary
studies it was found that the values of 2-h blood glucose are better able to
discriminate the presence of vascular disease in a diabetes screening study than
the results of any of four assays of glycated haemoglobin (Yudkin et a!, 1988).
2.6 OGTT VARIABILITY
The implication of the biological variability of the OCWF is likely to be
much smaller for people classified as normal or diabetic than for those categorised
as having IGT, because the IGT category has a range of 2-h blood glucose
concentration of only 3.3 mmol/l, the two margins are only 0.5 SD away from the
midpoint (Thdkin et a!, 199(J). Thus, if a population is selected as having IGT on
the basis of a single test result only a small proportion would be expected still to
have JOT on repeat resting - whether the test is repeated at one week or five years.
In some published studies in which OG1'Ts were repeated in people with
IG after an interval of < 1 year the rate of reversion to normal tolerance was 28-
67% and that of "deterioration to diabetes" 4-9% (Riccardi et al, 1985; Forrest et
a!, 1988). The fact that people discovered to have IGT in the first test are
reclassified on repeat testing begs the question where they really belong.
Someone with a two hour blood glucose concentration of 9.5 mmolJl in the first
test and of 6.5 mmolll in the second could be in the category of "JOT normal" and
returning to the biological set point or in the category of "lOT in transition " and
testing low on the day of the second test. A recent study has looked at
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electrocardiographic evidence of CR1) in 52 people classified as having ICfl on
the basis of the results of a single OUlT and found that the prevalence of these
changes increases with increasing degrees of intolerance on the second test
(Msdkin et al, 1988). This supports the hypothesis that these 52 people comprised
a mixture of "lOT normals" with a low prevalence of CHD, "false negative
diabetics" with a higher prevalence of CHD, and some patients with true JOT,
perhaps in transition.
There is some recent evidence of another factor that may contribute to the
changing of category among people shown by a single test to have lOT. A study
recently performed in six villages in rural Thnzania in which a 75g OGTT was
given to 6299 people (Swai et a!, 1988). In some 8% of these a repeat OGIT was
performed within seven days. On the second occasion only one quarter of the
people with a two hour blood glucose exceeding 10 mmol/l on first testing were
still "diabetic", while over three quarters of those with initial IUF had reverted to
normal and 3% had diabetes. That this was not simply regression to the mean was
shown by the fact that when the population levels of 2-h blood glucose were
reconstructed from this sample there was a highly significant decrease of 0.4
mmol/l between values at screening and those at recall and the estimated
population prevalence of JOT fell from 7.6% to 3.3% on repeat testing (Yudldn et
a!, 1990). If the phenomenon is widespread it would imply that the
epidemiological survey of glucose intolerance in a population may appreciably
overestimate the prevalence of both JOT and diabetes.
2.7 THE PREVALENCE of IGT
The prevalence is the number of cases in a population at a specific time
while the incidence is the number of new eases occurring in a population during a
specified period of time, often one year. Knowledge of the prevalence of diabetes
and lOT in the population provide important information on the definition and
classification of the disease, its early detection, its genetic and environmental
background, its social and economic impact, and the effect of the disease on
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health and the quality of life. The prevalence may need to be known, as well, for
public health or research reasons. Recent epidemiological studies using similar
OGFft showed higher prevalence of IGT than NIDDM. The prevalence of IG
varies widely between different populations in the same country and between
different countries.
A health examination survey carried out in Italy showed that 3% were
diabetic and 6% have IGT according to the EASD diagnostic criteria (Riccardi et
al, 1985). In the USA population aged 20-70 years, OG1T data showed a total
diabetes prevalence of 6.8% by NDDG and WHO criteria and the prevalence of
undiagnosed diabetes by both criteria [NDDG=3.2%] and [WHO=3.4%] were
almost equal to that of previously diagnosed diabetes [3.4%] (Harris et al, 1987).
However the rate of IGT [11.2%] by WHO criteria was more than twice the
NDDG estimate [4.6%]. It has also been shown that both obesity and parental
history of diabetes were associated with significantly higher rates of diabetes and
IGT. On the other hand among second-generation Japanese American men, in
Nisei, such prevalence, estimated to be 20%, have diabetes (both previously
diagnosed and undiagnosed) and 36% have ICTF (Fujimoto et a!, 1987).
Migrant Asians from the Indian subcontinent tend to have an increased
prevalence of IGT as compared with other ethnic groups in the same country.
There have been very few studies from India (Ramachandran et al, 1988)
reporting prevalence rates of IGT using WHO criteria and the rates are much
lower when compared with those in migrant Indians elsewhere (Zimmet et al,
1983; Omar et al, 1985; Beckles et a!, 1986; Ramachandran et a!, 1988, Dowse
eta! 1990; Swai et al, 1990). The low prevalence rates of IGF reported in migrant
Indians in Coventry, UK (Simmons et a!, 1989) are presumably due to initial
screening values being set too high.
There were no significant differences in the prevalence rates of IGT
between Melanesians and Indians in Fiji irrespective of gender and rural/urban
environment (Zimmet et a!, 1983). In Trinidad (Beckles et a!, 1986), in men,
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prevalence rates of lOT were highest in Indians, intermediate in Africa and mixed
and lowest in white populations. This was in contrast to that found in females of
all groups, where the rates were similar. In Mauritius, the age standardised
prevalence of lOT was significantly greater in women than men in all ethnic
groups (Dowse et al, 1990). In Thnzania , both the Muslim and Hindu Indians had
significantly higher prevalence of ICT compared with ethnic Africans (Swal et al,
1990; McLarty et a!, 1989). The prevalence rate was significantly higher in
Muslim Indians than in Hindu Indians. There were no gender differences amongst
Hindu Indians while, in Muslin Indians, women had an increased frequency of
lOT as compared with men.
There is a wide variation in the ratio of the prevalence of NIDDM to the
prevalence of ICfl' in different societies and, lOT is more weakly related to age
than is diabetes mellitus, even in people of different ages within the same
population (Yudkin et al, 1990). This may be because some populations (such as
those with a high prevalence of IGT compared with the prevalence of diabetes)
have a skewed unimodal distribution and others (with a higher prevalence of
diabetes) a bimodal one; the diabetic 2-h blood glucose concentration mode
differs in different populations; the degree of skew of a single curve differs; or the
number of people with KIT or its rate of transition differs.
Finally one question might be asked; should we screen for those lOT
individuals to advise therapy? A widespread and costly screening programme to
detect IGT seems unjustified at present (Editorial, 1980). Another opinion
(Tuomilehto et a!, 1987) stressed that high risk groups should be screened for lOT
and the screening should probably be repeated at regular 5 to 10 year intervals.
Subjects with lOT should be given individual health education counselling and
treatment to improve the metabolic state.
2.8 SIGNIFICANCE of IGT
The clinical relevance of the finding of lOT has been reviewed and
debated extensively (NDDG, 1979; Stern et a!, 1985; Bennett, 1985). It has
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become clear from prospective studies that this category of glucose intolerance
has unique attributes not shared by subjects with normal glucose tolerance or
overt diabetes. The presumed significance of IGT (Stern et al, 1985) is threefold:
firstly it is commonly believed that it represents a transitional state between
normality and diabetes, thus it emphasizes that mild degrees of glucose
intolerance have a different prognostic significance than the diagnosis of diabetes.
Secondly, 1(11 is also believed to be a risk factor for cardiovascular disease, either
in its own right, or as a consequence of its presumed precursor relationship to
diabetes. However KiT is not predisposed to microvascular disease. Thirdly, the
use of the term "IGT" avoids many of the psychosocial and economic
implications that a diagnosis of diabetes carries, and as such alleviates many
problems for physician and the patient, particularly if the impaired tolerance can
be corrected (Bennett, 1983 , Fantus, 1987). A discussion on these aspects are
given below.
2.9 DETERIORATION to DIABETES in IGT
Stages.	 The natural history of diabetes can be defined in general as
a number of stages relating to the course and development of diabetes and which
apply to both common types of the disease and, therefore, several stages were
proposed (Bennett, 1984). The first stage is genetic susceptibility. The second is
the state of potential abnormality of glucose tolerance, a statistical risk class
including subjects who have normal glucose tolerance but who by virtue of other
characteristics have substantially increased risk for the development of diabetes.
Thirdly is IGT, a phase in the development of type II diabetes, and as only
recently recognised, in type I also. The fourth is diabetes without complications,
a stage in which chronic hyperglycaemia is present and symptoms attributable to
hyperglycaemia may or may not be present. The fifth is diabetes with vascular
complications, but without associated symptomatology or disability. Lastly is
diabetes with disability, when complications of diabetes lead to functional
impairment. However, progression through these stages is not inevitable; many
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people with characteristics which are risk factors for abnormal glucose tolerance
never progress, and many people with IGT remain nondiabetic after many years
of follow up. On the other hand, The natural history and consequences of JOT
differ in many respects from those of diabetes mellitus and do not justify the
expectations inevitably associated with the diagnosis of "diabetes mellitus"
(Zimmet, 1985).
Rates, course and prognosisOur ability to predict metabolic deterioration
in subjects with JOT is limited. Early reports (O'Sullivan etal, 1966) demonstrate
frequent remissions among persons diagnosed as having chemical diabetes, 54 %
of whom exhibit an unexplained return to normal levels over the next two years.
Others suggest that in at least 20% of persons with JOT, diabetes mellitus
eventually develops (Davidson, 1985). While this group carries a greater than
normal risk of ultimately developing diabetes, several population-based follow-up
studies have shown that the risk of decompensation is in the range of 1.0 - 4.5 per
year (Anger et a!, 1982) over a 5 or 10 year time span. Depending on criteria
used, at least 8.9% and at worst 52.5% of a group of female chemical diabetes
patients (IGT) were calculated to deteriorate over a 10 year period and the
cumulative rate of developing diabetes was found to be 32% when the (USPHS)
criteria were applied (O'Sullivan et al, 1968). In the Birmingham survey
(BDSWP, 1962; BDSWP, 1970; BDSWP, 1976) 21.4% of "glucose tolerance test
diabetics" (1-h > 10.0 and 2-h > 7.5 mmol/l) in capillary blood changed to "florid
diabetes" (fasting glucose > 7.2 mmol/l over 5 years) (BDSWP, 1970) and
subsequently 45.2% of OTT diabetes became florid diabetes over a 10 year period
(BDSWP, 1976). In the Whitehall survey, 27 of 204 men [13.2%] with IGT were
found to worsen to diabetes during a 5 year follow-up period (Jarrett et a!, 1979).
In the Bedford study, 8.5% deteriorated over 8.5 years, 15% deteriorate to
diabetes in 10 years but if obese at baseline, this rises to 19.5% (Keen eta!, 1982).
In the Swedish study, 29 % of untreated male patients with IGT developed
diabetes over 10 years (Sartor et al, 198(1). However, in the Osaka study, the rate
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of worsening to diabetes after 7 years was 38.5% [5.5 %/year] for those with lOT
and 22.9% [3.3 %Iyear] for those with 2-h blood glucose values between 6.1-11.1
mmolJl (Sasaki et al, 1982). In Nauru, 1(31' carries an unpredictable prognosis,
and the relative risk for NIDDM for subjects with JOT at baseline was 3.6 over a
6.2-year period (King et a!, 1984). In the Pima Indians with ICTI' [n=384] who
were followed over a median period of 3.3 years, NTDDM developed in 31 %, ICTI'
remained in 26%, and 43% reverted to NOT (Saad et a!, 1988). Thus, in Pima
Indians, a 6-fold increased risk has been demonstrated, like, the 7-fold
increased risk shown in Malta (Schranz, 1989). Up to one half of subjects with
JOT may not have a progressive condition, while in 29%-59% IGT does appear to
equate with "early diabetes" (Mutch et a!, 1982).
Therefore, these population studies, demonstrated a trend in the natural
history of IGT over 5-10 year period and showed approximately one third of
individuals reverting spontaneously to normal, one third remaining JOT and one
third deteriorating further to NIDDM. These studies confirm, also, the
heterogeneity of 1(31.' category.
Predictors. There are many factors which can result in the final
resultant of lOT and each is likely to show natural evolution, in some cases
towards worsening, in others towards normalization. In addition to such factors as
the presence of genetic susceptibility to diabetes and the taldng of diabetogenic
drugs, there are the effects of obesity per se [and of weight change], of emotional
factors and their neuro-endocrine-metabolic consequences, of insulin resistance
and unknown contributions to the outcome in respect of glucose tolerance. Thus, a
critical, yet still unresolved issue concerns who will progress to overt diabetes?.
Several longitudinal studies of lOT have appeared in the literature all of
which examine "determinants" of future diabetes and all of those examined
different ethnic groups, e.g Pima Indian, Caucasoid, Japanese and Micronesian.
An old study showed that, diabetes occurred 5 times more frequently in
people with initial post OGTT blood glucose from 7.8-9.4 mmol/l [140-169
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mg/dl], and 15 times more frequent in those with blood glucose of more than 9.4
mmolIl [169 mgldl] (O'Sullivan et al, 1965). This study also showed that diabetes
occurred very much more frequently in people 20% above IBW, and as shown
subsequently, those above 150% of IBD at the time of diagnosis were at increased
likelihood of deterioration (O'Sullivan et al, 1968).
Subsequently, more recent longitudinal studies conducted in several
populations show that, the strongest and consistent independent risk factor for
deterioration to NU)DM, either for all subjects or for those with IGF alone, is the
baseline blood glucose itself -either the fasting and/or the post-load level
(Dau,nerie et al, 1989; Sicree et al, 1987; Balkue et a!, 1985, King et a!, 1984,
Kadowaki et al, 1984, Sasaki et a!, 1982, Jarrett et al, 1979). Even after taking
into account the other risk factors such as obesity or family history of diabetes
mellitus, the risk increased significantly as a function of the degree of glucose
intolerance (Bennett, 1985).
Another possible significant predictive factor is the degree of obesity. In
studies from Japan (Sasaki et a!, 1982; Kadowaki et a!, 1984) obesity has been
found to be an independent predictor, in contrast to studies from UK (Keen et al,
1982; Jarrett et a!, 1979) and Nauru (King et al, 1984) where it was inconsistent
in its effect. In the Bedford Study (Keen et a!, 1982), BMI became a significant
factor only during the later five years of the ten-year follow-up, thus, obesity
revealed a "delayed diabetogenic effect". Thus, obese subjects had a 2.9-fold
increase in incidence of NIDDM compared with non-obese persons. However,
after adjustment for plasma glucose and serum insulin levels, obesity was no
longer predictive of progression to NTDDM (Yadkin et a!, 1990.
An old prospective study showed that a family history of diabetes did not
influence the frequency of worsening to diabetes (O'Sullivan et a!, 1968). A
Japanese study revealed that, sex was also significant, indicating that risk of
worsening to diabetes was greater in males than in females (Sasaki et a!, 1982).
Systolic blood pressure was negatively associated with subsequent diabetes, in the
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Whitehall study (Jarrett et al, 1979) and in Nauru (King et al, 1984).
When IVGT'ft were performed yearly on 116 middle-aged non-obese
subjects for 6 yrs, it was found that age, fasting plasma glucose and the increment
index at presentation were significant predictors of the behaviour of IGTT,
whereas, sex, treatment and family history were not significant predictors; and
other factors such as islet cell antibodies play an additional role (Stowers et al,
1981).
A critical, yet still unresolved issue concerns whether those who will
progress to overt diabetes with fasting hyperglycaemia respond to OGTT
primarily with hypoinsulinaemia or hyperinsulinaemia. In definite diabetes, it has
been known that the insulin response to glucose is increased, but heterogeneity of
plasma immunoreactive insulin responses in subjects with IGT is still a matter of
discussion and the predictive value of a low insulin response for the development
of diabetes remained controversial (Kosaka et al, 1980; Keen, 1980; Fajans,
1980). Subsequently, a low insulin response was regarded as a significant
independent risk factor for the development of diabetes in subjects with lOT, even
when one takes other risk factors into account (Kadowaki et al, 1984;Knowler et
al, 1986). Data from Nauru have shown that subjects with higher post-load serum
insulin levels [presumably indicative of insulin resistance at base-line were more
likely to progress to either LOT or diabetes over a 6-year period (Sicree et al,
1987). Conversely, amongst subjects with LOT, progression to NIDDM was
predicted by lower base-line insulin responsiveness. Similar results for subjects
with JOT have, also been described in Pima Indians and Mexican Americans
(Saad et al, 1988; Haffner et al, 1988).
The presence of hyperinsulinaemia and hypertriglyceridaemia in young,
lean Australian Aborigines [from the desert] with lOT was recently reported
(O'Dea et al, 1988), and this suggested that the hyperinsulinaemia and
hypertriglyceridaemia form part of the metabolic adaption of the 'thrifty' gene
(Ned, 1962). Also, the tendency to hyperinsulinaemia/insulin resistance may be
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the modem expression of this 'thrifty' genotype.
Thus, these findings of these various studies suggest a teleological
sequence in the development of NIDDM leading from compensated
hyperinsulinaemia and insulin resistance, through moderate hyperglycaemia and
hyperinsulinaemia, to increasing hyperglycaemia and decreasing insulin response,
and ultimately to (3-cell decompensation and diabetes (Zimmet et a!, 1989).
The longitudinal and cross-sectional studies in Pima Indians have shown
that ICiT in obese subjects is primarily due to a reduction in insulin action with
normal pancreatic (3-cell secretory function (Lillioja et al, 1988). Later, persistent
hyperglycaemia increases the pancreatic secretory function culminating in (3-cell
failure and diabetes. Both insulin resistance and impaired insulin responsiveness
lead to subsequent development of diabetes in subjects with JOT (Saad et a!,
1988; Knowler, 1986).
There are, therefore, many problems in defining a true change in glucose
tolerance category, particularly in people with lOT. If the variability of a test can
result in the recategorisation of people as "deteriorating to diabetes" and thereby
exclude them from further study the frequency of such "deterioration" will be
substantially over-estimated. To show a true change in a variable that has a poor
biological or assay reproducibility the change in the level of the variable should
exceed 2 SD of the intraindividual variation (Yudkin et a!, 199(J). This criterion
will, however, merely define 2.5% of the population as having deteriorated in the
second test. The method employed in the Bedford and Whitehall surveys to define
deterioration to diabetes was the requirement for two consecutive or three non-
consecutive 2-h capillary blood glucose values [SOg OGTl'] to be equal to or
more than 11.1 mmolll [or symptoms and signs of hyperglycaemia] (Jarrett et a!,
1979; Keen et a!, 1982; Jarrett et a!, 1984).
Because the OGTT used to define IGT was performed only once,
however, those so defined might include people with IGT who were "false
negative diabetics" re-establishing their biological set point (Yudkin et a!, 199(J).
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A more satisfactory approach would be to repeat the OGTT on at least three
occasions each time in order to reduce the CV to less than 20%, but this is
unacceptably demanding for both subjects and investigators.
The value of the study in Pima Indians is that knowledge of the previous
degree of glucose tolerance in people with IGT allows exclusion of these "false
negative" diabetics from investigation (Saad et al, 1988). Nevertheless, the high
rate of deterioration to diabetes of these people was probably found because only
one 2-h blood glucose concentration of 11.1 mmol/l or more was necessary to
define diabetes, and this may have occurred frequently in people with true set JOT
or even, on occasions, in those with concentrations at the upper end of the normal
range.
The observation that rates of "deterioration to diabetes" increase when
criteria are less rigorous was noted in the Whitehall Study (Jarrett et al, 1979;
Jarrett et al, 1984). Several studies have looked at factors that may improve the
ability to predict deterioration to diabetes in people with JOT. In Pima Indians
(Saad et al, 1988), as well as in Japanese (Kadowaki et al, 1984) and Nauruans
(Sicree et al, 1987), a poor insulin response to a glucose load predicts
deterioration. Nevertheless, cross-sectional studies of glucose intolerance may
misclassify diabetic patients as having IGT, and these patients may show an
impaired insulin response to a glucose load as a consequence of diabetes (Lillioja
et al, 1988, Reaven et a!, 1968, Modan et al, 1986).
If a later OG1"l' were to show deterioration to diabetes in these people the
poor insulin response might falsely be interpreted as a predictor, rather than a
consequence of diabetes. The Pima Indians study is unique as longitudinal data
make it improbable that those with IGT were false negative diabetics. The ability,
shown in other studies, of using either fasting or 2-h plasma glucose
concentrations to predict deterioration to diabetes (Keen et al, 1982; Ito et a!,
1983; King et al, 1984, Kadowaki et a!, 1984, Jarrett et a!, 1984A; Saad et al,
1988; Sicree et a!, 1987) could again reflect the possibilities of an initial false
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negative OCTET result.
Therefore when the concept of deterioration to diabetes and the instability
of the JUT class in the light of data on the variability of the biological response to
a glucose load was analysed an additionaicriterion were suggested to categorise
people with IGT and that measures of insulin and of proinsulin like molecules are
possible candidates for this task (Yadkin et a!, 1990).
In conclusion all these studies showed that baseline blood glucose
concentration was the most powerful and consistent predictor. Obesity was a
further independent predictor in the two Japanese studies (Sasaki et a!, 1982;
Kadowaki et a!, 1984) but was inconsistent in its effect in the United Kingdom
(BDSWP, 1976; Jarrett eta!, 1979; Keen et a!, 1982) and Nauru (King et al,1984)
studies. An early insulin response in the OGTT have been found to be additional
independent predictor in some studies.
Thus, although the incidence may be low, the eventual prevalence of
diabetes may be high. These people will have considerable influence upon the use
of expensive health care facilities and their early recognition may allow successful
intervention.
2.10 CARDIOVASCULAR RISK in IGT
Several epidemiological studies carried out in the last few years have
shown an increased frequency of clinically significant atherosclerotic events and
have suggested that IGT might be associated with a high risk for CVD (Jarrett et
a!, 1982, Fuller eta!, 1980). While studying the lack of association between CHD
mortality and diabetes duration it has been pointed out that subjects with JOT but
not diabetes have an increased risk of CVD relative to non-diabetics (Jarrett et a!,
1984A). Moreover, he concluded that the supposition that in some way
hyperglycaemia or its associations causes the increased prevalence of
macroangiopathy in terms of atherosclerosis/CHD can be challenged (Jarrett,
1984B, Jarrett, 1984C). He pointed out that macroangiopathy seems to be
independent of diabetes duration among NIDDM patients. Also the level of
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glycaemia seems to play a minor role since NIDDM and IGT appears to have a
similar risk for CHD, but a totally dissimilar risk for microangiopathy.
Furthermore, NIDDM seems to arise from groups of patients within the general
population having higher than average frequency of risk factors for CHD.
The association between IGT and hypertension had been repeatedly found
in several clinical and epidemiological studies. Hence, when several risk factors
were examined, blood pressure (systolic and diastolic) was the only one
significantly associated with IGT despite the fact that treated hypertensives were
excluded (Wiccaro et al, 1984).
Uncertainties about the relationship between IGT and serum lipoproteins
still exist .. When the plasma lipoprotein composition was evaluated in
individuals with JOT [n = 65], it was found that they have significantly higher total
triglyceride values but total cholesterol levels were similar in IGT and each of the
control groups (Capaldo et al, 1983). However, no significant correlations were
found between serum lipoproteins and blood glucose levels either fasting or after
OGT. Another study found that elevated mean levels of total cholesterol, LDL-
cholesterol and triglycerides in women rather than in men with IGT (Ganda et al,
1985). The mean HDL-cholesterol levels were 20% lower and LDL/HDL
cholesterol ratios were 60% greater in women than in men with JOT. These
observations indicate that lOT can be associated with significant alterations in
lipid metabolism, particularly in women. The Paris Prospective Study of 943
individuals with glucose intolerance [01] found that hypertriglyceridaemia
emerged as the major risk factor of coronary artery death in subjects with lOT
(Fontbonne et al, 1989). In addition, plasma cholesterol and plasma insulin levels
[fasting and 2-h] were significantly higher in those who died from CHD compared
to those that did not.
The prevalence of ECG abnormalities was nearly doubled in both the JOT
and diabetic groups in the Whitehall Study. Despite inconsistencies regarding an
excess CHD mortality at the upper extreme of blood sugar distribution, nearly all
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the International Collaborative Group Studies showed an increased prevalence of
defined ECG abnormalities in the IGT range (Stamler et al, 1979). In the
Whitehall IGT group there was a significantly increased prevalence of certain
specific ECG findings - ST depression, T-wave inversion and left bundle branch
block - all of which have been shown to be associated with a significantly
increased CHD risk in another analysis of the whole Whitehall population. The
mortality rate was about 3 times higher than that in the NGT group for IGT
individuals with small Q-waves, frequent premature beats and sinus tachycardia.
Abnormalities of the resting ECG may, therefore, define at-risk groups of subjects
with 1(11' who are particularly suitable for dietary or drug intervention.
It is currently unclear as to whether hyperglycaemia increases CHD
mortality except among those with extremely high post-challenge
hyperglycaemia (Fuller et a!, 1983). An excess in mortality in IGT, as compared
with normal subjects was confirmed by the Bedford (Jarrett et al, 1982) and the
Danish (Anger et a!, 1982) studies. This is also found in the bi-ethnic population
of Fiji (Sicree et a!, 1985), and Nauruans with IGT had a higher relative risk than
those with NIDDM of mortality, although this was not significantly in excess of
that of individuals with NGT (Zimmet et a!, 1988). The 9 year follow-up data
from the Chicago Heart Association Project in Industry found that asymptomatic
hyperglycaemia was associated with an increased risk of death from CHD with
greater relative significance in women than in men (Wen-harn et a!, 1986).
Individuals with JOT have also been studied by Jarrett and co-workers (Jarret et
a!, 1984A) in a 10 year follow-up of men in the Whitehall Study. It was found
that baseline blood glucose significantly predicted both all-cause and CHD
mortality in this group of men and that all-cause mortality rates were higher in the
less obese. Age and blood pressure were the two factors most strongly related to
subsequent death from CHD in the glucose intolerant and diabetic groups. This
study confirmed the importance of hypertension as an associated risk factor in
these types of diabetic subjects. A recent evidence showed subjects with lOT had
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mortality rates nearly identical to those of newly diagnosed diabetics, 2.7/1000
per year and 2.9/1000 year respectively (Fontbonne et a!, 1989). This study also
produced evidence that the increased risk of death from CHD in subjects with
glucose intolerance [GI; JOT or NIDDM] may be a consequence of the clustering
of CVD risk factors with insulin resistance. In general, these studies clarify
whether individuals with JOT are more prone to atherosclerosis of the coronary
vessels than the general population.
On the other hand, lOT is of little or no importance as a risk factor for
atherosclerotic PVD (Vaccaro et a!, 1985). In the Micronesian population of
Nauru, where NTDDM is present in 24% of the population and 80% of those over
55 years have IGT (Zimmet et al, 1984), retinopathy occurs in 24 % of all
diabetic subjects (Zimmet et a!, 1984). In those with ICr it was only 2.5% and in
newly diagnosed diabetics 6%. The majority of patients had background
retinopathy of varying severity, only 1.2% of males and 2% of females having
proliferative lesions.
On the basis of these epidemiological studies a blood glucose level of 200
mg/dl measured 2-h after a 50g OGrT has been suggested as a practical criterion
which distinguished between those 'at risk' of diabetic complications and those
with lOT but without significant risk (Jarrett et a!, 1978). Thus, it is conceivable
that NJDDM and/or IGT and atherosclerosis share a number of antecedent
metabolic risk factors, possibly on a genetic basis, which predisposes the
individual to either diabetes, atherosclerosis or both of these clinical outcomes.
Furthermore, the levels of cardiovascular risk factors in subjects with JOT were
more like those in the diabetics than in those with NOT.
2.11 INTERVENTION IN IGT
As described above patients with JOT are at risk to develop overt NIDDM
(1 %-5 %Iyear), and in many populations they have an increased incidence of
macrovascular disease (NDDG, 1979). Thus, intervention at any of the previously
mentioned stages may prevent progression to a later stage and IGT may be a
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critical stage in the development of diabetes because it is the earliest recognizable
stage in this process, and there is some evidence that its progression to diabetes
can be prevented (Bennett et a!, 1984). There have been a few attempts to
determine the effect of intervention on IGT and a number of possibilities were
examined, namely drug treatment, dietary intervention, weight loss, exercise, or
multiple intervention.
A borderline diabetic state was improved by short-term energy restriction
or weight loss, and successful results of dietary advice and physical training were
reported in 48 middle-aged IGT males (Cederhoim et a!, 1985). In this study,
OGVF was restored to normal in 25 IGT subjects who were given dietary advice
and two weekly exercise sessions during a period of 6-12 months, and it improved
in 12 IGT males given dietary advice alone and in II lOT males participating in an
exercise group for 3 months. The mean body weight was decreased and the
working capacity improved, even in the diet-treated group.
In another two studies diet and tolbutamide or phenformin showed no
discernible effect on the subsequent incidence of diabetes (Jarrett et a!, 1979;
Keen et a!, 1982). Moreover the size of the samples in these trials is so small that
their results are compatible with an effect as great as a 50% reduction in the
incidence of diabetes. In the "glipizide trial", 23 IGT subjects were treated with
2.5 mg daily (Camarini et a!, 1983) At follow up after three years, the mean
width of the muscle capillary basement membrane had decreased to a level similar
to that in normal subjects, whereas the width in 18 untreated IGT subjects was
increased at follow up. In the 10 year follow-up study a significant difference in
the rate of development of diabetes was found between subjects randomised to
treatment and a "no therapy" group (Saltin et a!, 1980). While there was no
overall difference in those randomised to tolbutamide (500 mg t.i.d), placebo or
diet only, it was notable that of 23 subjects who continued to take tolbutamide
throughout the trial, none developed diabetes. None of the tolbutamide treated
subjects had developed manifest diabetes, compared with 13 % of the diet-treated
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and 29% of the untreated subjects. These subjects represented only half of those
randomised to this group, and whether this represents a true therapeutic effect , or
whether those who elected to continue tolbutamide were a self-selected group
who for other reasons had a lower risk of development of disease, is unknown. No
case of myocardial infarction or intermittent claudication had occurred in the
tolbutamide treated IGT subjects and the rate of pathological ECG changes was
close to that in the normoglycaemic control group.
Therefore, these studies, utilising a variety of suiphonylureas for treatment
of patients with lOT, have failed to show any effect of two to eight and one-half
years of treatment on glucose tolerance or progression to overt diabetes (Lebovitz
et al, 1986), although one of these claims that ten years of treatment with
tolbutamide (1.5 g/d) markedly improves glucose tolerance, reduces progression
to overt diabetes, and decreases the development of cardiovascular disease (Sailor
et a!, 1980). In light of the large number of studies showing no effect of
sulphonylureas in patients with IGT (Lebovitz et a!, 1986) this latter study will
need to be amply confirmed before there can be any consideration of the use of
sulphonylureas in patients with lOT.
Thus, because of the uncertainties in these studies it seems unwise to
recommend wide-spread detection and treatment of IGT at this time except on an
experimental basis. Debatably, if treatment of lOT with drugs, diet, or exercise
will indeed delay or prevent diabetes, the detection and treatment of persons at
this stage could reduce the incidence of NTDD. In the view of the magnitude of
the problem and the evidence that the progression of the disease at this stage is not
inevitable, further investigations should be given high priority as this may be the
most opportune stage to prevent NTDDM and its complications.
2.12 SPECIAL GROUPS with IGT
The potential significance of lOT in pregnancy has become more widely
recognized and both the WHO and the NDDG draw attention to the special
significance of glucose intolerance in pregnancy. This was emphasized at the
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Second International Workshop Conference on GDM (Metz ger et a!, 1985).
JOT in childhood was also reported. A ten-year prognosis of JOT in 140
siblings of 67 children with IDDM concluded that the 2-h OGTT identified a
subset of the sibling cohort at increased risk for the development of IDDM
(Rosenbloom et a!, 1981, Rosenbloom et al, 1982).
Glucose tolerance is known to decrease with advancing age (DeFronzo,
1989). This decline begins in the third or fourth decade of life and is progressive
throughout the entire adult life span. Mean fasting plasma glucose concentration
changes only slightly with increasing age whereas average 2-h plasma glucose in
an OGTT rises about 0.5 mmol/l per decade after 50 years of age (Keen et a!,
1982). There has been much debate whether this JOT is physiological and hence
whether diagnostic criteria ought to be age-related as in the nomogram of Andres
(Chen et a!, 1985; Andres, 1971). This will remain unresolved until prospective
studies are available in the elderly, but for the time being the criteria of the WHO
and NDDG are to be applied uniformly irrespective of age. However, JGT in
pregnancy, childhood or elderly are beyond the scope of this thesis.
2.13 SECONDARY IGT
IGT, likewise diabetes mellitus, can be associated with pancreatic
diseases, disease of hormonal aetiology, drug induced or chemical induced
conditions, abnormalities of insulin or its receptors and certain genetic syndromes
(WHO, 1985). These, also, will not be discussed further here.
2.14 PATHOGENESIS OF IGT
As shown before, NIDDM and JOT are common and are responsible for a
great deal of morbidity and mortality in adults. Current treatment is imperfect,
reflecting our ignorance of the pathogenesis of these disorders. The pathogenesis
of IGF and NIDDM would seem to be either impaired insulin secretion, impaired
insulin action or possibly some combination of the two. The current status of lOT
and NIDDM pathogenesis was described elegantly recently (Davidson, 1985).
Glucose intolerance in diabetes results from a lack of glucose utilization.
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As a consequence, glucose remains in the circulation and is responsible for
hyperglycaemia. Impaired glucose oxidation in human diabetes has been
demonstrated. However, glucose intolerance in diabetes cannot be entirely
explained by a lack of glucose oxidation. Glucose storage, principally in the liver
plays an essential role in glucose homeostasis. A defect in glucose storage is
certainly one of the main causes of glucose intolerance in diabetes, mostly
because this phenomenon is directly under the control of insulin. Since different
mechanisms regulate glucose storage and oxidation the study of these two
parameters was expected to a better understanding of the pathophysiology. The
results suggest that in IDDM complete insulin deficiency seriously impairs two
major mechanisms regulating glucose homeostasis, i.e. glucose storage which is a
high rapid phenomenon, and peripheral glucose oxidation, which is a slower and
delayed one. Whereas in NTDDM, where a weak insulin response is present, the
defect in glucose oxidation is markedly attenuated. As a consequence, glucose
storage deficiency, although less important than in IDDM, remains the major
cause of glucose intolerance.
Like NIDDM, insulin resistance is a characteristic feature of patients with
JOT (Olefsky, 1981; Olefsky et al, 1977; Reaven et a!, 1976). Patients with IGT
have relatively mild insulin resistance, whereas patients with NIDDM have more
severe insulin resistance (Olefsky, 1981). Furthermore, as the degree of
carbohydrate intolerance worsens, the frequency of insulin resistance increases
(Olefsky et al, 1977). Thus, many, but not all patients with JOT are insulin
resistant, while essentially every NIDDM patient with significant fasting
hyperglycaemia displays this abnormality. Using the glucose clamp techniques
(Bergman et a!, 1985) significant insulin resistance has been demonstrated in the
overwhelming majority of NIDDM patients studied, while the presence of insulin
resistance has been variable in subjects with JOT.
It was also shown that people with IGT, as a group, have raised
concentrations of insulin both when fasting and after a glucose load (Modan et al,
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1985, Lillioja et al, 1988; Saad et ci, 1989) and show insulin resistance when
investigated with glucose clamp techniques (Lillioja et a!, 1988; Reaven et ci,
1989). Patients with IUT (n=5) have insulin resistance in NEFA and glucose
metabolism but not in ketone body metabolism (Singh et at, 1987).
People with ICTI show hyperinsulinaemia and insulin resistance, both in
cross-sectional (Lillioja et a!, 1988; Reaven et a!, 1989) and in longitudinal (Saad
et ci, 1989) studies. As a group their mean concentrations of insulin when fasting
and two hours after a glucose load are increased by roughly 50% and 250%
respectively (Liilioja et ci, 1988; Saad et al, 1989), while their insulin stimulated
glucose disposal is reduced by some 70% (Reaven et ci, 1989).
Though a true deterioration from normal to IGT is associated with an
increase in fasting and post-load insulin concentrations and in insulin resistance, it
is not clear whether a person classified as "IGT normal" would also show
hyperinsulinaemia during the abnormal OGIT. Possibly, therefore, measures of
insulin, employed as surrogates for those of insulin resistance, might help define
patients with true IGT (Saad et ci, 1989, Reaven a ci, 1989). Not all people with
IGT progress to diabetes; those who do seem to show a deterioration in insulin
response to glucose, suggesting that insulin deficiency, super-imposed on insulin
resistance, is the cause of the further deterioration in glucose tolerance (Saad a al,
1989). If this is so measures of insulin might distinguish two subgroups of
patients with true IGT: those in transition (who deteriorate to diabetes) showing
failing (3-Cell function and those with persistent hyperinsulinaemia who remain
glucose intolerant. Hyperinsulinaemia in the presence of raised fasting
concentrations of glucose is taken to imply insulin resistance (Turner et ci, 1982).
Though insulin resistance has been shown in people with IGT and diabetes by
using infusions of exogenous insulin (Reaven et ci, 1989), "hyperinsulinaemia" in
diabetic patients may be in part a manifestation of raised concentrations of intact
and split proinsulin (Temple et a!, 1989), which seem to be detected by standard
radioimmunoassays for insulin.
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The implication of these fmdings is that insulin deficiency may be a more
important contributor to the aetiology of diabetes than has been suspected, but it
remains to be seen whether "IGT normals" and "false negative diabetics" might be
distinguished from patients with true IGT by the use of more sensitive and
specific assays for insulin-like molecules. Preliminary findings have suggested
that raised concentrations of these molecules - rather than of insulin per se - are
associated with the excess cardiovascular risk in diabetic patients (Nagi et a!,
1989), and it is an intriguing possibility that both the hyperinsulinaemia and the
cardiovascular risk associated with IGT may also represent the consequences of
raised concentrations of these molecules.
Thus, from the information which is currently available, the following was
concluded (Davidson, 1986). For unknown reasons, in persons destined to have
IGT and NIDDM, insulin resistance develops. Those whose pancreatic /3-cells
can meet this challenge by secreting increased amounts of insulin continue to
have normal glucose concentration or JOT at the expense of hyperinsulinaemia.
Only those with a genetic predisposition will develop NIDDM. This
predisposition involves a limited ability of the /3-cells to continue to synthesize
and secrete the extra insulin demanded of them. Thus, NIDDM ensues when the
/3-cells can no longer respond well enough to prevent fasting hyperglycaemia.
2.15 CONCLUSION and FUTURE
In my thesis work, I have discussed IGT, a term which was coined by
NDDG and accepted by WHO in 1980, to describe a state intermediate between
diabetes meffitus and normality. People with JOT who have high glucose levels
and low insulin responses early in the glucose tolerance test, appear to be more
likely to progress with time from JOT to diabetes mellitus. This group of subjects
is also at a high risk of developing macrovascular disease. I have also enumerated
various preventive measures for NIDDM and Jar. Insight on pathogenesis was
also given.
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Further studies are therefore required to determine its natural history and
its clinical relevance in progression of diabetes and macrovascular disease. In
clinical terms it is probably worth searching for 1(11' in high risk populations eg.
Saudi Arabia, but not in, for example, UK, where rates are not particularly high
and the risk of underlying CVD is negligible. Finally, IGT is an interesting
phenomenon and its relationship with NIDDM and cardiovascular disease,
particularly in the contest of preventive medicine, are worthy subjects for
research.
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SUMMARY
Diabetes in Saudi Arabia is very common. This chapter elaborates on this problem with
particular emphasis on epidemiology and associated risk factors. Some aspects of diabetic
complications have also been included. In addition a short comparison of the characteristic(s) of
diabetes was included.
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CHAPTER THREE:	 DIABETES MELLITUS IN SAUDI ARABIA
3.1 INTRODUCTION
Saudi Arabia is the largest country [land area: 2,240,000 sq km] in the
Arabian Gulf. The estimated total population is about 12 million, including 28 %
non-nationals (James eta!, 1990). The population growth rate of 6.5 % per annum
is due both to an increase in immigrants and a rise in the national population.
Improved standards of living and health services have contributed to a longer
life expectancy which is now 62 years. The rapid economic growth of Saudi
Arabia has led to drastic change in life-style of the people with effects on health,
nutritional status and the expression of disease patterns. Diabetes is emerging as a
major health problem ((Bancroft, 1984; Sebai, 1987; Sebai, 1987; Abdella, 1988;
Ekoè, 1988; El-Hazmi, 1990)). This chapter summarizes the available present
knowledge on diabetes mellitus in Saudi Arabia.
3.2 EPIDEMIOLOGY:
3.2.1 Dia2nosis
3.2.1.1 OGTT
The OGTT remains the gold standard test for the diagnosis of diabetes in
Saudi Arabia (Ismail, 1987). Using WHO criteria, the fasting plasma glucose was
found to be normal in many non-pregnant Saudi subjects with diabetes which led
Bell and colleagues (1984a) to conclude that the WHO recommendations are not
entirely suitable for interpretation of glucose values in Saudi Arabia. They found
that on the basis of post-OGIT values [75 g], 6 % of those classified as diabetics
had a fasting value of < 5.0 mmol/1 which, according to WHO criteria, if taken on
its own would exclude diabetes. On the other hand, many normals [59%] as well
as subjects with diabetes [42%] had fasting glucose levels of ^ 5.0- < 6.7 mmol/1.
There is, therefore, a large overlap in the fasting values of diabetics and
normals and the 2-h post glucose value is essential for diabetic screening. This is
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indeed recommended by WHO. The unsuitability of the present WHO fasting
glucose criteria has recently been shown for other populations (Finch et al, 19.90).
3.2.1.2 Glycosuria
The correlation between plasma and urine glucose was e'en poote ttat
elsewhere since Saudi diabetic subjects were found to have a mean renal threshold
for glucose higher than in American and European population (Bell et a!, 1982).
Many of those with serum glucose values ^ 10.0 mmol/l did not exhibit glycosuria
[men 50%, women 48%] and when the serum glucose levels were between 12.1
and 14.3 mmol/l many men and women [62% vs 75%] did not have glycosuria.
Therefore, not only is glycosuria unsatisfactory for diagnosis but self-testing urine
for glucose is an unsatisfactory method of diabetic control in Saudi diabetic
patients.
3.2.1.3 Symptoms on diagnosis
A notable feature of the cases detected in one survey was the denial of
classical symptoms despite glucose levels as high as 26.2 mmol/l (Bacchus et
al,1982). Nocturia was absent in approximately 50 % (Ahmed et a!, 1987) and
polyuria was mild (Kingstone et a!, 1986) or rare (Ahined, 1989).
3.2.2 Prevalence:
Little was known of the prevalence of diabetes mellitus in Saudi Arabia
before 1975. One of the earliest observations stated that "maturity onset diabetes
mellitus and impaired glucose tolerance are common in Arabs in Riyadh; they are
not usually associated with obesity" (Cook, 1976). Seven years later a further
report suggested a high rate of diabetes amongst other diseases (Dodd, 1983).
Several reports have now described the high prevalence of diabetes mellitus in
Saudi Arabia. Some of these reported from the central region (Abu-Aisha et a!,
1980; Bacchus et al, 1982; Bell et a!, 1984A; Bell et a!, 1984B), Some reported
from the western region (Mira et al, 1983; Fatani et a!, 1983; Fatani et a!,
1985A; Fatani et a!, 1985B; Fatani et a!, 1987; Fatani et a!, 1987) while one was
conducted in different regions (El-Haz,ni et al, 1989). Two of the studies were
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hospital-based and five were community-based. Urban and rural comparisons
were also carried out (Fatani et a!, 1985A; Fatani et a! 1987). In population based
studies the prevalence in the total population ranged from 2.5 % to 5 % with rates
higher in the elderly and in the obese. Recently, a prevalence of 6 % was observed
for fasting blood glucose> 7.8 mmol/l in 14 % of university community males in
Riyadh (Anokute, 1990). Details of these studies are shown in 'Thble 3.1.
3.2.3 Risk factors
Studies of diabetes mellitus in Saudi Arabia have clearly demonstrated
correlations of diabetes mellitus with some risk factors such as gender, age,
obesity, social class and family history.
One population based study showed a prevalence of 2.5 % in males and
4.7 % in females (Bell et al,1984). The prevalence in women was also twice that
for men [5.9 % vs 2.9%] in a rural area (Fatani et al,1987). However, the opposite
was found in an urban survey [males 5.6 %; females 4.2 %] (Fatani eta!, 1985).
The higher prevalence of diabetes in general in females in Saudi Arabia may be
related to a greater tendency for obesity in the female than in the male population
and could also be related to parity, although this was not investigated (Bell et a!,
1984).
Diabetes is also related to increasing age in Saudi Arabia as in other
countries. The prevalence was 11 % in subjects over the age of 40 years [yr]
(Abu-Aisha et a!, 1980). Although, no diabetic subjects were under the age of 25
yr and only one male diabetic subject [1 %] was discovered up to the age of 34 yr,
an overall prevalence of 6.5 % - 11 % was found in the age group [55-64 ys] and
23 % in those above 65 ys (Bacchus et al,1982). In Bell's study there was no
diabetes in females less than 35 yr of age, with the peak [29 %] at age group 45-
54 yr although no females of greater than 65 yr were surveyed (Bell et a!, 1984).
This is also confirmed by the comparative study of hyperglycaemia where the
prevalence was low in persons under 20 yr old and the majority of cases were 40
yr and above (El-Haznii et a!, 1989). In general, rates were approximately 20 %
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in the over 55 yr [Iäble 3.1]; higher than in Caucasian populations (Ekoè, 1988).
Overweight was reported in a few studies in Saudi Arabia. It was found
more in diabetics [65 %] than in non-diabetics [26 %] (Bacchus et al,1 982). All
the females were overweight, 66 % being between 35 and 55 % above their ideal
body weight (Bell et al, 1984). In urban dwellers, obesity was two-fold commoner
in women than in men. Diabetic men [35 %] were more obese compared to non-
diabetic men [19 %] and, similarly, diabetic women were obese [79 %] compared
to non-diabetic women [52 %] (Fatani et a!, 1985). In rural dwellers, the rate of
obesity in adult [^ 15 ys] diabetics [41 %] was significantly higher than in non-
diabetics [29%] (Fatani a a!, 1987).
Social class had a strong positive correlation with diabetes in Saudi
Arabia. In urban dwellers, social class status (British Registrar-General
classification) revealed a higher proportion of diabetics among subjects of social
class 1 and 2 than social classes 3,4 and 5 (Fatani et al, 1985'). Similar rates were
seen in rural areas (Saudi Arabian Civil Service Bureau Scheme) (Fatani et al,
1987). This could have been related to ovemutrition. First degree family history
of diabetes was found more in the new and untreated referred adult diabetics [21
%] compared to the overall positive family history [28%] (Laajam et al; 1987).
3.3 TYPES A1D FEATURFJS OF DIABETES
3.3.1 Primary Diabetes
The Saudi diabetic population is composed of 85 % NIDDM and 15 %
IDDM (Ahmed, 1989). The prevalence of IDDM was found to be 0.3 % in the
age group 0-14 ys (Fatani et a!, 1985). Three cases of maturity onset diabetes of
youth [MODY] have also been described in Saudi in the western region
(Kassimi,1981). Circulating immune complexes [14 %, 9 % and 8 %] and islet
cell antibodies [31 %, 9 % and none] were detected in Saudi subjects with IDDM
[n=73], NIDDM [n=35] and control [n=24] respectively; and when ethnic
comparisons were carried out, immunopathological mechanisms might be
involved more in Egyptian IDDM than in Saudi IDDM (Ibrahim et a!, 1983).
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Recently, the frequencies of ICA, CF-ICA and organ specific antibodies
have been evaluated among Saudi Arab diabetic children [n = 86] (Abdullah et al,
1990) and newly diagnosed adult diabetic subjects [n-138] (Al-Attas et a!, 1990A).
The results of the former suggested that Arab diabetic children have a lower
prevalence of thyroid antibodies than European or American Caucasian diabetic
subjects and thus the regular screening for these antibodies was not justified. The
latter study showed that ,in relation to age at onset above 35 yr, only 13 % of
Saudi adult diabetic subjects are characterized by ICA. Moreover, recent findings
indicated that there was no relationship between endogenous insulin secretion and
the presence of ICA in newly diagnosed adult Saudi diabetic subjects suggesting
further that these subjects have only mild insulin deficiency (Al-Attas et a!, 1991).
These findings seem to fall halfway between those reported in Caucasians and the
few reports on non-Caucasian populations (Al-Attas et al, 1991). Furthermore,
Saudi IDDM had a slow acetylator phenotype which might be relatively
ineffective in detoxifying a proposed toxic natural substrate that can precipitate
type I diabetes (Price Evans et al, 1985).
Little is known of pancreatic function in subjects with diabetes in Saudi
Arabia. El Attas et al (1990) found recently that the newly diagnosed diabetic-
patients in Saudi Arabia is characterized by high basal C-peptide and insulin
levels which increase significantly with stimulation, suggesting diminished but
present endogenous B-cell function. Moreover, they also suggested in a different
study that a varying degree of obesity influences the rate of both beta cell
secretion, insulin resistance and impaired lipid metabolism (AlAttas eta!, 1990C)
Recently, the population gene frequencies of restriction fragment length
polymorphisms of the human insulin gene, which is located on the short arm of
chromosome 11, were studied in Saudi Arabians [n = 148] blood donors (Johansen
et a!, 1990). They found that the Class 3 allele frequency were four times higher
in Arabs than in Philipinos, but they did not examine whether or not low or high
allelic Class 3 was associated with low or high prevalence of atherosclerosis,
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hypertriglyceridaemia or NIDDM.
Finally, Saudi Arabian diabetics display different HLA markers from both
European and Asian populations. In a single reported study there was an increased
frequency of HLA BW 35 in IDDM, with an apparent increase of HLA B8 and
unlike IDDM of Caucasian origin, there was no increase in HLA B15 and B18
(Fatani et al, 1986). The frequency of HLA B52 was reduced in both IDDM and
NIDDM reaching statistical significance in the latter.There have been no reports
of so-called "malnutrition related diabetes mellitus".
3.3.2 Secondary diabetes
Pancreatic disease, diseases of hormonal aetiology, drug-induced or
chemical-induced conditions, abnormalities of insulin or its receptors, and certain
genetic syndromes are the main five groups that can lead to secondary diabetes
(WHO, 1980). A few reports from Saudi Arabia has demonstrated such an
association with respect to liver diseases, insulin receptors defects or genetic
syndromes. Diabetes [fasting values > 7.8 mmolIl] was present in patients with
chronic active hepatitis [8 %], cirrhosis [40 %], and hepatoma [15 %], compared
with of all other patients aged 35 ys or over, undergoing liver biopsy (Kingston et
al, 1984). Compared to this high prevalence of diabetes in liver disease, only 3%
of the diabetic patients had chronic hepatitis or cirrhosis. This high prevalence of
diabetes in chronic active hepatitis and cirrhosis in Saudi Arabia may due to the
insulin insensitivity of chronic liver disease acting over many years in a
population with a high genetic predisposition to diabetes. Patients with bilharzial
liver disease show impairment of liver function as well as diminished insulin
secretion as evidenced by insulin:glucose [JIG] ratios (Saeed et al, 1983). It is
possible that liver function may not be entirely responsible for the disturbance in
insulin status and glucose tolerance and factors related to the haemodynamic
changes due to portal hypertension and portosystemic shunts may have a
more significant role than previously accepted (Saeed et a!, 1983). Moreover,
insulin receptor antibodies causing steroid responsive diabetes mellitus was
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reported (Fonseca, 1984) and a distinct autosomal recessive hereditary syndrone
associated with glucose intolerance has been observed, as well, in six Saudi
Arabian patients from two highly inbred families (l4bodhouse et al, 1983).
3.3.3 Features of diabetes
There are both clinical similarities and differences between NIDDM in
Saudi Arabians and in Europe and North America (Bacchus et al, 1985). The
distinctive biochemical features of Saudi NIDDM include moderately severe
hyperglycaemia; relative insulin deficiency but sufficient insulin present to
prevent ketoacidosis; normal serum cholesterol; hypovolaemia; and
hyperosmolarity (Ahmed, 1989). Saudi diabetics were similar to NIDDM
reported from the west in being overweight and middle age of onset, having a
positive family history and resistance to ketoacidosis (Kingston et a!, 1986).
3.4 ACUTE COMPLICATIONS [Diabetic ketoacidosis]
Diabetic non-ketosis in young non-obese (Fonseca et al; 1985) and
diabetic ketoacidosis were reported in Saudi Arabia (Kingston et a!, 1982; Jan,
1982; Fatani et a!, 1983; Mira et al, 1987; Mira et al, 1988). Adult diabetic
subjects were characterized by well-tolerated hyperglycaemia and resistance to
ketoacidosis (Kingston et a!, 1982). Both IDDM [55%] and NIDDM [45%] were
predisposed to admission [Hospital stay 2-3 weeks] due mainly to poor
compliance [66%] with mean blood glucose and pH of 26 mmol/l and 7.2
respectively and they require a mean of 3 L total fluid replacement in the first 5h
(Mira et al, 1987). The use of continuous low dose intravenous insulin infusion
were recommended (Jan, 1982) and insulin oedema particularly in children was
found (Abdullah et al, 1989). Reported mortality Iwas, 3 % (Fatani et al, 1983)
and 4.3 % (Mira et a!, 1987).
3.5 CHRONIC COMPLICATIONS
NIDDM patients show the full range of microvascular and macrovascular
complications (Ahmed, 1989). However, coronary artery disease [CAD], large
vessel peripheral vascular disease {PVD], retinopathy and proteinuria were less
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common than in Caucasians (Kingston et al, 1986). It is postulated that normal
blood pressure and cholesterol values probably explain the lower incidence of
macrovascular complications (Ahmed, 1989).
3.5.1 Microvascular
Retinopathy is a common complication of diabetes in Saudi Arabia (Bashi
a al,1987; Wifai, 1987). In a cross-sectional study it was found in 24 % [n=64],
four of whom had proliferative retinopathy ; 31 % were insulin-dependent.
Diabetes duration [11 vs 6 ys], smoking [31 % vs 6 %] and presence of
proteinuria [31 % vs 11 %] between those with and those without retinopathy
were significantly different but the prevalence of hypertension did not differ.
Photocoagulation is the present mainstay of treatment in diabetic retinopathy
(Khatib, 1987). Nephropathy, defined as macroproteinuria, > 550 mg/24 h with a
positive reagent strip-test, was found in 13 % of IDDM within 5 years of onset
and 18% after 5 years of diabetes (Fatani et a!, 1985; Fatani et al, 1989). No
reports of microalbuminuria have appeared, however, in screening for
nephropathy. The diagnosis of neuropathy was based on the presence of persistent
symptoms or signs of peripheral neuropathy in the presence of peripheral pulses,
mononeuropathy, or autonomic neuropathy. It was observed in 17 % of newly
diagnosed diabetic adults (Laajam et a!, 1987) and occurred with the highest
frequency of the specific complications with no significant differences between
IDDM [28 %] and NIDDM [24 %] subjects (Fatani et a!, 1989). The correlation
between duration of diabetes mellitus and neuropathy was significant in NTDDM
but not in IDDM (Fatani et al, 1989). Also reported were neurovascular
complications, including diabetic foot disease, which was frequent in all diabetic
groups (Hagroo et al, 1987). In Saudi Arabia, diabetic foot gangrene is usually
due to factors other than macrovas.cular occlusion because peripheral pedal
vessels are easily palpable in the majority of cases (Kingston et a!, 1986).
3.5.2 Macrovascular complications:
Macrovascular complications [CAD; cerebrovascular accident, CVA; and
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PVD] were found to be impressively low in Saudi diabetics (Kingston et al, 1986,
Hagroo et al, 1987; Fatani et al, 1989). The prevalence,in one report, of CAD
and of large vessel PVD were 1.3 % and 4.0 % respectively (Ahmed, 1987). CAD
[7 % vs 10 %], CVA [1 % vs 2 %] and PVD [5 % vs 3 %] showed no significant
differences between IDDM and NIDDM subjects but there was a significant
positive correlation between duration of diabetes mellitus and macrovascular
complications in NTDDM [4.5 ± 0.3 ys] but not in IDDM subjects [7.4 ± 0.5 ys]
(Fatani eta!, 1989). Systolic time intervals, which were simple non-invasive tests,
may be of value in selecting diabetic subjects at high risk of cardiovascular
complications (Tongia et al, 1984). Normal blood pressure, low cholesterol and
low insulin levels may individually, or in combination, may account for the low
frequency of atherosclerotic complications (Kingston et a!, 1986; Ahmed, 1989).
The majority of IDDM [80 %] and NIDDM [71 %] had one or more
complication (Fatani et a!, 1989). There were no significant differences between
the frequencies of complications in IDDM vs NTDDM subjects except in the case
of nephropathy where IDDM [18 %] had a significantly higher frequency than
NIDDM [11 %J (Fatani et al,1989). The prevalence of micro- and macrovascular
complications of Saudi IDDM vs NIDDM were neuropathy [28 % vs 24 %],
nephropathy [18 % vs 11 %], retinopathy [13 % vs 8 %], coronary heart disease
[7 % vs 10 %], peripheral vascular disease [5 % vs 3 %] and cerebrovascular
accident [1 % vs 2 %J respectively (Fatani et a!,1989). In IDDM [age 32 ys],
there was a positive correlation between duration of diabetes mellitus [7.4 ys] and
nephropathy, but this correlation was not significant in the case of nephropathy,
retinopathy and macrovascular disease (Fatani et a!, 1989). In NIDDM [age 46.5
ys] a significant positive correlation was found between duration of diabetes [4
ys] and nephropathy, retinopathy, and macrovascular complications, but there was
no correlation between duration and nephropathy (Fatani et al,1989). However,
there were no previous single epidemiological study that reported on hypertension
in Saudi Arabia.
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3.6 LIPIDS
The established normal reference ranges for serum cholesterol in healthy
adult Saudi Arabs were [males 3.2 - 6.2 ; females 3.5 - 5.5 mmol/l] (El-Hazmi et
al, 1982, Bacchus et al, 1982, E1-Havni, 1991), and these levels are generally
normal or low in Saudi Arabians compared with Northern Europeans (Cook:
1976; Bacchus et al. 1982). However, In diabetic patients, levels were slightly
higher than normal for Saudi Arabians, but lower than those reported for normal
subjects from Europe and America (Kingston et al: 1986). These levels had a low
correlation with serum glucose and thus, hyperglycaemia per se was not an
important variable influencing serum cholesterol levels (Kingston et al: 1986).
No reports on lipids in conjunction with diabetes.
3.79 MANAGEMENT AN) CARE:
Modification of diet and increase of activity reduced weight in 83 % after
3-4 months and decreased serum glucose values in 72 % and thereafter should be
the first and principal mode of treatment particularly for Saudi NIDDM subjects,
even though, dietary advice was not usually given and oral hypoglycaemic drugs
were prescribed for the majority of referred diabetic subjects (Kingston, 1985).
Education of diabetic subjects in Saudi Arabia should be greatly
emphasised into the nature and self-management of their disease (Larson, 1982),
since problems might be encountered in caring for Arabic origin subjects which
either be due to their failure in receiving the maximum benefit from even the most
rudimentary treatment resources (De Senarciens et al, 1983), or encountered
when non-Arabic speaking diabetic health care providers challenged with the
problem of instructing non-English speaking Saudi Arabian diabetic subjects
(Vêiss, 1984).
3.8 MONITORING
Self-testing urine for glucose is an unsatisfactory method of control in
majority of Saudi diabetic subjects since they exhibit a high renal threshold and
day-to-day control should be assessed by blood glucose measurements if possible
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or with medium- or long- term glycated proteins. Several of the latter have been
examined in Saudi Arabia.
Glycated haemoglobin values, in line with other studies; correlated with
fasting blood glucose (Mira et al, 1985) but not with age (Al-A ayash et al, 1987)
or duration of diabetes (Ajabnoor et a!, 1987), were not different between men
and women (Kilshaw et al, 1983) and the values in IDDM were higher than
NIDDM (Mira et a!, 1985). It is also a valid measure of monitoring diabetic
control in the presence of both normal and abnormal haemoglobins as in sickle
cell anaemia subjects particularly in the eastern provinces where these
predominated (Al-Torki et a!, 1987). Alternatively, serum fructosamine is useful
in monitoring medium-term glycaemic control (Ajabnoor et al, 1988; Ajabnoor et
al, 1990) and glycated fibrinogen which is more sensitive in reflecting mean
blood glucose changes over a shorter period of observation [2-3 days] (Ardawi er
a!, 199(J).
3.9 SPECIAL TOPICS IN DIABETES:
When the effects and safety of Ramadan fasting [May/June 1985] on diabetic
subjects [32 NIDDM and 20 IDDM] have been evaluated, it is suggested that
diabetic Muslims in Saudi Arabia could observe fasting provided that proper
attention is given to the state of control (Khogheer et a!, 1987).
3.10 CONCLUSION:
This chapter demonstrated that diabetes mellitus is an emerging problem
in Saudi Arabia, particularly in urban areas. Further studies are needed to
determine the prevalence, incidence, types, genetics, aetiology, complications,
treatment and prognosis, in order to plan services and to minimize the future risks
of this health problem in Saudi Arabia. Hence the study objectives were
perceived and shown with the methods and results in the next few chapters.
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GENERAL OBJECTIVES
Most studies that attempt to measure the prevalence of diabetes in Saudi
Arabia [Chapter 3] have a priori notion that environmental factors play the major
role in the high prevalence of diabetes in this community but no one has actually
assessed any of these factors. Moreover, no data were available on the associated
risk factors. The need to conduct a survey among the urban subpopulation was
thus perceived. Therefore, the main objectives of this study can be stated broadly
as follows:
1. To describe the prevalence rates of glucose intolerance (diabetes and
impaired glucose tolerance) and the associated cardiovascular risk factors in a
cross-sectional pilot urban community and to compare these with respect to
different glucose tolerance groups and nationalities. In addition, establishing in
statistical terms, the relative importance of factors considered necessary to foster
the development of diabetes in this community [Chapter 5].
2. To test the reproducibility of OGfl' in sub-sample [Chapter 6].
3. To describe the dietary pattern and to investigate any differences between
glucose intolerance or nationality groups [Chapter 7].
4. To describe the physical activity pattern and to investigate any differences
between glucose intolerance or nationality groups [Chapter 8].
5. To examine the effect of nationality on different metabolic, dietary and
physical activity variables [Chapter 9].
6. To describe the hormonal and the metabolic responses between the
glucose intolerance groups and to elucidate whether defects in insulin secretion
and/or insulin action are responsible for the glucose intolerance [Chapter 10].
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SUMMARY
This chapter outlined briefly the general methods used in this study. This required three
visits, an interviewer-administered questionnaires, and involved an anthropometric and blood
pressure measurements, OGTI, blood sampling and assaying for hormones and metabolitea and
involved using certain machines and instrument. Specific methods are presented in the appropriate
chapter.
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CHAPTER FOUR:	 GENERAL METHODS
4.1 PLAN and ASSESSMENT
Many of the factors that might affect the study design should be identified
before conducting any survey, (Abramson, 1990). The methods of ascertaining
such factors are described below.
4.1.1 First visit (Official approval and evaluation):
Before designing the study, acquiring research materials and formulating
the questionnaire, site visits, interviews, discussions and examination of published
studies and government reports were carried out to identify the different factors
and problem areas thought to affect either the conduct and/or the anticipated
objectives or results of the study. The preliminary interviews, with managerial
personnel responsible for the Health Service or other study-related official
government authorities in the Jeddah region, showed the difficulty encountered in
arranging and conducting these personal interviews, especially if no previous
contact with the managers existed. Despite this, it was felt that a lot of the
background information and facilities required could be attained. Familiarity with
the services provided in the majority of the primary health centres and some
hospitals was also acquired. The author, being an employee of the Ministry of
Health, requested the issuing of official letters from the M.O.H to support him in
conducting personal interviews with a number of government officials for the
purpose of collecting more supplementary data and information. Accompanying
the letters, was a brief summary describing the author's research objectives and the
purpose of conducting this study. It is fair to mention at this point that the author
experienced encouraging as well as frustrating times during the course of
conducting these official surveys.
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4.1.2 Second visit (Pilot study):
The aims of this visit were to examine the feasibility, arrange the
requirements, assess the difficulties and perform a pilot study. This involved
piloting the field methods discussed below as well as using a preliminary
questionnaire with 30 subjects in a primary health clinic. This showed that the
questionnaire needed to be refined, adjusted and most importantly conducted by
interview, since mailing the questionnaire was found impractical. Further
evaluation of the difficulties of taking a biological or informative sample in
Jeddah to the final stage of analysis at Newcastle Upon Tyne was assessed.
Furthermore, additional interviews with officials were carried out. The
information obtained and the basic data collected led to refinement and
adjustment of the final plan of the major study. This was done between November
2nd, Wednesday 1988 and January 10th, Tuesday 1989.
4.1.3 Third visit (Main studies):
Based on the previously stated objectives and the insight gained from the
pilot study, a final set up of the samples and format of the questionnaire was
designed for the Jeddah Cardiovscular Diseases [CVD] study En =95]. In this study
the full range of the field methods were employed. The basic general data, and all
physical and biological variables that were obtained for the pilot study [n =30]
were added to that obtained from the main study [n=95] and the results of both
[n =125] presented later [chapter 5]. However, the data obtained from dietary and
physical activities questionnaires in the pilot study were mainly investigatory,
proved unreliable and have therefore been excluded. Hence, only the dietary
[Chapter 7] and the physical activity [Chapter 8] responses from the main study
are presented. Efforts were made to ensure that the data were collected under the
same condition. Simultaneously, two other studies were conducted [Chapter 6,
10]. This visit was between June-November 1989. During both visits, volunteers
were tested and interviewed in one day between 08:00 till 13:00 and if necessary
requested to return to the afternoon between 16:00 - 19:dO to complete their
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sheets. The period for each visit was selected because most, if not all, people were
settled as it precedes the mid-year holiday.
4.1.4 Study city, JEDDAH:
Knowing in brief the background of the city is of great importance in
understanding its urban nature, in explaining the relevant features of the whole
subpopulation living in this city and in interpreting the pattern of risk factors
found in this urban community. This section is intended to provide the reader with
general information about Jeddah (Al-Harbi, 1988, Al-A nsari, 1982). The name
Jeddah, 'Grandmother', and the legendary tomb of Eve, located near the city, give
a strong indication of the ancient character of the city. At present, Jeddah is the
largest city in the western region of Saudi Arabia and the principal sea port on the
Red Sea. Over the last three or four decades the growth of the city has been truly
spectacular, and has transformed it from a homogeneous to a heterogeneous urban
environment. The city can be divided spatially into three zones; the old town area,
the transitional area and the contemporary area. Historically, the city's role was,
and still is, as a port and gateway to the Holy City of Makkah. Presently, Jeddah
is of prime importance, both socially and economically, to the kingdom since in
1980, 80% of the food stuff imported to the country arrived through the port of
Jeddah and 30% of the government's project expenditure was invested in the city
during the second five year plan. It is situated on a coastal plain, called "Tuhama"
and located in the arid zone between the mild climate of the Mediterranean Basin
and the monsoon climate of the Indian Ocean. This gives the city an average
monthly temperature of 25-30 °C. The lowest (14 °C) is during December and
January and the highest (47°C) is during June. High relative humidity is the
characteristic, rain is very rare (40 mm annually) and the most prevailing winds
are from the north and north-west.
Throughout the centuries, a large number of Jeddah's population has
consisted of Muslims of different national origin, who came for Hajj and later on
settled in Jeddah. In addition, there have been a few non-muslims who came for
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trade, business, work or diplomacy. Since 1978 Jeddah population has shown a
steady increase until it reached 1,234,200 inhabitants in 1985, with foreigners
constituting about 53 %. The population age structure since 1978 is similar to the
Third World Countries and has remained relatively stable recently. Of the total
population 41% is less than 15 years old, 58 % is in the adult group (15-64) years
and 1 % is those aged 65 years and over. Government and private Health Services
are provided through major referral hospitals as well as primary health care
centres distributed to serve most of the districts in the city. It is homogeneous
with respect to the environment but not to the lifestyle. However, generally, each
district is homogeneous in both environment and lifestyle, which in the proposed
area, is affluent and non-traditional.
4.1.5 Study area:
The recruitment of this study was carried out in three different places and
in two periods of time. Al-Salama Primary Health Care Centre (PHC) was
selected from amongst six PHC centres which serve the North West region of
Jeddah. Availability of facilities, central location and familiarity with the
investigator were the reasons for its selection. Al-Shaty Teaching Hospital was
the second place for this study. In this hospital, a recruiting clinic was established
on arrival by the investigator. It is called the Screening Clinic for Diabetes and
Hypertension. Two months later, the investigator moved to the newly opened
Diabetic and Hypertension Centre where he established the same screening clinic
with the name of the Well-Adult Clinic [WAC].
4.1.6 Publicity:
An invitation to a "FREE TEST" for diabetes, hypertension and lipids was
offered using different means. Invitation posters were attached to notice boards at
the place of the study and a descriptive sheet in Arabic was distributed to
everyone attending the place of the study. The governmental hospitals and PHC
centres were also informed by through the dissemination an official circular.
Special explanatory and invited visits were carried out by the investigator to some
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of these centres. On the second visit more than 3,000 sheets were distributed to
some medically related places such as chemists shops in addition to non-medical
places such as supermarkets and some governmental departments. The invitation
was to attend on any day except Friday and pre-registration was requested as late
as one day prior to the day of investigation. An official permission letter was
arranged for the working subjects. The response rate [50 %] was estimated by
dividing the numbers of those registered initially and those who came for the test.
Women were asked in the pilot visit to attend this free test, but they were
unreliable attenders as they depended on others for transport. Furthermore, the
unavailability of a nurse during the study period made exclusion of women from
the study inevitable.
4.2 FIELD METHODS:
4.2.1 Subjects:
A representative group for either the whole city population or a district
community was conceived impossible during the first visit, due to many
limitations including time, cost and personnel (Lameshow et al, 1990). Any
subject who was male, age between 20 - 65 and living in Jeddah with any
nationality was welcomed for the study. Those known by simple question to have
diabetes or hypertension were excluded from the study even if they registered for
investigation. Pre-registration was requested or needed to ensure understanding
of the instruction required for this study, which was explained by the investigator
who also provided the subject with an appointment slip which indicated the day
and time of the test. Thus sampling bias can not be excluded and extrapolation for
the whole community should be treated cautiously.
4.2.2 The Health Questionnaire:
The WHO oriented health questionnaire (Laparasicy ci' al, 1987; Rose,
1982) contained questions on five main aspects namely: general, personal and
medical history, cardiovascular; social habits; dietary and physical activity
[Appendix 1-5]. On arrival, each subject was given this questionnaire to look
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through before it was administered and completed individually by the investigator
using the direct questioning technique on the same day of attendance. The
questionnaire initially written in English was translated into Arabic but the
English version was included. The time required to complete the whole
questionnaire varied between 45 to 75 minutes per subject, utilizing the waiting
time for the physical measurements and blood samples. Biases during the
interview could have arisen from the interviewers or the respondents. Interviewer
biases may be caused by incorrect questions, incorrect recording of responses,
intentional omissions, biases associated with interview setting, distractions,
confidentiality and anonymity of the respondent, and the degree of rapport
between the interviewer and the respondent (Lydeard, 1991). Respondent biases
arise because the respondent may misunderstand what the interviewer has
requested, receive nonverbal clues to the 'right answers' from the interviewer; or
have a need to give 'socially desirable' answers. Respondent biases may lead
respondents to overestimate facts such as income and age. In order to minimize
interviewer and respondent biases, the interviewer during the pilot study trained
himself to anticipate and recognize potential sources of distortion and bias in
addition to avoidance of value judgments by the interviewer. Nonresponse rate
was also minimized when the interviewer conveyed warmth, understanding and
trust.
4.2.3 Body fat estimation:
There were two techniques for estimating body fat. The direct techniques
include densitometry, total body water, total body potassium and uptake of lipid-
soluble inert gases. The indirect techniques include skin-fold measurements,
weight: height ratios and waist-hip circumferences (Gibson et al, 1990). Of the
later techniques only the last two were used in this study. Anthropometric
measurements can be derived directly from a single or combination of raw
measurement(s) and are of two types : growth and body composition
measurements. The most widely used anthropometric measurements of growth are
71
height [Stature] and weight. They are employed in epidemiological studies as
indirect measures of obesity, because measurements of weight and height are
easy, quick, relatively noninvasive, and are precise and accurate with care and
training (Lohman et al, 1988). However, obesity indices cannot be used to
distinguish between excessive weight produced by adiposity, muscularity, or
oedema. Standing height was measured once using a stadiometer, to the nearest
0.5 cm, without shoes and head cover, the back square against the wall tape, eyes
looking straight ahead, with a set square resting on the scalp and against the wall.
Weight was measured once with a beam balance to the nearest 0.1 kg without
shoes,in light dress and undergarments. The 'Quetelet's index" or body mass
index [BMI] was then calculated [Weight(kg)/Height(cm) 2] since, it was
considered to be the least biased by height and easily calculated for most adult
population (Garrow et a!, 1985). However, it is not a valid index for those under
twenty or over sixty-five years of age, or for those who are pregnant or lactating
and should not be used as an index of body fatness in individuals with a grossly
abnormal relationship between leg and trunk length. (Gibson a a!, 199(J).
Most anthropometric methods used to assess body composition are based
on a model in which the body consists of two chemically distinct compartments:
fat and fat-free mass. The latter consists of the skeletal muscle, nonskeletal
muscle and soft lean tissues, and the skeleton. Anthropometric techniques can
indirectly assess these two body compartments. Subjects should fast overnight
prior to the measurement and wear little clothing to ensure that the tape is
correctly positioned. Subjects should stand erect with the abdomen relaxed, arms
at the sides, feet together and with their weight equally divided over both legs.
To perform the waist circumference [WC] measurement, the lowest rib
margin is first located and marked with a felt tip pen. The iliac crest is then
palpated in the midaxilary line, and also marked. An elastic tape is then applied
horizontally midway between the lowest rib margin and the iliac crest, and tied
firmly so that it stays in position around the abdomen about the level of the
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umbilicus. The elastic tape thus defines the level of the WC, which can then be
measured by positioning a fibreglass tape over the elastic tape (Jones et al, 1986).
Subjects are asked to breathe normally, and to breathe out gently at the time of the
measurement to prevent them from contracting their muscles or from holding their
breath. The reading is taken to the nearest millimetre. For the hip circumference
[HC] measurement, the subject should stand erect with arms at the side and feet
together. The measurement should be taken at the point yielding the maximum
circumference over the buttocks (Jones et al, 1986), with the tape held in a
horizontal plane, touching the skin but not indenting the soft tissue (Lohman et al,
1988).
The waist-hip circumference ratio [WHIR] can be measured more precisely
and provides an index of both subcutaneous and intra-abdominal adipose tissue. It
is a simple method for describing the distribution of both subcutaneous and intra-
abdominal adipose tissue (Larsson et al, 1984; Jones et al, 1986). Results of
computer tomography scans in twenty-eight women showed a high degree of
correlation between the WHR and the proportion of fat situated intra-abdominally
at the umbilical level (Ashwell et a!, 1985). It was suggested that WHIR greater
than 1.0 for men and 0.8 for women were indicative of increased risk of
cardiovascular complications and related deaths, although more research is
needed before specific recommendations for classifying waist-hip ratios can be
made (BjOrntorp, 1987). In a semi-random, age-stratified sample of 4349 British
Caucasian adult men, it was found that 4% had a WHIR > 1.0, the cut-off point
associated with increased risk of mortality and morbidity, and 12 % had values
between 0.95 and 0.99. Moreover, the WHIR increased with age and excessive
weight, both separately and in combination.
4.2.4 Blood pressure measurements:
Blood pressure was measured twice on each participant during the waiting
time for the two hour OGIT. Once was on arrival and the second was anytime
between the 1-h and 2-h blood samples. Each measurement was preceded by at
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least a three minute resting period. All were made on the right arm (unless
injured or otherwise unsuitable) with subjects seated and the arm supported at
heart level (Petrie et al, 1986; O'Brien et al, 1990). In this study, the Copal UA-
231 automatic sphygmomanometer was used (Meyer-Sabellek et a!, 1990). This
machine was evaluated in the field against the ordinary standard mercury
sphygmomanometer, and found to be a useful instrument for epidemiological
survey work by removing some of the observer variation in the measurement of
blood pressure (Rogers et a!, 1988). The standard adult-size (12x23 cm) cuff
provided with instrument was used, irrespective of the arm circumference. The
instrument was demonstrated to the participants before BP measurement. A peak
inflation pressure at 180 mmHg was used and this was increased to 220 mmHg if
the first pressure proved inadequate. The machine recorded the diastolic pressure
at phase 5. The means of the two readings was taken and the results interpreted
according to the WHO Criteria (WHO, 1978).
4.2.5 The oral glucose tolerance test (OGTT):
Solution:
Bottles of 300 ml solution degassed, with an orange flavour, containing
100 g of dextrose were used (SunDexTrade)*. In order to get 75 g (WHO), 75
ml of solution was withdrawn and discarded and the bottle was refilled to 300 ml
mark using canned water.
'The Sun-dex-Trade 100, an oral carbonated OFF beverage, lOg glucose/fluid ox (29.57 ml) USA by cuatoms laboratories. lngredient 100
grams dextrose (D-ghicose), citric acid, orange flavour extract, aitificial colouring sod sodium beozoste.
Protocol:
The WHO, 1980 protocol was followed which involved the following.
The OGTT was administered in the morning after at least three days of
unrestricted diet (greater than 150 g of carbohydrate daily) and usual physical
activity. The test was preceded by an overnight fast of 10-16 hours, during which
water was allowed. Smoking was not permitted during the test. The presence of
74
factors that influence interpretation of the results of the test was recorded (eg.
medications, inactivity, infection etc). After collection of the fasting blood
sample between 0800 and 0900 hours, the subject was given 75 g of glucose as
above over the course of 5 minutes. Blood samples were collected 1 hour and 2
hours after the test load.
4.2.6 Sampling scheme and tubes preparation:
In the morning of the study, each subject was asked to confirm the
overnight fast of 10-14 h, otherwise he was given another appointment. Three
venepunctures were used in the community study. Indwelling cannulae (Branula)
were inserted into the subjects' right and left antecubital veins unless
inconvenience or failure prevented this. Local anaesthesia was used for the study
described in chapter 10. Informed consent (in writing) was obtained for both tests.
Blood was collected into tubes containing fluoride oxalate for glucose, lithium
heparin for NEFA, 5 ml perchloric acid for metabolites, trasylol for glucagon and
plain for other estimations. In the pilot study fasting samples were taken for
glucose, insulin, cholesterol, triglycerides, uric acid and fructosamine. Additional
1-h and 2-h samples for glucose and insulin were taken. In multiple samples
OGIT study [chapter 10] two fasting samples were taken; for hormones [insulin,
C-peptide, proinsulin and glucagon]; for intermediary metabolites [glucose,
lactate, alanine, glycerol, pyruvate, 3-hydroxybutyrate and NEFA]; for lipids
[cholesterol and triglycerides] and for fructosamine. Further samples were taken
for hormones and metabolites at 30,60,90 and 120 minutes. For insulin, C-
peptide and proinsulin an additional sample at 10 and 20 minutes was also taken.
The samples was obtained on the specified time plus or minus 5 minutes. Once
collected these samples were centrifuged immediately at 4°C and the serum or
plasma kept at -40 °C for later analysis at Newcastle. Since no bedside
measurement of blood glucose was available, all the samples were analysed at
Newcastle. However, to inform subjects about their results an aliquot was taken
for routine analysis for glucose and lipids by local methods.
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4.2.7 Packing, storage and transportation:
The samples were prepared in groups in plastic bags and kept in a -40°C
freezer. They were packed in the morning with dry ice in an icebox, sealed with
an adhesive tape around the brim and left at room temperature until the departure
time at night. On arriving at the department in Newcastle (within 24h) the
samples were moved to the appropriate freezers until assayed. All were still
frozen on arrival.
4.3 LABORATORY METHODS:
INSTRUMENTS:
4.3.1 The Yellow Spring Instrument [YSI]:
The Yellow Spring Glucose Analyser instrument, Model 23AM, is a
quantitative device for measuring glucose in blood plasma and blood serum for in
vitro diagnostic purposes using a sample of 25 l. It is based on the glucose
oxidase enzyme hydrogen peroxide sensor which is highly specific for glucose.
4.3.2 The Cobas Bio Centrifugal Analyser:
Many of the spectrophometric and fluorometric assays in this thesis were
performed using a Cobas Bio centrifugal analyser model 8326 (Roche, Basle,
Switzerland). The instrument can measure up to 24 samples and 3 standards for
any particular assay. The sequence of events may be summarised as follows: the
instrument pipettes into separate disposable cuvettes, a water blank (used for
internal standard) and 3 standards and 24 samples either without or with the main
reagent. The contents of the cuvette are mixed at approximately 2000 rpm and
then the start reagent is pipetted in. The Cobas can be programmed to read
changes in absorbance or fluorescence from either the first (main reagent) or
second addition (start reagent). The result is calculated from the change in
absorbance or fluorescence, by first subtracting the end reading from the internal
blank and extrapolating this result from the standards. Details of the individual
assays are described below.
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ASSAYING PROCEDURES:
PROTEIN HORMONES
4.3.3 - Insulin:
Serum insulin was assayed in the department laboratory by a double
antibody radioimmunoassay technique ( Soeldner and Slone, 1965). Five hundred
and fifty microlitres of insulin standards (Welicome Reagents Ltd, UK) or sample
and 50 l anti-insulin serum (raised locally in guinea pigs) in borate buffer pH
8.0, were incubated at 4°C for 48 hrs. 50 d of 125j insulin (CMD, Bournemouth,
UK) was added to each tube, the tubes were further incubated at 4°C for another
48 hrs. Separation of bound from free insulin was achieved by adding 1 ml of
anti-guinea pig insulin (Weilcome, UK) to each tube. The tubes were left to stand
at room temperature for 30 minutes, spun at 1850 g for 30 minutes, the tubes
decanted, and the precipitate counted using a gamma counter. The normal adult
fasting range was 2.8-13.5 mU/l with intra-assay coefficient of variation (CV)of
4.2% and inter-assay CV of 4.8 %.
4.3.4 - C-peptide:
Serum C-peptide was assayed after extraction of proinsulin and insulin
with Sepharose bound, anti-insulin antibodies(Heding, 1975). C-peptide was
measured by ethanol precipitation radioimmunoassay (Heding, 1975) using the
M122l antibody and a synthetic standard (Novo Research Institute, Denmark)
with delayed addition of labelled C-peptide (Novo Research Institute, Denmark).
One hundred microlitres of standard or sample was incubated with 100 l of
antiserum (1:25000) for 24 hours at 4°C. To this mixture at 4°C was added 100
of 'I-Tyr-C-peptide. The mixture was further incubated for 24 hrs at 4°C. After
this period 1.60 ml of 96% (v/v) ethanol was added to each assay tube, vortexed
and centrifuged at 2000g for 10 minutes. After discarding the supernatant, the
precipitate was washed with 2.0 ml of a solution composed of 960 ml 96% (v/v)
ethanol, 18 ml assay buffer, and centrifuged at 3000 g for 10 minutes. The
supernatant was discarded, and 0.5 ml of 0.05 M NaOH added to each precipitate
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and counted. The adult reference range was between 0.18 and 0.52 nmol/l. The
intra- and inter-assay coefficients of variation were between 5.9 and 7.2 and 7.9
and 10.1 % respectively.
4.3.5 - Proinsulin:
Proinsulin was measured by immunoradiometric assay (Dhahir, Cook and
Self, in press). 220 l polyclonal quinea-pig antibody to human proinsulin [Eli
Lilley], equivalent to 2.2 g protein, partially purified from serum by ammonium
sulphate precipitation, was coated to the wells of Immulon Immunostripstm
[Dynatech] by incubating at 4°C for 24h. The plastic was then treated by
incubation with a solution of 1 % bovine serum albumin for 30 mm to reduce
non-specific binding of protein and the wells washed three times with a 0.02 %
solution of Tween 20 in 0.1 M phosphate buffer, pH 7.4 . 200 jd serum sample or
standard in bovine serum were incubated in the wells for 24 h at 4°C after which
the wells were washed 4 times with the Tween solution. 200 l of 125-iodine
labelled monoclonal antibody to C-peptide [PEP-001], a gift from [Novo
Laboratories, Bag svard, Denmark] containing about 200,000 counts per minute
were then added to the wells and incubated for a further 24h at 4°C. Finally the
wells were again washed 4 times with the Tween solution and the wells broken
part from the strips for counting of radioactivity. Typically, a sensitivity of 0.4
pmol/l [zero + 2.5 sd] intact proinsulin was obtained with this procedure. Cross-
reactivity observed with 32/33 split promnsulin and 65/66 split proinsulin was
77.9% and 61.0% respectively with respect to intact human proinsulin.
4.3.6 - GlucagonL:
Glucagon samples were sent to Denmark for assay. There, glucagon was
measured by double antibody radioimmunoassay using small, vertical, dry paper
wicks. Free and antibody bound radioactive hormone are located at opposite site
ends of the paper strips. The wicks are cut through the middle and the two halves
are placed vertically into counting tubes. The percentage activity of bound
hormone or the bound/free ratio is calculated for serum and standard samples
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(Orskov et ci, 1968). The interassay CV was 9 %.
STEROID HORMONES
4.3.7 - Sex hormone binding globulin (SffBG):
The sex hormone binding globulin was determined using the Farmos
diagnostic immunoradiometric assay kit [Farmos SHBG-IRMA]. The procedure
is based on the principles of a "sandwich type" non competitive "liquid phase"
immunoradiometric assay(Hammond et ci, 1985). Serum samples, controls and
standards were diluted in assay buffer. A mixture of 125j labelled monoclonal
SHBG antibody and anti SHBG antiserum is then added to aliquots of samples,
controls and standards. The mixture is incubated for 1 hr. Solid phase donkey
anti-rabbit IgG antiserum is then added, followed 15 minutes later by 2 ml 0.9%
NaC1. After centrifugation the supernatant is decanted to waste. The
radioactivity of the solid-phase matrix pellets are counted in a gamma counter.
The normal adult fasting range was 2.8-13.5 mU/l with intra-assay CV of 4.2%
and inter-assay CV of 4.8%
METABOLITES:
Whole blood [0.5 ml] was added volumetrically to 2 ml 0.77 mol/l
perchioric acid and thus weighing omitted in the field. After mixing, the tube was
centrifuged at 2500 g for 5 mm and the protein-free supernatant removed. The
supernatant was placed in plain tubes and stored at - 40 °C for later analysis at
Newcastle. Glucose, lactate, pyruvate, alanine, glycerol, acetoacetate and 3-
hydroxybutyrate were determined in the unneutralised perchiorate extracts by
fluorometric enzymatic methods (Burrin et ci, 198 7;Harrison et ci, 1988) on the
Cobas Bio. The assay cocktails and reaction sequences are given below briefly.
4.3.8 - Glucose:
Two aliquots of plasma were used, one for immediate analysis to inform
the subjects and the other to be kept stored in deep freezers for assaying at
Newcastle. For the former purpose, the SKD glucose test kit method, based on 0-
toluidine reaction, was used which was subsequently substituted by an enzymatic
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method using a Beckman Astra System. At Newcastle, plasma glucose was
measured in the department using the YSI. The principal reactions were
three (Burrin et al, 1990). The glucose assay in YSI is dependent upon the glucose
oxidase which results in the formation of D-gluconic acid and hydrogen peroxide
as follows:
Reaction I:
D-glucose + 02	 lucoseoxidase> D-gluconic acid + H202
The hydrogen peroxide produced is measured by electrode.
The probe, then oxidises a constant portion of the hydrogen peroxide at
the platinum anode (Reaction II).
Reaction II:
H202	> 	 2H+O2+2e
The current thus created is directly proportional to the glucose level in the diluted
sample. The circuit is completed by a silver cathode at which oxygen is reduced to
water (Reaction ifi).
Reaction Ill:
4H + 02	 >	 2H20-4e
Although a great amount of oxygen is present in this process, note that the
23AM does not measure oxygen. Nor does it respond measurably to normal
changes in atmospheric pressure. The plasma glucose samples taken for
classification or confirmation purposes were based on this method.
Glucose samples taken for glucose with the other metabolites during the
metabolic responses following OGTF study [Chapter, 10], were analysed using
the Cobas Bio Centrifugal analyser. The reaction sequence for the assay is:
Glucose + ATP	 Hexokinase	 Glucose-6-phosphate + ADP
Glucose-6-phosphate + NADP 	 G6PDH
6-phosphogluconate + NADPH + H
Main reagent: 0.7 ml glucose buffer, 0.7 ml pyruvate buffer, 2.25 mg NADP and
2.6 mg ATh
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Start reagent: 7.0 uL hexokinase and 7.0 Ui G6PDH.
The coefficients of variation of the assay were 1.2, 1.1 and <1 % for mean
plasma glucose levels of 3.8, 9.3 and 15.4 mmol/L.
4.3.9 L-lactate:
Main Reagent: 0.1 M Tris-HC1, 1% (vlv) hydrazine hydrate and 1 mM NAD pH
9.3. Start Reagent: 30 U/mi lactate dehydrogenase.
The assay CVs was 7.2% for low and 4.4% for high values. The reaction
sequence for the assay is:
L-lactate + NAD	 LDH	 pyruvate + NADH + H
4.3.10 Pyruvate:
Main Reagent: 0.4 MK phosphate and 40 uM NADH, pH 7.0;
Start Reagent: 2 U/mi lactate dehydrogenase. The assay CVs were 5.0% for low
and 4.7% for high values. The reaction sequence for the assay is:
Pyruvate + NADH + H LDH>	 L-lactate + NAD
4.3.11 Alanine:
Reagent: 40 mollLtris (hydroxymethyl) methyl-amine buffer, pH 10. The enzyme-co-
enzyme stock were 2 mg NAD, 10 uL in imi phosphate buffer plus 0.7 ml alanine
dehydrogenase. The assay CVs were 6.5% for low and 6.4% for high values. The
reaction sequence for the assay is:
Alanine + NAD	 ADH
>
	 Pyruvate + NADH + H
4.3.12 3-Hydroxybutyrate:
Buffer: 0.1 mol/l TRIS, 1 mol/l hydrazine hydrate, 2.7 mmol/l EDTA
[disodium salt] adjusted to pH 8.5 with 10 mol/ hydrochloric acid.
Enzyme reagent	 : 10 mg NAD and 350 l 3-hydroxybutyrate dehydrogenase
[7.5 U] in 5 ml 0.1 mol/l phosphate buffer, pH 7.4. The working reagent is
prepared by adding 0.7 ml of this solution to 8.8 ml of the buffer. Top standard
[120 mol/l] was used to set up PM voltage. The assay CVs were 5.6% for low
and 6% for high values. The reaction sequence for the assay is:
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3-Hydroxybutyrate + NAD
Acetoacetone + NADH + H
4.3.13 Glycerol:
Reagent: Glycerol buffer of 0.2 moIJL glycine buffer containing 1 mol of
hydrazine and 0.01 mol of magnesium chloride per litre. The enzyme-co-enzyme
stock were: 2 mg of NAD, 2 mg of ATP and 5 l of glycerol-3-
phosphodehydrogenase [G3PDH]. The assay CVs were 7.0% for low and 4.3 %
for high values. The reaction sequence for the assay is:
Glycerol + ATP
	 Glycerokinase	 Glycerol-3-phosphate + ATP
Glycerol-3-phosphate + NAD
G3PDH
>Dihydroxyacetone phosphate + NADH + H
LIPIDS
4.3.14 NEFA:
Fatty acid concentration was determined using a NEFA Wako commercial
kit on the Cobas Bio Centrifugal Analyser (Kizox and Jones, 1984). The reaction
depends on the conversion of fatty acid to acyl-00A by acyl CoA synthetase
[ACS]. Coupling of this synthetase with acyl-CoA oxidase [which oxidises acyl
CoA to enoyl CoA and generates H 202], has made it possible to quantify non-
esterified fatty acid. The H 202
 generated by the oxidase is determined by the
oxidative coupling of the H202
 with 4-aminoantipyrine and phenol by peroxidase
[POD], which produces a coloured quinone dye that can be determined by
measuring the increase in absorbance at 500 nM. The assay CVs were 2.7% for
low and 2% for high values. The reaction sequence for the assay is:
NEFA + CoA + ATPAcylCoAsynthetase Acyl-CoA + AMP + PPi
Acyl-CoA + 0	 ACO2
H202
 + 4-aminoantipyrine + phenolPOD
Enoyl-CoA + H202
Red quinone dye
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4.3.15 Cholesterol:
Total serum cholesterol was measured enzymatically by the in Cobas Bio
analyser after hydrolysis of cholesterol esters by cholesterol esterase and
oxidation of cholesterol by cholesterol oxidase. This method is based on Deeg et
al (Deeg et al, 1982). The assay CVs were 3% for low and 2% for high values.
The reaction sequence for the assay is:
Cholesterol ester + }i20 	 Cholesterol esterase Cholesterol + RCOOH
------------------------>
4.3.16 Triacylglycerols (Triglycerides):
Serum acyiglycerols were measured in the Cobas Bio analyser using an
enzymatic method (Megram et a!, 1982). They are measured as glycerol using
glycerol kinase after hydrolysis of the triacylglycerols by lipase to glycerol. The
assay CVs were 2.4% for low and 2.3% for high values. The reaction sequence
for the assay is:
Triacylglycerols	 Lipase	 Glycerol + fatty acids
Glycerol + ATP	 GK	 Glycerol-3-phosphate + ADP
Glycerol-3-phosphate + 02 G-3-P-oxidaseDihydroxyacetone phosphate + H202
4.3.17 Uric acid:
Serum uric acid concentration was determined by an enzymatic
colorimetric method (Fossati et a!, 1980) with uricase and 4-aminophenazone
[PAP] using Cobas bio [4.3.2]. The principle of the reaction is:
Uric acid + 0 + 2 H20 Uricase	 allantoin + CO + H202	 2	 2
The quinoneimine formed is proportional to the uric acid concentration
and it is determined by measuring the absorbance in the range of 480 - 550 nm.
The CV for serum uric acid levels of 5.9 mmoIJl was 1.8 %
4.3.18 Fructosainine:
Serum fructosamine was measured using a Cobas Bio Centrifugal analyser
(Roche, Diagnostics, UK). The method employed is similar to that described by
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Hindle et al (1985). In this method serum is mixed with 0.1 mmol/1 carbonate
buffer, pH 10.35, containing 0.25 mmoIJl nitroblue tetrazolium (NB!') at 370 C;
the absorbance at 530 nm was measured at 11 and 15 minutes after mixing.
Quantitation was by comparison with standards of 1 deoxy-1-morpholinofructose
(DMF) in albumin (40 gIl) similarly treated.
4.3.19 HOMA assessment of 13-cell function and insulin resistance:
The fasting plasma glucose and insulin concentrations in each normal
subject or NIDDM patient are set at a level characteristic for that individual for a
given state of nutrition (Turner et al, 1979). The fasting plasma insulin
concentration is largely determined by the glucose concentration and the basal
hyperglycaemia in diabetes appears to arise from the feedback loop between the
liver and 13-cell, thereby maintaining an effective insulin action in the liver and at
the periphery. The degree of basal hyperglycaemia is thus determined by a
combination of 13-cell deficiency and insulin resistance. The interpretation of the
'set' of a feedback ioop termed "homeostasis model assessment" [HOMA]
(Matthews et al, 1985). Thus, HOMA was based on estimation of fasting glucose
and insulin concentration. Assuming that normal-weight normal subjects aged <
35 years have 100 % 13-cell function, and an insulin resistance of one, the values
for a patient can be assessed from the insulin and glucose concentrations by the
formulae: 13-cell function [%] = 20 x insulin I [glucose - 3.5], and [near
approximation] resistance = insulin I [22.5 e" Zl1C08] (Matthews et al, 1985). It
should be noted that these data are based on Caucasian subjects.
4.4 GENERAL STATISTICAL APPROACH
In order to interpret and make sense (Abramson, 1988) in using these data
further analysis and computing should be carried out.Statistics furnishes ways and
means to defme objectively and introduce order to the steps and procedures used
for forming conclusions from a sample of data. Statistics is mainly concerned with
describing of the population characteristics and analysis or testing hypotheses
(Daniel, 1991). The categorical qualitative data, nominal and ordinal as well as
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the numerical quantitative data, discrete or continuous were the main types of data
used in this thesis mainly from a survey. The tests that apply to draw inferences
from ordinal information are not suitable to be applied to categorical information
but can still be applied to cardinal information with a loss of efficiency. The tests
that apply draw inferences from cardinal information are not suitable to be applied
to categorical or to ordinal information. For this thesis, there were four sets of
samples of different sizes that were intended to examine different aspects
including the OCTVF reproducibility [n=35 subjects, chapter 6], dietary [Chapter
7] and physical activity assessment [Chapter 8] [n=95 subjects] and the metabolic
and hormonal responses [n=43 subjects, Chapter 9] but all were drawn from one
main subpopulation [n= 125 subjects, Chapter 5] . While it is felt that it is not
important to get a proportional representation of the different types for study
purposes, it was shown that a reasonably unbiased sample representation with
respect to the various types of areas of interest was achieved. Also it is
generally recognised that in developing countries this type of survey is not
common and that awareness of people towards responding to such exercise is still
relatively low. When the responses were by ranking as in dietary assessment, it is
to be noted that rank one signifies the highest degree of importance, in relative
terms, given to the respective parameter and so on, in an ascending order, for the
rest of the ranks. There are two interpretations for explaining no rank occurrence;
the first is that a respondent does not have enough information to acknowledge
and rank the particular parameter, the second is that the respondent does not
consider the particular parameter to be important enough to be included for
ranking. In some questions, the first interpretation seems to apply to a number of
respondents and the second interpretation applies to the rest. In this study the
second interpretation is considered to be more plausible. This is mainly due to the
high number of the no rank occurrences for specific factors/parameters that are
originally expected to have a low level of importance from insights gained from
the field study.
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The data were carefully prepared and examined before proceeding to the
substantive analysis in particular with respect to extreme values [outliers] or the
distribution of observations. Data were described numerically in means with
standard deviations [SD], standard error of the mean [SEM] or range as measures
of central tendency or dispersion (Swinscow, 1983). At the same time a histogram
was produced to see the shape of the distribution and two quantities were
examined, the skewness, which is a measure of asymmetry, and kurtosis, which is
a measure of flatness or peakedness.
Furthermore, all data were tested for normality by using the Kolmogorov-
Smirnov one sample test [K-S] (Armitage, 1987). This non-parametric test was
used to determine how well a random sample of data fits a particular distribution
[Uniform, normal, or Poisson] and it is based on comparison of the sample
cumulative distribution function to the hypothesized cumulative distribution
function. The K-S one sample test takes explicit account of ordering and deals
with each of the observations on a separate basis and so no information is being
lost because of grouping. The K-S output might show an observed significance
level of 0.05, small enough to cast doubt on the assumption of normality. This
revealed normally distributed variables like age, BMI and glucose and thus
parametric tests were applied and skewed variables like insulin and SHBG. The
latter were non-linearly transformed by using log 10. It has the unique property that
it is possible to get a confidence interval for the difference between the groups
that relates to the original data and fortunately, taking logs is very often successful
in removing skewness and also making variances more equal. This approximated
a normal distribution but when this cannot be achieved the rank distribution-free
[non-parametric] methods were used (Siegel et al, 1988).
Throughout the thesis except chapter 6, testing the null hypothesis in
responses between three groups [glucose intolerance groups namely; NOT, iar,
NIDDM], or between two groups [nationality wise groups namely; Nationals and
non-nationals] was carried out. To assess whether a factor had a significant effect
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over all groups, the analysis of variance for a normally distributed or transformed
variables or alternatively the Kruskal-Wallis one-way analysis of variance were
used.
When comparing between the two groups of nationality or between any
two groups of glucose intolerance categories, the unpaired t test or the non-
parametric comparison of two groups, Mann-Whitney test were applied
appropriately. A crosstabulation or frequency tables [contingency tables]
procedure with the Chi squared statistics for large cells samples or the Fisher's
exact test for small samples were also considered when comparing two or more
categorical data. Descriptive data, both continuous [Mean, SD, SEM or Range]
and categorical [No (Percentages)] were presented in tables and some were
illustrated diagramatically using linear or bar graphs.A p value of < 0.05 was
considered statistically significant and indicated accordingly by abbreviations
namely; a (i<0.O5), b (p<0.Ol), or c (p<0.00l).
4.5 COMPUTING METHODS:
A single-user configuration of the microcomputer systems (IBM, 1987)
and (Amstrad, 1989); were used to facilitate the layout of this thesis ((VJrdstar
60, 1989). These run the Micro Soft Disk Operating Systems (MSDOS, version
3.01) and thereby MSDOS computer applications softwares packages. The
investigator handled the data collected using the following software for:
management (dBase III Plus, 1990) ; statistical analysis (SPSS/PC+, 1989)
(Brown, 199(J) graphical presentations (Micrografx, 1988; and/or Fig F, 199(3) in
addition to some of the utility programmes (Davis, 1989).
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SUMMARY
This chapter includes an overall description and analysis of the examined population
including socioeconomic and environmental factors. The prevalences of NIDDM,IGT,
hypertension and some related cardiovascular risk factors; insights into the pathogenesis of
glucose intolerance and finally, comparisons based on glucose tolerance groups are shown and
discussed.
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CHAPTER FIVE:
POPULATION FEATURES, RISK FACTORS and PATHOGENESIS.
5.1 INTRODUCTION
Case finding for diabetes mellitus with or without the postulated causal
factors had become almost a traditional activity worldwide (Jarrett, 1986). The
OGTF is the best screening test at present (Home, 1988) but if glucose loading is
not possible the use of a fasting plasma glucose has been recommended (Finch et
al, 1990). Others have, however, found that both fasting blood glucose and serum
fructosamine are poor screening and diagnostic tests for diabetes, and glucose
loading is required (Swai et al, 1988). IGT cannot be diagnosed at all without
glucose loading, as its definition depends on the 2-h post-load value.
A major objective of a community screening programme should be to
identify individuals with ^ one diabetes risk factors (Position- Statement, 1989).
The major risk factors or high-risk groups for NIDDM include : 1) a family
history of diabetes; 2) Obesity; 3) Ethnicity; 4) age > 40 years; 5) previously
identified IGF;and 6) hypertension or significant hyperlipidaemia. Identifying the
magnitude and the spread of these clusters of risk factors within a community or
between communities is also a common epidemiological practice. Symptoms of
diabetes included excessive thirst and hunger, frequent urination and weight loss
may be useful in the diagnosis but should be confirmed by glucose testing. The
effect of socioeconomic and environmental factors on diabetes were known and
described before [Chapter 1]. An increased frequency of hypertension in diabetes
is well-known (Jarrett et al, 1975) and, although half of diabetic subjects might
have hypertension the true association between hypertension and diabetes once all
confounding factors are considered is still controversial (Drury, 199(J). Diabetes
mellitus is also characterised by a lack of insulin secretion and/or increased
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cellular resistance to insulin resulting in hyperglycaemia and other metabolic
disturbances (Rossini et al, 1988).
NIDDM is common in Saudi Arabia with a prevalence of 4.5 - 6 % in
adult middle-aged males [Chapter 3]. All surveys to date were, however, carried
out using a single fasting sample [either whole, capillary blood or plasma] with or
without urine collection as a first screening procedure. This will underestimate
the true prevalence rate and does not allow estimation of the prevalence of lOT.
Moreover, no study has examined the occurrence in diabetes of hypertension,
central obesity or metabolic-endocrine groups of risk factors. Earlier studies, also
did not differentiate between nationals and non-nationals with respect to these
aspects [Chapter 9]. Thus, the prevalence rate of diabetes in Saudi Arabia is
probably much higher than the rates reported previously [Chapter 3] and this
hypothesis needs to be investigated (Ekoe, 1988). Hence, the aims would be:
1). To describe socioeconomic and environmental aspects that might be related to
glucose intolerance.
2).To find out the prevalence of glucose intolerance (NIDDM and ICT!') using the
WHO recommended OGrr.
3).To assess the prevalence of hypertension, obesity whether gross or abdominal,
and some metabolic and endocrine risk factors.
4).To compare these aspects and risk factors in the glucose tolerance groups.
5.2 SUBJECTS and METHODS
Jeddah city is homogeneous in environment but not in lifestyle. However,
the samples collected from two areas were, in general, homogenous in lifestyle
and were mainly middle-class. Initially, there were 250 subjects who recorded
their names and agreed to participate in the study. However, the total number
who actually turned up and were examined fully was 125 giving a response rate of
50%. It should be emphasized that the results presented in this chapter were
obtained from the continuous variables that were available for the whole
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examined group (n= 125) and from the questionnaire data (categorical) that were
available only for 80% of the subjects (n=95), since the questionnaire data that
were obtained from the pilot group (n = 30) were basically investigatory and found
to be unreliable and thus excluded. The strategy in describing the results and the
discussion section will follow the following scheme. Firstly, a general description
for the population features will be given. Secondly, comparisons in relation to
glucose intolerance groups will be discussed.
Chapter four provided a detailed description of what will be briefly
summarized here. The study was conducted over a period of 12 weeks and in two
different places but under comparable conditions. Male subjects of 20 years and
above were included and subjects who at the time of study had already been
diagnosed as having diabetes or hypertension were excluded. A detailed
description of the study was given a day or more in advance to each subject who
signed an informed consent and came on appointment. To maximize attendance
an official off-work sheet was provided if necessary and the weekends were
utilized when appropriate. The investigation utilized the whole morning and
maximum of three subjects a day were handled by the investigator. Subjects
attended at 8:30 am having fasted from 11:00 pm the night before. On arrival,
each subject was guided to their place to wait for approximately 15 minutes
during which the study description and instructions were reiterated to them. Once
overnight fasting was confirmed the participants were subjected to further
examination. Anthropometric measurements were performed including weight
[kg] and height [cm] to deduce BMI [kglm2]; and waist [cm] and hip [cm]
circumferences to calculate WHR. Fasting venous samples were taken for
glucose, fructosamine, cholesterol, triglycerides, uric acid, insulin, proinsulin and
SHBG.
OGFft were then performed. Beforehand, subjects ate their normal diet
which contained a minimum 300g of carbohydrate. No instruction was given
regarding physical activity, since the pilot study at visit two [section 4.1.2] had
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indicated that the subjects were generally inactive. Smoking was not permitted
and no-one drank alcohol. Glucose [75g in 300ml] was consumed over five mm
and the time after the first sip of solution was recorded. Post load samples at 1-h
and 2-h were also taken for glucose and insulin. The waiting time between
samples were occupied with filling up the set of questionnaires, blood pressure
recording and health education or entertainment. Sitting blood pressure was
measured twice on the same arm using an automatic sphygmomanometer. The
questionnaire which was completed by the investigator by interview with each
participant, was written in English [Appendix 1-5] but translated by the
investigator on the same sheet into the language spoken by the participants
[Arabic]. A feedback questionnaire about the study were requested from the last
half of the subjects.
Blood was separated using a refrigerated centrifuge and stored at -40°C for
subsequent analysis in Newcastle. There, each metabolic or endocrine variable
was assayed appropriately [section 4.3]. All measurements and subsequent
analyses were performed by the author.
Most cut-off points for biological and non-biological variables are often
based on recommended classifications, while the minority were selected
arbitrarily by the investigator. The concept of likelihood or risk of a particular
parameter can be used in which the two intervals are designated high-risk and
low-risk group. This approach is used for all measured parameters in this study
including dietary [Chapter, 7] and physical activity [Chapter, 8] assessment.
Dichotomous grouping was carried out for some socioeconomic factors.
Hence, residence duration in Saudi Arabia was defined by a cut-off point at >15
years; high education level was considered for university or above responses and
high income [social class] by earning a salary of 4500 SR [$1200] or above per
month. A family history of diabetes or hypertension was recorded when any first
degree relative [either father, mother, brother or sister] had these disorders.
Smoking cigarettes was considered only for analysis and as the number of ex-
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smokers was small, they were counted with non-smokers.
Criteria, definitions or cut-off points for the various variables are shown in
Thble 5.1. Diabetes and IGT were defined according to the 1985 WHO criteria for
epidemiological studies using venous plasma - that is, a fasting venous plasma
concentration ^ 7.8 mmol/l or a venous plasma glucose concentration two hours
after OGTT ^ 11.1, or both, for diabetes; and a fasting plasma glucose
concentration ^ 7.8 mrnol/l with a venous plasma glucose concentration two hours
after OGTT of 7.8-10.9 mmol/1 for IGT. Body mass index was calculated as
weight/height2
 (kg/rn2). Overweight was defined as a BMI ^ 27 and obesity as a
BMI of ^ 30. WHR greater than one which divided the number of subjects into
two halves is considered high. Since, all subjects were found above the cut-off
points of 0.93 which was suggested by Larsson et al (1984) for Swedish men, or
0.92 which was suggested by Jones et al (1986) for British men.
Hypertension was defined based on WHO criteria (WHO, 1978) - that is,
systolic blood pressure ^ 160 mmHg or diastolic pressure ^ 95 mmHg, or both.
Mild hypercholesterolaernia was defined as a serum total cholesterol
concentration of ^ 5.2 mrnol/1. Hypercholesterolaemia, was defined as a serum
total cholesterol concentration ^ 6.5 mmol/l. Hypertriglyceridaemia was defined
as a serum triglyceride concentration ^ 1.7 mrnol/l. Hyperuricaemia was defined
as a serum uric acid concentration ^ 0.42 mmol/l.
Data were handled with dBase+ffi and analysed by means of SPSSC+,
and was based on glucose tolerance groups (discrete explanatory variable). The
data have also tested for normality using K-S test. Differences between the three
groups were examined by means of ANOVA for normally distributed variables
[age, BMI] or by means of the Kruskal-Wallis test. Similarly, the comparison
between any two groups were by unpaired t test or Mann-Whitney test. A p value
<0.05 was taken to be significant.
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5.3 RESULTS
Total study group:.
An endogenous place of origin was found in 56 %, unlike the duration of
residence of> 15 years in Saudi Arabia which was found in 43 %of the total study
group. The majority of subjects [92%] had their basic primary school or above
while 1 % were illiterate. The majority of subjects are working [96%] either with
Government [47%], a private firm [42%] or were self employed [7%] and none
were unemployed. Only 1 % were retired and 3% were students. The monthly
income was used as an index for social class and an arbitrarily income of 4500 RS
($1200) is used as a cut-off point. Thus, "low" social class subjects (56%)
slightly exceeded "high" social class subjects (44%). Marriage was found in 93%
and consanguinity with wife is shown in 31 %. This population had 398
children of whom 5% had died, and none of their children were known to have
diabetes mellitus.
Social habits covered different activities. Smoking presently or in the past
was found for cigarettes [46%], shisha [Hookah, Hubble-bubble pipe] [34%], both
[8%], cigars [2%] and none were pipe smokers. Regularity in smoking was found
for cigarettes (77%) vs shisha (63%). Smoking of more than 10 cigarettes a day
was found in 59% and 55% smoked for ^ 10 yrs. Smoking of shisha 5 times per
week was found in 47% and smoking for ^ 10 years was found in 37%. Shisha
smokers usually used 1-4 boxes per week [weight 0.5 to 1 kg per box of tunbac
(old fermented fruits)]. 41% never smoked either cigarettes or shisha. Past and
short experiences of drinking alcohol or eating Qat [Plant from Yemen] were also
found in 17% and 5% respectively. The experience in drinking alcohol extended
sometimes between 1 to 22 years whilst for Qat the most recent experience was 1
year prior to the questionnaire. All Qat-eaters are from Yemen.
The historical background revealed several aspects. At least a fifth of the
subjects gave a history of one or more of the classical symptoms of diabetes.
Excessive urination was found in 27%, thirst in 18%, hunger in 20%, unchanged
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weight during the preceding three months in 58% and impotence in 8%. Although
known subjects with diabetes or hypertension were excluded from the study, a
few subjects still responded positively and had been told by a doctor, at one stage
of their life, that they had diabetes (7%), high blood pressure (7%) and high lipids
(2%). Almost a quarter (23%) of them gave a history of receiving off-counter
medicines for short-term illnesses which they were asked to stop on the day of
investigation. They gave, also, a history of having pain or discomfort, pressure or
heaviness in their chest (7%), had a history of severe pain across the front of their
chest lasting for half an hour or more (2%), had a history of having pain in either
leg on walldng (24%), while none had weakness or loss of strength in an arm or
leg lasting for 24 hours.
A family history of diabetes was found in 24% of fathers, 25% in mothers,
and both parents in 6.3% and in both parents plus either brother or sister in [1%].
A history of diabetes in any first-degree relative was found in 48.4%. Similarly,
family history of hypertension was found in fathers [16%], mothers in 20% and in
2% in both parents. A history of hypertension in any first-degree relative was
found in 39%. A family history of both diabetes and hypertension was found in
23%. There were a total number of 593 siblings of whom 20% were already dead;
18% gave a history of diabetes and 11% hypertension.
The prevalence rates of glucose intolerance and risk factors in the whole
population are shown in Table 5.1. Glucose intolerance according to WHO
criteria was found in 41 % with 14% diabetes and 27% IGT. Also shown, are high
rates of gross obesity [29%], abdominal obesity [50%], hypertension [5%], mild
hypercholesterolaemia [29%], hypertriglyceridaemia [27%], hyperuricaemia
[40%], first-degree history of diabetes [48.4%] and smoking in [43%].
Glucose tolerance groups:
The classification of subjects according to glucose tolerance groups and
compared by two criteria [WHO and NIDDM] is shown in Table 5.2. Those
classified as NGT and NIDDM showed no differences. The rates for lOT by
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WHO was double the rate of those found by NDDG, but with the creation of 14 %
in a non-diagnostic group in the latter criteria.
Age structure by glucose tolerance groups is shown in Table 5.3. A
normally distributed age structure is clearly observed. Half of the subjects [47%]
were between 35-44 years. The prevalence of NIDDM increased with age and
those above 35 years had double rates than those before 35 years.
Data related to glucose tolerance groups are presented in tables [5.4 - 5.81.
The general socio-economic characteristics of these subjects by glucose tolerance
groups showed no significant differences in various aspects including education
and social class [income].
The glucose tolerance status in relation to risk factors [Table 5.5] showed
that subjects with NI1)DM and KiT had significant [p < 0.0001] and higher rates
of family history of diabetes only compared to NGT. Smoking was higher in
NIDDM, lOwer in IGF, but that was not significant. Also, subjects with NTDDM
had a two-fold increased rate, but not significant because of small numbers, of
obesity and a two-fold increase in abdominal obesity whereas IGT subjects had
intermediate values and WHR was only significant [p =0.03]. The rates of
hypercholesterolaemia [^ 6.5 mmol/l] in NIDDM and IGT subjects were the same
and three times higher than in people with NGT, and there was a three-fold
increase in hypertriglyceridaemia in NIDDM whereas IGT subjects had
intermediate values [^ 1.7 mmolll] [p =0.02]. However, there was no significant
relationship between hypertension and glucose tolerance status, nor with
hyperuricaemia.
General and clinical characteristics by glucose tolerance groups are shown
in Table [5.6]. Age is comparable, although it tended to be higher, but not
significantly as so the glucose intolerance worsens. Also, subjects with IGT and
NIDDM were slightly shorter than normal [ns]. BMI was similar for both ICIT and
NIDDM [KiT vs NGT, [p < 0.05]. WRR was significantly [p < 0.01] higher in
NIDDM versus NGl'. Systolic and diastolic blood pressure were slightly higher in
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the glucose intolerance groups compared to those with NOT, but these differences
were not significant.
Glucose, insulin, fructosamine values and 13-cell function and insulin
resistance as assessed by the HOMA model were all shown in Table 5.7.
Obviously and not surprisingly, the glucose AUC was significantly higher in
subjects with NU)DM, intermediate in lOT and lowest in NOT. The same trends
were also found for fructosamine. Also, fasting insulin was higher in NLDDM,
intermediate in lOT and lowest in NOT, but this was not significant. However, the
insulin AUC was significantly higher in lOT vs NOT [p =0.00001] and NIDDM
[p=O.006] and both NGT and NIDDM had comparable values. HOMA
assessment of 13-cell function showed that subjects with IGT had significantly
higher values than NOT [p < 0.05] and NIDDM [p < 0.05] subjects, and those
with NIDDM had the lowest values as compared to NOT [p <0.05] and JOT [p <
0.05] subjects. Insulin resistance evaluated also by HOMA revealed higher values
for NTDDM [p <0.01] and intermediate for lOT [p <0.05] when compared to
those with NOT.
The metabolic-endocrine group of risk factors including cholesterol,
triglyceride, uric acid, fasting insulin and proinsulin, proinsulin:insulin molar ratio
and SHBG are shown in Table 5.8. Fasting insulin was discussed earlier.
Proinsulin values were significantly higher in NIDDM, intermediate in lOT and
lowest in those with NOT, [NU)DM vs lOT, p= 0.001; NIDDM vs NOT, p=
0.00001; IGT vs NGT, p = 0.003]. The proinsulin:insulin molar ratio differed
significantly in subjects with NTDDM compared with those with JOT [p 0.02] and
with NOT [p=0.002]. SHBG values were comparable and not different between
the three glucose tolerance groups.
5.4 DISCUSSION
A cross-sectional epidemiological study provides estimates of the
prevalence of diabetes or other diseases together with information on the general
characteristics of the studied population at the time when the study is conducted
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(Vst, 1978). A high prevalence of diabetes meffitus in Saudi Arabia have been
recorded in few studies (Fatani et 1, 1987; Bacchus et al, 1982, see Chapter 3).
Although, their samples were large, these studies lack the initial screening using
an OGT which allows identification of subjects with IGT. These studies were,
also, deficient in determining several confounding factors known to contribute to
the increased prevalence of diabetes such as socio-economic, environmental or
physical measurements. This study is the first which has used the OGU in initial
screening and reported cases of IGT. It was also, originally planned to examine
several anthropometric and metabolic-endocrine group of risk factors and has
demonstrated for the first time several features which were not reported before in
Saudi Arabia, although mentioned in the literature worldwide.
High rates of both NIDDM [14%] and IGT [27%] were shown in this
study compared to previous prevalence estimate for diabetes of 5 %. These
prevalence might be too high due, perhaps, to selection bias, yet the figures are
alarming. Similarly, we have reported risk factors prevalence not reported before
in conjunction with diabetes in Saudi Arabia, such as smoking [43%], gross
obesity [29%], abdominal obesity [50%], hypertension [5%] and lipids
[Cholesterol, 7%; Triglyceride, 14%]. This has emphasized the importance of
screening such factors in any community programme. Both genetic and
environmental factors are of importance in the aetiology of diabetes mellitus
(V.st, 1978) and can contribute to this high prevalence.
Prevalencediffers with gender. NIDDM is commoner in females than in
males in the USA, whereas the reverse is true in England (RWdn et al, 199(1). In
addition, urban-rural differences are known but none of these aspects were
compared in this study and are obvious topics for future work. Only males were
studied which accords with some major studies carried out in western societies
(Jarrett et al, 1979; Keen et a!, 1982).
The prevalence of NIDDM, in this study, increased with age a finding
consistent with previous reports (Davidson, 1979; Defronzo, 1981) and act as
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independent determinant of glucose tolerance (Shimokata et al, 1991). Also, there
was an increased prevalence of NIDDM and IGT in those who had a positive
family history of diabetes and this may, at least, reflect that many of the subjects
were aware about the disease in their family.
The WHO and NDDG recommendations have been the most widely used
diagnostic criteria since 1980. They were similar since, 1) both permit the
diagnosis of diabetes in asymptomatic individuals with unequivocally elevated
plasma glucose concentrations and, 2) both recommend that in asymptomatic
individuals, a 2-h 75 g OGTT be performed to establish a diagnosis of diabetes or
IGT. They also differ in two major aspects which has lead to discrepancies in
classification of individuals based on OGTT results. 1) To class an OGTT as
normal, WHO does not stipulate an upper limit of normal, and implies that FBG
may not be ^ 6.7 mmol/l, since such levels constitute diabetes, whereas NDDG
requires a FBG < 6.4 mmol/l. 2) To classify an individual using WHO criteria,
mid-test glucose values are not considered, and need not be obtained. Moreover,
NDDG recommends 5 PG values, whereas WHO requires only two. Both,
however, require fasting and 2-hour post load glucose values, but NDDG also
recommends that glucose values at mid-test levels [½ hr, 1 hr or 1 ½ hr post load]
be used in order to determine an individual's diagnostic class. If the glucose level
of one of these mid-test samples does not meet certain specific criteria, the OCTT
is considered "Non-diagnostic" in the NDDG classification. Thus in this study, it
is inappropriate to use NDDG criteria since it gave 14 % as non-diagnostic,
although the rate of IGT reduced to half.
The 2-h value after 75 g OGTT may be used alone or with the fasting
value for epidemiological or population screening purposes. The fasting value
alone is considered less reliable since true fasting cannot be assured and spurious
diagnosis of diabetes may more readily occur.
Fructosamine, along with glycated haemoglobin, is a poor screening and
diagnostic test for diabetes and I(fl (Swai et al, 1988). In this study the diagnosis
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was not based on fructosamine but the differences that were found in the glucose
tolerance groups agreed with the report which showed that fructosamine seems
unsuitable for the diagnosis of mild abnormalities in glucose tolerance
(Guillausseau et a!, 1990).
Diabetes has been suggested to be a disease of the rich, and rich people
living in poor countries are known to have a higher prevalence than the poor of
these countries (W?st, 1978). Although, the prevalence for the whole population
agrees with this concept, the social class as indicated by income among other
socio-economic and environmental factors did not suggest an important role in
determining the prevalence of IGT and NIDDM. However, family history of
diabetes is a major known determinant for high rates of glucose tolerance as
evidenced again in this study where NIDDM and IGT were found more frequent
in those with a family history of diabetes. Smoking habits, unlike alcohol was a
major problem in this community. Rarity of diabetes among children of this
population might be an indirect estimate and indicator that type I diabetes was
rare.
The overall prevalence of hypertension in a community will vary
according to the age range of the population included in the survey and the
demographic characteristics of the community studied. This is the first to report
on hypertension in a community screening which was shown to be high but the
association of hypertension with glucose intolerance was not clearly found.
Several prospective studies have supported the definition of the category
of IGT, intermediate between normality and diabetes [Chapter, 2]. As an
intermediate category of glucose tolerance, it could be expected that people in the
JUT group should differ from both normal and diabetic subjects in some respects,
if this category is a true entity. This study has examined certain variables
comparing the IUT group with both normals and NLDDM. The results indicate
that means or proportions for some of the variables are indeed intermediate
between those for normal and NTDDM groups and in some showed significance.
100
As IGT is defined using plasma glucose concentration, therefore it is expected
that the mean glucose levels between three groups [NUF, I(TI' and NIDDMJ will
differ. As high plasma glucose concentration, gross obesity, abdominal obesity,
serum cholesterol and triglyceride concentrations, hyperinsulinaemia and
hyperproinsulinaemia are risk factors for atherosclerosis, the observed differences
in the means and prevalence of these variables could help to explain why IGT
subjects are at a higher risk for CVD than those with NGT.
Generalised and abdominal obesity have previously been found to be
strong risk factors for the development of diabetes (Gaal et al, 1988). Obesity
alone is said to carry a 3.2 fold diabetic risk but when the fat distribution
predominated in the upper body segment this risk increased to 10.3 (Emara et al,
1988). More importantly, as shown in this study, abdominal localization of
adipose tissue, irrespective of the degree of obesity was associated with NIDDM
or glucose intolerance (Bjorntorp, 1991).
This study reported low rates of hypercholesterolaemia compared with a
previous report from Riyadh of larger sample En =8291] (Inam ci' al, 1991). The
6.5 mmo/l.
rates at ^ 5.2mmolllwere29% vs 38% and 7.2% vs 11% at6%. Cholesterol
values tended to be higher in the glucose intolerance groups as shown in previous
reports. Hypertriglyceridaemia is a prominent feature in this community and not
surprisingly was significantly higher in those with NIDDM. In addition to
hypertriglyceridaemia, upper-body obesity, glucose intolerance and hypertension
forms in this community what is called • 'the deadly quartet" (Kaplan, 1989).
Uric acid levels, in the 'pre-diabetic state', are often high. Later the values
come down to normal or even below the control values once clinical diabetes
supervenes (Her,nan et al, 1982). In addition, hyperuricaemia may be part of a
constellation of abnormalities found in the pre-diabetic state namely an obesity-
hypertension-hypercholesterolaemia-hyperuricaemja syndrome (Albert! et al,
1986). My study demonstrated that hyperuricaemia is part of the risk factor
constellation but uric acid was unchanged in those with NIDDM or lOT.
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One of the pathophysiological schemes of classifying insulin resistance
include circulating pre-receptor antagonists of insulin action and one of these is
hyperandrogenaemia. Low SHBG values are a sign of hyperandrogenicity and can
predict the development of NTDDM (Lindstedt et a!, 1991). However in my
study, subjects with NIDDM did not have low SHBG as compared with those
with NGT. Thus, SHBG would not be considered as a predictive factor for
NIDDM in men as shown here and appears therefore to play no role in the high
rates of diabetes and obesity seen in this high risk population.
HOMA model assessment revealed that NIDDM had hypofunction of the
/3-cell which was reduced by 6%, in contrast to the 13% hyperfunction in those
with IGT. Similarly, insulin resistance was a prominent feature in both NIDDM
where it was severe and IGT which was mild. It seems that subjects with IGT
characterized by mild degree of insulin resistance and hyperfunction of /3-cell, but
once /3-cell function deteriorates and insulin resistance becomes the prominent
feature, hyperglycaemia and NIDDM develop. The fmdings of proinsulin support
that found in Pima Indians with NIDDM who have a dispropotionate elevation of
proinsulin consistent with the hypothesis that /3-cell dysfunction associated with
hyperglycaemia leads to the release of proinsulin-rich immature granules (Saad et
al, 1990).
In conclusion, this population of urban men showed high rates of glucose
intolerance and CVD risk factors including smoking; obesity, gross and
abdominal; hypertension and hyperlipidaemia. Screening with proper intervention
for diabetes and IGT is recommended in Saudi Arabia using WHO criteria,
providing that the high rates described here are confirmed in a full study. Other
cardiovascular risk factors such as hypertension, obesity and lipids should not be
ignored in the screening programmes with special consideration for abdominal
adiposity. Finally, environmental factors presumably have a role in the high
prevalence of glucose intolerance found in these populations in Saudi Arabia.
These will be discussed in the future chapters.
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It must be emphasised, however, that this is a pilot study and bias cannot
be excluded and therefore, a full study will be of great interest. Moreover, with
the limitations of a cross-sectional study, there was no possibility of
discriminating between the variables which are predictive of subsequent diabetes
and those which are not. Hence, equally interesting would be a prospective
longitudinal study on the same group [n= 125] sometime during late 1993 and
early 1994 as a three year follow-up study.
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Table 5.1
Prevalence of glucose intolerance and risk factors in the whole population [n= 1251
Criteria!	 n
Definition!
Cut-off point.
NIDDM	 (WHO, 1980)	 17	 13.6
IGT	 (WHO, 1980)	 34	 27.2
All glucose intolerance	 51	 40.8
Overweight	 (^27)	 68	 54
Obesity	 (^30)	 36	 28.8
High WHR	 (>1.0)	 63	 50
Hypertension	 (WHO, 1978)
-Definite	 (160/95)	 6	 4.8
-Borderline	 (140/90)	 12	 10
Hypercholesterolaemia	 (^ 6.5)	 9	 7.2
Hypercholesterolaemia/ mild 	 (^ 5.2)	 36	 29
Hypertriglyceridaemia	 (^ 2.2)	 18	 14.4
Hypertriglyceridaemia/ mild	 (^ 1.7)	 34	 27
Hyperuricaemia	 (^ 4.2)	 50	 40
Family history of diabetes	 any first-degree relative	 46	 48.4
Smoking	 Cigarettes only	 45
	
43
Nationality	 ID identity [n= 125]	 76	 61
[n=95]	 48	 51
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75
74
53
52
33
0
8
17
15
33
25
18
30
33
33
<25
25 - 34
35 -44
45 -54
^ 55
All
4	 3
38	 31
59	 47
21	 17
3	 2
125	 100
Table 5.2
Classification of glucose tolerance groups [WHO vs NDDG].
CRiTERIA	 NGT	 IGT	 NIDDM	 Non-	 Total
-diagnostic
WHO	 n	 74
	
34
	
17
	
125
(%)	 (59)	 (27)	 (14)	 (100)
**NDDG n	 74
	
16**	 17**	 18	 125
(%)	 (59)	 (13)	 (14)	 (14)	 (100)
All values for classification are based on venous plasma concentration.
**The National Diabetes Date Group (NDDG) requires an intermediate time point of ^ 11.1 inmol
(2.0 gIl) for these categories.
Table 5.3:
Age structure by glucose tolerance groups no (%)
Age Group	 Glucose tolerance groups (%)(years)	 H	 NGT	 IGT	 NIDDM
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Table 5.4
Environmental and socio-economic by glucose tolerance groups (n = 95).
NGT	 IGT	 NIDDM
n	 55	 25	 15
(%)	 (58)	 (26)	 (16)
Nationality:
Saudis	 45	 58	 62
Non-Saudis	 55	 42	 38
Place of origin:
Saudi Arabia	 51	 61	 63
Elsewhere (Mediterranean
Indian, South East Asian
and Africa)	 49	 39	 37
Residence duration in
Saudi Arabia:
up to l5yrs	 60	 42	 69
>l5yrs	 40	 58	 31
Education level:
Up to secondary school	 61	 65	 44
University or above	 39	 35	 56
Income (SR):
Up to 4500	 63	 38	 56
>4500	 37	 62	 44
Symptoms of CVD:
The response to the questions:
uHaveyoueverh	 ?"
-Pain or discomfort in chest 	 3	 15	 6
-Severe pain across the front of
chest lasting for half an hour
or more
	 2	 4	 0
-Pain in either leg on walking 	 25	 12	 38
-Weakness or loss of strength in
an arm or leg lasting for 24 brs 	 0	 0	 0
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Table 5.5
Risk factors prevalences by glucose tolerance status.
Glucose tolerance groups (%)
NGT	 IGT	 NIDDM P value
Family history of diabetes	 33	 84	 47	 0.0001
Smoking	 46	 37	 53	 as
Obesity [^ 30]	 26	 35	 47	 as
WHR[> 1]
	 42	 56	 77	 0.03
Hypertension [160/95 mmHg]	 7	 3	 0	 as
Hypercholesterolaemia [^ 6.5 mmol/l] 4	 12	 12	 as
Hypercholesterolaemia [^ 5.2 mmol/l] 27	 29	 35	 as
Hypertriglyceridaemia [^ 2.2 mmol/l] 11	 15	 29	 as
Hypertriglyceridaemia [^ 1.7 mmol/l] 20	 29	 53	 0.02
Hyperuricaemia [^ 4.2 mmol/l]	 39	 38	 47	 as
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Table 5.6:
Clinical characteristics by glucose tolerance groups in mean ± SEM or range[n= 125].
NGT	 IGT	 NIDDM
n(%)	 74(59)	 34(27)	 17(14)
Age	 37±7	 39±8	 41±9
[yrs]	 (20-55)	 (20-60)	 (30-64)
Weight	 78 ± 15	 83 ± 13	 82 ± 15
[kg]
Height	 1.70 ± 0.1	 1.69 ± 0.1	 1.68 ± 0.1
Em]
1BMI	 27 ± 5	 29 ± 4	 29 ± 5
[WIH2]
Waist	 95.3 ± 11.5	 99.5 ± 9.6	 101.5 ± 11.7
[cm]
Hip	 95.1 ± 11.0	 98.5 ± 9.1	 99.2 ± 11.5
[cm]
2w!	 1.00 ± 0.02	 1.01 ± 0.02	 1.02 ± 0.04
Systolic BP	 119 ± 16	 120 ± 12	 120 ± 11
(mmHg)
Diastolic BP	 74 ± 11	 76 ± 10	 77 ± 10
(mmflg)
1,NGT vs IGT, p=O.03
2, NGT vs NIDDM, p=O.Ol
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Table 5.7:
Glucose and insulin during OGTT (75g); fructosaniine and the calculated area under the
response curve [AUC] for glucose and insulin in mean ± SEM [n=125].
NGT	 IGT	 NIDDM
Glucose mmol/1:
Fasting
1-h
2-h
Glucose AUC
inmol 11 h
"23Fructosamine
mmol/1
Insulin mU/i.
Fasting
1-h
2-h
4'5'6lnsulin AUC
mU 1 1 h
5.3 ± 0.1
8.8 ± 0.3
5.8 ± 0.2
13.3 ± 0.2
2.4 ± 0.03
13.3 ± 1.4
111.2 ± 5.4
76.6 ± 5.3
134.1 ± 6.5
5.5 ± 0.1
11.3 ± 0.4
8.9 ± 0.2
17.2 ± 0.4
2.5 ± 0.05
16.9 ± 1.2
135.2 ± 8.2
151.6 ± 12.1
202.4 ± 13.1
179 ± 16
4.2 ± 0.3
8.6 ± 0.8
16.1 ± 1.2
16.5 ± 1.4
27.5 ± 2.2
2.8 ± 0.1
24.3 ± 3.8
76.2 ± 15.1
96.9 ± 18.6
131.6 ± 24.1
148 ± 35
8.4 ± 1.1
ILOMA model assessment of:
78'9 -ceii function	 157 ± 19
1O.Il.12j yp jt	 3.2 ± 0.3
1,NGTvsNIDDM,p=O.001	 2, NOTvs LOT, pO.06
3, lOT vs NIDDM, p=0.03
4, NOT vs NIDDM, p=ns	 5, NOT vs JOT, p=O.0000L
6, lOT vs NIDDM, p=O.O06
7, NOT vs NIDDM, p=ns 	 8, NOT vs LOT, p=O.O2
9, lOT vs NIDDM, p=ns
10, NGTvsNIDDM, p=O.00001
	 11, NOT vs JOT, p=O.0004
12, lOT vs NIDDM, p=O.000S
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Table 5.8:
Metabolic-endocrine group of risk factors in mean ± SEM [n= 125].
NGT	 IGT	 NIDDM
Cholesterol
[mmolIl]
1Triglyceride
[rninolll]
Uric acid
[mmol/l]
2 Fastmg insulin
(pmol/l)
4&SProinsuiin
(pmolIl)
78'9Proinsulin/
insulin molar ratio
SHBG
(nmol/l)
4.7 ± 0.1
1.3 ± 0.1
3.8 ± 0.1
79.7± 8.2
8.6 ± 0.6
0.14 ± 0.01
35.2 ± 1.9
4.9 ± 0.2
1.4 ± 0.1
4.0 ± 0.2
101.2± 6.9
14.7 ± 1.6
0.15 ± 0.01
35.6 ± 4.9
4.9 ± 0.3
1.9 ± 0.2
4.0 ± 0.3
146.5 ± 22.9
27.0 ± 3.3
0.22 ± 0.03
34.4 ± 5.5
1, NIDDM vs iar and NGT, p=O.00S
2, NOT vs N1DDM, p=O.0003
4, NOT vs NIDDM, p=O.00001
6, lOT vs NIDDM, p =0.001
7, NGT vs NIDDM, p=O.002
9, IGT vs NIDDM, p =0.02
3, NGT vs IGT, p=O.000S
5, NOT vs JOT, p =0.003
8, NOT vs IGT, p=ns
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SUMMARY
The reliability of the OGTT was examined in 35 urban middle-aged male subjects in
Saudi Arabia with varying degrees of glucose intolerance. Subjects were recruited as part of a
screening programme for diabetes, JUT and cardiovascular risk factors performed during the
summer of 1989 at Jeddah. Two identical OG1'Ts of 75 g anhydrous glucose in 300 ml water were
performed within a period of 8 weeks and interpreted according to WHO 1985 criteria. Glucose
and insulin were measured fasting and at 1 and 2 h. The first test suggested that eight of the 35 had
diabetes and 12 Impaired Glucose Tolerance hUT]. On repeat testing three with IGT became
'normal', and two with diabetes became JUT, with one 'worsening' to IGT. For the whole group,
glucose AUC (Mean ± SEM)was lower on retesting (24.0 ± 2.0 mmol/l/h, p <0.05), a trend
evident in each subgroup. Similar changes were found in insulin AUC (Mean ± SEM) (174 ± 17
mUll/h, p <0.05). The fasting insulin:glucose ratio (Mean ± SEM) were consistently lower (2.0 ±
0.2, p < 0.00 1) on repeat testing. Our results suggest that in this community the standard OGTF
[75 g] may have poor reproducibility, and that labelling subjects on the basis of a single OGU
during a screening program or in a clinical sitting should be carefully interpreted.
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CHAPTER SIX: OGIT reproducibiWy
6.1 INTRODUCTION
It is known that the OGTT is a test with poor reproducibility with a
coefficient variation of the 2-h blood glucose concentration of up to 40 %
(MacDonald et al, 1965; Kosaka et al, 1966). Poor reproducibility of the OCTrI'
for the diagnosis of JOT has also been described, with only 56 % of subjects with
IGT at the first test showing glucose intolerance on a second OGTT (Riccardi et
al, 1985). More recently a study in which the OGfl was repeated within a week
suggested that a single 2-h postload measurement may be inadequate for the
accurate assessment of lOT and diabetes prevalence, particularly in those unused
to blood sampling (Swai et al, 1991).
Similar information concerning the intra-individual variability of glucose
and insulin responses to OGTT is not available for individuals living in Saudi
Arabia. Therefore, we have measured the plasma glucose and insulin responses
during two identical OGTT' s in a cohort of male individuals with different
degrees of glucose intolerance during a screening programme.
6.2 SUBJECTS AND METHODS
The study group consisted of 35 adult men with an age range of 20-65 yr.
The first OGl' was performed during a screening programme for detection of
glucose intolerance and CVD risk factors during the summer of 1989 at Jeddah,
Saudi Arabia, while the second was carried out 1-60 days later [mean 13 days].
All subjects were approached and invited to participate in repeat testing without
informing them of the initial diagnosis.
The studies were conducted at the recently constructed diabetes and
hypertension centre by permission of the Ministry of Health [MOH]. Subjects
were asked to present themselves at 08:30 h having fasted from 23:00 h the
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previous evening. They were asked to follow their normal diet which contained a
minimum of 300 g of carbohydrate. Subjects were generally inactive, none had any
known disease, or were ingesting any drug, and none drank alcohol. Height was
measured without shoes, and weight in light clothes was measured using a beam
balance. Two identical OGTT's.were performed by the administration of 75 g
anhydrous glucose as an orange-flavoured dextrose solution in a volume of 300
ml, consumed over 4-5 mm. Venous blood was drawn for measurement of plasma
glucose and insulin before (fasting), 60, and 120 mm after taking the glucose load.
All samples for plasma glucose, serum insulin and serum fructosamine
estimation were deep frozen (-40°) and subsequently assayed in Newcastle upon
Tyne. Assays for samples from the two OG1Ts samples were performed under
identical conditions. Plasma glucose was measured by a Yellow Springs
Instrument analyser (Yellow Springs, OH, USA) using a glucose oxidase method
(Chua et al, 1978) with an intr-assay CV of 1.1 %. Plasma insulin was determined
by a radioimmunoassay technique (Soeldner and Slone, 1965) with intra-assay
CV of 4.2 % and inter-assay CV of 4.8 %, and serum fructosamine using a
centrifugal analyser (Hindle et at, 1985) with a CV of 1.5 %.
Area under the curve (AUC) was calculated by the trapezoidal rule (Matthews et
a!, 1990; Le Floch et al, 199(J) . All comparisons were based on the diagnostic
outcome of the first test judged according to a recommended criteria for
epidemiological screening (WHO, 1985). Thus, diabetes was defined as plasma
glucoseat2h ^ 11.1 mmo/l, andiciTasfasting <7.8 mmollland2-hbetween7.8
- 10.9 mmolll. Results were expressed as mean ± SD or range, and were analysed
using SPSSPC+ packages (Norusis, 1986) with Student's paired t test for the
whole group and for the subgroups separately.
6.3 RESULTS
Thirty five subjects [28 %] of those attending for a first OGTT En 125]
agreed to come again for the second O(flT. Subject characteristics are given in
Table 6.1. At the first test 15 of the 35 subjects [43%] had 'normal' glucose
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tolerance, 12 [34%] had Impaired Glucose Tolerance and 8 [23%] had diabetes.
Fructosamine levels were unchanged between the first and the repeat test.
The changes that occurred in glucose tolerance on repeat testing are shown
in 'Thble 6.2. Although the total prevalence of IGT remained the same [34 %] on
the first and the second OCTfl, three subjects [25 %] returned to normal glucose
tolerance but were replaced with two previously classified as diabetic and one
previously 'normal'. No 'normal' subject was reclassified as diabetic. Thus, the
apparant prevalence of diabetes fell to 18 %, and all glucose intolerance to 52%.
Glucose area under curve (mean ± SEM) was lower on retesting for the whole
group (24.0 ± 2.0 mmol/l/h, p < 0.05), a trend evident in each subgroup (Table
6.3). Similar changes were found for 1-h plasma glucose concentration (Mean ±
SEM) (9.7 ± 1.0, p < 0.05), although differences were not significantly different
at fasting or at 2-h (Table 6.3), and also in insulin area under the curve (mean ±
SEM) [174 ± 17,p <0.05] and forfastinginsulinconcentration [11.4 ± l.l,p <
0.001] (Table 6.3).
The fasting insulin:glucose ratio differed between tests [p < 0.00 1], and between
IGT and diabetes subgroups [p < 0.05] (Table 6.4). Only the fasting
insulin:glucose ratio was consistently lower on repeat testing (Table 4).
6.4 DISCUSSION
The reproducibility of a measurement is one criterion for judging the value
of a test. If test-retest measurements performed within a short time relative to the
evolution of the disease vary appreciably, the reliability of the test in individual
subjects is reduced. Reproducibility inevitably affects the sensitivity and
specificity of the test, and interpretation of OG1Ts should take this into account
(Rushforth et al, 197S).
Prevalence estimates of diabetes and IGT within communities are now
quoted on the basis of a single OGT after a 75 g glucose load. However, a
number of studies have shown an up to 50 % variability in blood glucose values
within individuals after a glucose load (Home P, 1988). Therefore, a single 2 h
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glucose may result in the misclassification of individuals. For this reason, WHO
and others have recommended that, for clinical purposes and during screening
programs when the primary purpose is to identify asymptomatic diabetic
individuals, no one should be labeled as having diabetes on the basis of a single
abnormal blood glucose value. However, in epidemiological studies where the
primary purpose is assessment of the prevalence of diabetes and IGT within
communities, WHO considers a single elevated 2 h blood glucose sufficient for
the diagnosis of diabetes (WHO, 1985).
Misclassification of a few individuals may occur, but on repeat testing, a
similar degree of missclassification should occur, and an overall prevalence
estimates should be unchanged. In the present study, although the total prevalence
estimate of IGT remained the same on repeat testing, 25 % of people were
misclassified with diabetes on the first test compared with the second test,
although numbers were very small. Hence, the study suggests that it is incorrect to
assume that if an entire population were to be rescreened within a short interval
the results of the second survey would be similar. A more marked changed has
been reported for a Tanzanian population (Swai et al, 1991).
The downward trend in plasma glucose values raises several queries. The
reduction in plasma glucose values might reflect methodological problems or
changes in the circumstances of the second test. However, to minimize bias, the
methods were carefully standardized and all the field and laboratory work were
performed by a single investigator. In addition, retesting of subjects was carried
out while the screening programme was proceeding so that the circumstances of
the repeat OGfl were similar to those of the first Oorr. Therefore, technical
reasons are unlikely to account for the downward trend.
Another possibility could be changes in diet or life-style between the first
and second tests. Prolonged intervals between tests make comparisons with the
initial test difficult because many factors could in the meantime have changed an
individual's glucose tolerance. In the present study, repeat testing occurred on
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average within 2 weeks to aviod changes in the life-style of the subjects.
Moreover, the subjects were also unaware of the diagnosis from the first OGTT.
Thus, it is unlikely that any consistent bias was introduced by differences in
preparation between the first and second tests or by the possible action that might
have taken place if they were aware of the abnormality.In addition fructosainie
was unaltered (and indeed tended to rise) suggesting no consistent lifestyle
changes. It is more likely that ill-defmed and nonquantifiable physiological and
psychological factors might influence gastrointestinal motility, glucose
absorption, and the release of gut factors, which have a major impact on insulin
secretion during the OCWF (Ganda et al, 1978). Anxiety could well have the most
important factor in this study, since most of the study participants were unused to
blood sampling.
This is the first study of this kind in this community and thus the results
cannot be compared with others, although the blood sampling in rural tanzanians
could be considered similar. If our observations are confirmed, they raise several
questions. How accurately does reported prevalence of diabetes and ICT in this
community or in different communities, usually based on a single OGfl, reflect
the true prevalence of glucose intolerance?. Doubts must also exist as to the
precision of diabetes prevalence estimates based on a single OGTT in field
studies. Hence, in the present study, the prevalence estimate of diabetes in the
retested sample were 25 % lower than the estimate of the first test, although the
estimates for ICfl remained the same. There has been a general trend in recent
years to broaden the range of values considered normal or borderline. People with
ICfl form an identifiable risk group, but, it is not possible to identify people at risk
of developing diabetes with acceptable specificity.
The plasma glucose differences between the two tests were not great for
each glucose tolerance category, but intraindividual OGTT differences in 1-h and
2-h levels as great as 2.2 mmoL'l of glucose are not uncommon, and differences
greater than 1.1 mmol/l almost usual (4st et al, 1964). These data confirm
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previous reports (McDonald et al, 1%5, Kosaka et al, 1966, Harding et a!, 1973;
Olefsky et a!, 1974, Riccardi, 1985, Le Floch et al, 1991) which suggested that the
plasma glucose response to serial OGTT's is not very reproducible within any
individual.
It was suggested that part of of the variation in response is attributable to a
considerable variation in levels of insulin secretion when duplicate tests are
performed (Olefsky et al, 1974). In the present study, the results also demonstrate
that the plasma insulin response varies considerably when an OGfl is performed
twice on the same individual within 60 days. Indeed, the plasma insulin response
between OGTT's was even more variable than the plasma glucose response.
Because of the known influences of the autonomic nervous system on insulin
secretion (Porte et al, 1973), one might anticipate that a subject's emotional
reaction to his first OGfl will be different from his reaction to a second OGTT,
and this could produce a consistent difference in the insulin response to the two
tests.
Certain straightforward conclusions follow from these results. The lack of
reproducibility of the glucose response to the OGTT emphasizes the danger of
diagnosing diabetes mellitus and IGT on the basis of a single abnormal OCTET, as
discussed in detail by others (MacDonald et al,1 965 , Kosaka et al, 1966). A
further conclusion concerns the insulin: glucose ratio. In an effort to define the
relationship between insulin response and diabetes, several authors have proposed
the concept of an "insulinogenic index" (Seltzer et al, 1967; Perley et al, 1966)
in which the insulin response during an OCTET is related to the coexisting glucose
response. This is most commonly done by dividing the two responses and
determining the hG ratio. It is obvious that the J/G ratio should be a reasonably
consistent characteristic of an individual if it is to provide any biological insights.
Given the lack of reproducibility of both glucose and insulin responses to an
OGTT, one might predict that there would be considerable variability in any
individual's J/G ratio. On the other hand, it might also be that if the direction and
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magnitude of change in insulin response followed the direction and magnitude of
change in glucose response, then the hG ratio would be a more reproducible
physiological measurement than either value alone. In the present study, fasting
insulin:glucose ratios were significantly different between tests, although fasting
glucose concentrations alone did not differ significantly. This might imply that the
glucose values were more reproducible than IGR values, although the IGR was
more indicative of poor reproducibility of the OCWF.
Our study was designed to analyse the reproducibility of glucose and
insulin responses to OGTT in a small cohort of glucose tolerance groups. For the
whole group, basal glucose and insulin levels were not reproducible and glucose
responses to OGTT showed significant bias was not shown for each diagnostic
category separately, perhaps due to a type 2 statistical error, which might be
resolved by a larger sample size. Although conditions of reproducibility seem to
be optimized, changes in digestion or absorption, and uncontrolled environmental
factors cannot be ruled out.
The detection of glucose intolerance, in presence of fasting
normoglycaemia, is rarely of benefit to the patient in the absence of obesity or
other risk factors and may prove a hardship for psychological reasons. Thus, the
clinician should carefully evaluate the medical indications and the potential
benefits derived prior to ordering an OCTI'T. Causion should be used in making a
diagnosis of diabetes mellitus based on this test when results are marginal.
Unfortunately no other diagnostic test for diabetes is available, and it is not
recommended that the use of the 0G1'T be curtailed as a result of our data until a
more definitive, more reproducible, and more practical test, is available. It is
hoped however that these results will provide greater insight into the meaning of
individual test results, and will also increase the responsibility which the
clinicians assume for the continued observation of suspects.
Finally, a specific recommendation for public diabetes detection programs
is that those persons classified s suspect on the basis of a screening test or other
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selected characteristics be retested periodically when the initial retest does not
indicate immediate referral to a physician. Values selected for referral should be
determined at the community level with the cooperation of local physician and
official agencies.
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ADDENDUM TO DISCUSSION
Table: 6.2 A
Change in glucose tolerance category between the first and repeat OGTT in number [%].
Test 2 in the whole group [n=125] was extrapolated.
Category	 N	 IGT	 Diabetes	 All
Repeated OGTT actual results [n=35]:
Age	 37	 39
BMI	 29	 29
[test 1]
	
15 (43)	 12 (34)
[test 2]
	
17 (49)	 12 (34)
44	 39
27	 29
8 (23)	 35 (100)
6 (17)	 35 (100)
Results extrapolated to whole group [n=42S]:
Age	 37	 39	 41	 38
BMI	 27	 29	 29	 28
[test 1]	 74 (59)	 34 (27)	 17 (14)	 125 (100)
[test 2]
	
84 (67)	 34 (27)	 13 (10)	 125 (100)
DISCUSSION:
The above table [6.2A] demonstrates the effect of extrapolating the results
of the repeated OGTT's to the whole group. This is necessary and desirable
because the repeat OG1'T group contains a higher proportion of patients with ICiT
or diabetes than the whole group, and the results in table 6.2 may therefore be
biased by the phenomenon of regression to mean. The first test showed that 17 of
the 125 subjects had diabetes and 34 IGT [chapter 5]. On repeat testing,
extrapolated to all subjects, ten subjects would move down to normal glucose
tolerance and 4 to IGT from diabetes. However 5 subjects would show
'worsening' to IGT from normal, so the total number with JOT remain
unchanged. However the small decrease in numbers of subjects with diabetes and
increase in subjects with normal glucose tolerance does still suggest some bias
between first and second tests.
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Table: 6.1
Characteristics of the subjects who had a repeat OGTT.
Glucose Tolerance Category	 All
Normal	 IGT	 Diabetes
n
	 15
Age	 (yr)	 37
(29-51)
BMI (kg/rn2)	 28.7 ± 5.1
Fructosamme (mmol/l):
First test
	 2.3 ± 0.1
Second test	 2.3 ± 0.1
12	 8	 35
39	 44	 39
(33-50)	 (30-55)	 (29-55)
29.4 ± 3.2	 27.2 ± 4.7	 28.6 ± 4.4
2.4 ± 0.1	 2.8 ± 0.3	 2.5 ± 0.1
2.4 ± 0.1	 3.3 ± 0.4	 2.6 ± 0.1
Number, or mean (range), or mean ± SD
Table: 6.2
Change in glucose tolerance category between the first and repeat OGTT.
First test category	 Total (Test 2)
Normal	 lOT	 Diabetes
0 (0)
2(25)
6(75)
8 (23)
Second test category
Normal
lOT
Diabetes
Total çlest 1)
14(93)
1 (7)
0 (0)
15 (43)
3(25)
9(75)
O (0)
12 (34)
17 (49)
12 (34)
6 (17)
35 (100)
Number (%)
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Table: 6.3
Plasma glucose and serum insulin concentrations and total area under the curve (AUC) in
the subjects who had a repeat OGTT.
Glucose Tolerance Cateorv (Test 1) 	 All
Test	 Normal	 IGT	 Diabetes
1
2
1
2
1
2
1
2
1
2
1
2
1
2
1
2
Glucose
(mmol/l)
Fasting
lh
2h
Glucose AUC
(mmolIlIh)
Insulin
(mUll)
Fasting
lh
2h
Insulin AUC
(mUll/h)
5.3 ± 0.1
5.2 ± 0.1
9.2 ± 0.7
8.6 ± 0.7
5.4 ± 0.3
5.6 ± 0.3
18.1 ± 0.8
17.5 ± 0.9
5.7 ± 0.1
5.8 ± 0.1
11.9 ± 0.5
11.4 ± 0.5
9.1 ± 0.2
8.7 ± 0.4
23.7 ± 0.7
23.0 ± 0.8
9.5 ± 1.5
9.1 ± 1.7
17.7 ± 2.1
16.5 ± 1.9
18.8 ± 2.2
18.5 ± 2.9
39.8 ± 5.0
37.9 ± 5.6
6.4 ± 0.4
6.3 ± 0.5
12.1 ± 0.8k
11.4 ± 0.7
9.7 ± 1.0
9.6 ± 1.1
25.0 ± 2.0
24.0 ± 2.0
18.1 ± 1.3c
11.4 ± 1.1
102.1 ± 7.4
103.1 ± 11.7
93.9 ± 7.0
89.0 ± 9.1
184 ± 12'
174 ± 17
18.1 ± 2.5c	 18.0 ± 1.8	 18.4 ± 2•5b
10.0 ± 1.3	 13.1 ± 2.0	 11.7 ± 2.9
113.8 ± 11.7	 116.2 ± 7.1
	 59.2± 13.8
122.4 ± 22.8	 109.0 ± 13.0 58.2 ± 13.0
85.2 ± 10.7	 120.4 ± 8.9
	
70.6 ± 14.2
80.2 ± 15.2	 116.4 ± 12.9 64.2 ± 15.2
190 ± 20	 214 ± 12	 127 ± 24
186 ± 32	 200 ± 21	 113 ± 20
Mean ± SEM
a, p < 0.05;	 b, p <0.01;	 c, p <0.001 compared to repeat test.
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Table: 6.4
Insulin : glucose ratios (IGR) in the subjects who had a repeat OGTT.
Glucose Tolerance Cate2ory
 (Test Ii	 All
Test	 Normal	 IGT	 Diabetes
1
Fasting
2
1
lh
2
1
2h
2
Mean ± SEM
a, p < 0.05;
3.3 ± O.4c
1.9 ± 0.3
12.3 ± 0.9
13.6 ± 1.9
16.2± 2.1
13.5 ± 1.8
3.1 ± o.3
2.2 ± 0.3
9.9 ± 0.8
9.9 ± 1.3
13.5 ± 1.3
13.9 ± 1.8
2.2 ± o.4
1.7 ± 0.6
4.1± 1.0
4.2 ± 1.2
4.5 ± 1.1
4.8 ± 1.3
3.0 ± 0.2c
2.0 ± 0.2
9.6 ± 0.8
10.2 ± 1.2
12.6 ± 1.3
11.7 ± 1.2
c, p <0.001 compared to repeat test.
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RES ULTS
CHAPTER SEVEN
DIETARY EVALUATION
CHAPTER CONTENTS:
Summary.
	
7.1	 Introduction.
	
7.2	 Subjects and methods.
	
7.3	 Results.
	
7.4	 Discussion.
"Diabetes is the disease of the rich and one that is brought about by the gluttonous
overindulgence in oil, flour and sugars."
(Ekod 1988-p. 99)
SUMMARY
The dietary habits of the Saudi Arabian population have been influenced by the influx of
foreign workers into the country, increased availability of a wide range of imported goods and
increased spending power. This study, done by questionnaire interview, describes the types of
dietary pattern becoming commonplace in the Kingdom, particularly the western urban province
and examined how the dietary habits or food could be influencing glucose tolerance.
123
CHAPTER SEVEN:	 DIETARYEVALUATION.
7.1 INTRODUCTION
The prevalence of NIDDM and IGT in population living in Saudi Arabia
and residing in Jeddah [Chapter 5] is very high suggesting an environmental
component in the aetiology of this disease, perhaps interacting with a basic
genetic predisposition to diabetes. An important environmental variable is diet.
However, the role of diet in the aetiology of NIDDM is as yet uncertain.
Since the beginning of this century many arguments have been raised to
support the idea that either a high sugar intake (Yudkin, 1969), or a high fat intake
(Himsworth, 1935) is responsible for an increased risk of diabetes. Dietary factors
that may be involved in the epidemiology of diabetes have been addressed before
(l4êst, 1978, WHO, 1985), but the role of qualitative aspects of the diet remains
unclear and the evidence implicating specific macronutrients was inconclusive.
Further research has addressed calorie excess as it relates to obesity, which has
been thought to play an important role in the epidemiology of diabetes (Baird,
1972). Other studies suggest, however, that it is not only the overconsumption of
calories leading to obesity that puts a person at risk for diabetes but also the
anatomic location of the deposited excess fat (Wgue et al, 1988).
Investigations of an aetiologic role for carbohydrates, specifically a high
refined-sugar intake, has had few supporters (Keen et al, 1974). However, a high-
fat "Western" diet appears to be more frequently linked to diabetes and its
vascular complications (Himsworth, 1935). Dietary protein has received less
attention than has fat as a dietary risk factor (Nuttall, 1984).In addition , a
'protective' effect of high dietary fibre intake was suggested (Trowell, 1975).
Since the discovery of oil in Saudi Arabia in 1938, many changes have
occurred in the lifestyle of the population. From being an isolated, nomadic
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Bedouin population, rapid urban development has occurred bringing the trappings
of the twentieth century (Sebai, 1981). Along with the increased wealth of the
country has come the inevitable changes in lifestyle for the majority of the
population. The sedentary lifestyle unknown to the people before has become the
norm as people move to the cities and the diseases of affluence are appearing. The
dietary habits previously determined by the limited availability of food have
changed; in particular, due to the influx of expatriate workers from the west and
third world countries. Traditional eating habits still prevail but intermingle with a
range of good and bad eating habits from the west associated with an upsurge in
the incidence of non-communicable diseases [NCD] such as diabetes and obesity
(Sebai, 1981). Since NIDDM is common in Saudi Arabia, a role for
environmental factors in the aetiology of this disease is suggested and thus dietary
intake was assessed. Therefore, the proposed objectives of this aspect of the
cross-sectional study, as described in this chapter were two-fold; 1) to describe
the diet and food intake habits of a sample of urban men living in Jeddah as a
whole; and 2) to investigate possible cross-sectional differences between glucose
tolerance groups and the frequent intake of different food items representing
dietary carbohydrates, fibre and fat.
7.2 SUBJECTS and METHODS
Habitual dietary intake was assessed using the food frequency
questionnaire [FFOJ method only. The study of present eating habits was carried
out by questionnaire interview between each subject alone and a single observer.
The aim of the interviews was to try to ascertain the quality of the diet by asldng
about the types of foods taken and the frequency with which they were eaten.
This was not a quantitative study although it is hoped to do this in the future.
Ninety five [95] individuals were interviewed, all were males with ages
ranging from 20-64 yrs. Although the individuals interviewed came from
different nationalities, all had lived in Jeddah for a while. Details of subjects
recruited, anthropometric measurements and sampling protocol for plasma
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glucose were described earlier [Chapter four]. Dietary assessment was performed
and the results compared in those with NIDDM [n=15], those with IG [n=25],
and the NGr group [n-55].
Dietary methodology:
Background. Nutritional assessment procedures were initially described in 1932
by the Health Organization of the League of Nations (Gibson, 1990). These can
be defined as: the interpretation of information obtained from dietary,
biochemical, anthropometric and clinical studies. The information is used to
determine the health status of individuals or population groups as influenced by
their intake and utilization of nutrients. Nutritional assessment systems (NAS)
can take one of three forms: surveys, surveillance, or screening (WHO, 1976). The
next few paragraphs outlined briefly methods used in nutritional assessment.
The nutritional status of a selected population group may be assessed by
means of a cross-sectional survey. This nutritional survey may establish baseline
nutritional data and/or ascertain the overall nutritional status of the population.
NAS utilize a variety of methods which are based on a series of dietary,
laboratory, anthropometric, and clinical measurements, used either alone or, more
effectively, in combination. Food consumption assessment methods produce
qualitative or quantitative information from food consumption surveys. Survey
data, collected at the national, household, or individual levels, can be expressed in
terms of nutrients and/or foods. This study used methods suitable for measuring
food consumption at the individual level.
Methods. The available methods used for measuring food consumption of
individuals can be classified into two major groups. The first group, known as
quantitative daily consumption methods, consist of recalls [24 hour or reflected 24
hour] or records [estimated food or weighed food], designed to measure the
quantity of the individual foods consumed over a one-day period. The second
group of methods includes dietary history and food frequency questionnaires
[FFOJ, both of which obtain retrospective information on the patterns of food use
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during a longer, less precisely defined time period. Such methods are most
frequently used to assess usual intake of foods or specific classes of foods. With
modification, they can provide data on usual nutrient intakes.
There is no ideal method for assessing food or nutrient intakes, the choice
depending primarily on the objectives of the study. Additional factors which
should be considered when choosing a method for assessing the food
consumption of individuals are the characteristics of the subjects within the study
population, the respondent burden of the method, and the available resources.
Generally, the more accurate methods are associated with higher costs, greater
respondent burden, and lower response rates.In population groups it is possible to
estimate the average use of specified foods by means of a FFQ. Such data can be
used for international comparisons of the relationship of patterns of food use to
health and susceptibility to chronic disease.
None of the current methods are devoid of systematic errors, or prevent
alterations in the food habits of the subjects. Since the desired information
required for my study was group or individual patterns of food use, and the
proportion of the population with a particular pattern and/or average use of a
particular food or food group, the food frequency questionnaire was used as the
preferred approach (Gibson, 199(J).
FFQ. A FFQ is designed to obtain qualitative, descriptive information about
usual food consumption patterns. It does not generally provide quantitative data
on food or nutrient intakes. The questionnaire consists of two components: (a) a
list of foods, and (b) a set of frequency-of-use response categories. The list of
foods may focus on specific groups of foods, particular foods, or foods consumed
periodically in association with special events/seasons, when it is designated a
focused questionnaire (Anderson, 1986). Alternatively, the food list may be
extensive to enable estimates of total food intake, and hence dietary diversity, to
be made.
The aim of the FFQ is to assess the frequency with which certain food
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items or food groups are consumed during a specific time period (e.g. daily,
weekly, monthly, yearly). The record is obtained by interview, or self-
administered questionnaire. The questionnaire can be semiquantitative when
subjects are asked to quantify usual portion sizes of food items, with or without
the use of food models. Specific combinations of foods included in a focused
questionnaire can be used as predictors for intakes of certain nutrients or non-
nutrients, provided that the dietary components are concentrated in a relatively
small number of foods or specific food groups. Examples include the frequency of
consumption of whole grain cereals, legumes, nuts, fruits, and vegetables as
predictors of dietary fiber intake. The method can also be used to assess the intake
of artificial sweeteners, certain contaminants present in specific foods, alcohol,
and condiments (Hunts, 1984, Anderson, 1986).
The FFQ should relate to simple, defined food categories: open-ended
questions should be avoided, as pre-formatted lists of food categories act as a
memory prompt. The data for the FFQ may be obtained by a standardized
interview or self-administered questionnaire, the former way is applied in this
study and took 15-30 minutes to complete. The results generally represent usual
intakes over an extended period of time and are easy to collect and process. The
FFQ imposes less burden on respondents than most of the other dietary
assessment methods. It is often used by epidemiologists studying associations
between dietary habits (both usual and past) and disease (Hankin et al, 1970),
although its use for estimating food intakes in the remote past has not been clearly
established (van Stavern et al, 1986). FFQ can also be used in combination with
more quantitative methods, providing additional or confirmatory data.
The data from a food frequency questionnaire are often used to rank
subjects into broad categories of low frequency and high frequency intakes of
certain foods, as in my study. In epidemiological studies, such rankings are often
compared with the prevalence and/or mortality statistics for a specific disease
within the population studied. Food scores can be calculated from food frequency
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data, based on the frequency of consumption of certain food groups (Guthrie and
Scheer, 1981). The scores can then be examined in relation to psychosocial
influences (e.g. level of education, income) as well as vital statistics. Comparisons
of the dietary patterns of different ethnic groups can also be made using a food
scoring system.
Studies on the precision of FFQ are limited but in one 90 % of the
responses differed by less than one point from the original measurement,
suggesting that the FFQ precision for classifying the frequency of food used was
good (Gibson, 1990).
Despite the increasing use of FFQ in epidemiological studies the dietary
methods in general and FFQ in particular are the most difficult to validate because
the 'truth' is never known with absolute certainty, and there is no guarantee that
the records represent the usual food intake (Block, 1982). Thus, subjects may eat
atypically during a dietary period, even though every effort is made to discourage
this. When FFQ was tested for validity (Mullen et al, 1984), they indicated that a
large proportion of individuals could accurately estimate their food intake using
the FFQ. The method is rapid with a low respondent burden and high response
rate but accuracy is a little lower than for other methods.
In this study, the collection of dietary data followed a format adapted from
the Laparasky (1987) diet-history method using the FFQ method only (Appendix
4). Each participant was asked his usual frequency of consumption of the listed
food items for the 1-2 month period before participation in the study. The list
consisted of 86 questions including food items that are rich sources of the
nutrients of interest and locally available. This study was intentionally
comprehensive to establish baseline data for future studies. Much of the difficulty
in finding strong diet-disease correlations arises from the inherent problems of
using dietary data collection methods in a free-living population (Morgen et al,
1978; Gordon et al, 1984).
Background information was gathered before the FFQ was administered to
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understand as fully as possible features of the subject's lifestyle that were relevant
to his eating habits. Information pertaining to his medical history, occupation,
socioeconomic status, education level, marital status, and physical activity was
noted. Usual meal and snacking frequencies, specific diet modifications
prescribed by a physician, or self-imposed, and frequency of home dining were
also solicited. The background information was used to elicit specific details in
the FFQ and to gain rapport with the subject to enhance reliability of reporting.
The variables assessed for this purpose were grouped into protein, fat,
carbohydrates, and beverages.
In this study, coding the responses to the food items frequencies were
aggregated and presented as percentages. Seven times a week or 1-6 times per
week were considered together as more frequent response and shown here only
because the number for each coding category is small. Similar aggregation were
performed when comparisons were made by glucose tolerance category.
Statistic. To test overall differences between the three or two diagnostic groups,
nonparametric chi-square tests were used. All statistics were computed by use of
SPSS software [SPSS, mc, Chicago]. All P values are based on two-sided tests of
statistical significance and P < 0.05 accepted as indicating significance.
7.3 RESULTS
Overall dietary habits and specific food intake for the whole population
are described first, followed by habits and selected dietary items in relation to
glucose tolerance groups. Subject characteristics were described earlier for the
whole population and by glucose tolerance groups [Chapter 5].
General dietary informations were presented in Table 7.1. The subject'
meal habits showed that the majority [88%] usually eat three main meals namely;
breakfast, lunch and dinner, with 12% eating two and none eating one meal. The
main meal was lunch in the majority [94%] and dinner in only 6% . Few [11%]
omitted breakfast, but if it was taken [73%] it was usually between 7:30 am and
10:30 a.m. with minority in the early [13%] or late [3%] morning. The same
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applies for lunch where the majority [78%] eat their lunch between 14:00 - 16:00
and the minority in either early [13 %] or late [9%] afternoon. 'Iking snacks
between main meals was found in 53 % and, in those taldng snacks this was
usually between lunch and dinner [74%], while the rest [26%] ate the snacks
either before breakfast, between breakfast and lunch and after dinner or before
sleeping. All lunches and dinners and the majority of breakfasts [73 %] and
snacks [53 %] were taken at home. This is supported by the fact that 86% of them
eat at their homes.
In the same table [7.1], the practices of dietary modification are shown in
the form of adding salt in 48%, decreasing the amount of fat in only 10 % or
decreasing of sugar in only 8%. Furthermore, all subjects were asked to identify
the brand name of seven food items including some dairy products and some fat-
containing food. These questions addressed the ability of the subjects to recall
some common products used daily. The table [7.1] shows that the trade name of
oil or fat items was known by 98% of the subjects, unlike milky-containing foods
[17%] and butter [27%]. Beliefs about diet and health would be of interest but this
was not examined in this study.
Food items representing different foods categories, which were taken at
least once per week, are shown in table [7.2]. Rice was the most popular
carbohydrate being taken by 96 % and bread [89%] was the second. Pasta [47%],
potatoes [42%] and cornflakes [31 %] were the least along with the honey [43%]
and jam [33%]. The traditional wholewheat products of kabsah, ghorsan and
jareesh were not asked about specifically, however, dates a traditional fruit, are
still fairly popular [65%]. Simple sugar was taken in tea by 92% while 28% took
sweetened coffee. Soft drinks were popular [86%].
Confectionery consumption is shown as well [fltble 7.2]. Biscuits [35%]
and nuts [35%] were the most commonly used while ice-cream [17%] and sweets
[15%] were the least. All of these foods were most commonly consumed during
weekend picnics and family gatherings.
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The frequency of fruit and vegetable consumption is shown in Table 7.2.
Large proportion of this population admitted eating at least once per week of
oranges [98%] and salad vegetables [98%]. These results may be a bit ambiguous
as in some Arabic dialects the same word is used for fruit and vegetables. Dates
[65 %] are still the most popular fruit and tinned fruit [7%] was not widely
consumed.
Foods containing protein are shown in Table 7.2. The most popular forms
of animal protein were chicken [94%] and lamb [93%]. This was followed in
popularity by fish [62%], beef [23%] and tuna [23 %]. A high consumption of
eggs was found in only 12% and offal was taken fairly frequently [36%].
Vegetable protein [Beans, 78%] in the form of pulses were popular.
Food items representing fat and oil intake are shown in Table 7.2. The
majority of those questioned used vegetable oil [79 %] for cooking, although
some used butter and ghee. The consumption of other high fat foods, such as
"kabseh", a traditional dish of rice, spices and usually meat or chicken cooked in
oil, was not asked. Olives [60%] and cream [30%] were the other popular foods,
being taken usually at breakfast with bread.
Dairy product food items are shown in Table 7.2. Cheese [93%], laban [70
%] and milk [68 %] are popular foods that have been taken traditionally in the diet
and their consumption is still quite high although cows milk has taken over in
popularity from camel and goats milk [not shown].
Finally, beverages and drinking habits consumption are shown in Table
7.2. Soft drinks as a whole [86%] or fizzy drinks [79%] were popular and tea
[98%] consumed more often than coffee [70 %].
General eating habits and selected food items based on glucose tolerance
groups are shown in table [7.2]. Thking snacks between meals was found more in
those subjects with NIDDM [80%] compared with JOT [64%] and NOT [73%].
Also those with NIDDM [25%] practised changing diet more frequent than those
either with IGT [19 %] or with NOT [9 %]. However, none of these showed
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statistical significance.
Moreover, certain commonly used food items were selected and presented
to discover whether any differences existed between the groups [lkble 7.3]. Rice
and bread were eaten more frequently by NIDDM subjects compared to both ICTF
and NGT. However, honey and jam were less commonly eaten by NIDDM
subjects. Interestingly, eating more than 7 eggs per week was found most
commonly in subjects with MDDM, intermediate in those with 1(11 and lowest in
those with NGr. Dates, other fruits and soft drinks were less commonly taken by
those with NIDDM. However, none of these showed significance when
compared.
7.4 DISCUSSION
Foods assessed in this study can be conveniently classified in ten
categories: Cereals; Starchy roots; Sugars and syrups; Pulses, nuts and seeds;
Vegetables; Fruits; Meat, fish and eggs; Milk and milk products; Oils and fats;
and Beverages. These can also be grouped under the essential nutrients of
carbohydrates, fats, proteins, minerals and vitamins.
It is known that restrictions on the food supply of a community affect
diabetes and this is well illustrated in U.K between 1940-1947 during which
mortality from diabetes was reduced by nearly 50 % (Himsworth, 1949).
Mortality rates do not necessarily reflect prevalence rates but there is no doubt
that rationing was beneficial to individuals susceptible to diabetes. On the other
hand, prosperity or westernization of a country might influence the prevalence of
diabetes. Saudi Arabia has passed through a prosperous phase during the last two
decades which, of course, has influenced food supply and intake, but no data are
available to show differences of diabetes prevalence before and after this increase
in food supply.
A single report, which analysed the import and export data at the national
level, showed that the trends in the diet shifted away from the traditional foods
and show a dramatic increase in the consumption of sugars, fats and oils during
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the period 1970-1980. It also showed a remarkable increase in the consumption of
cereals, fruits, potatoes, meat, eggs, milk, sugar, and fat and oil with a declining
consumption of fish and vegetables (Musaiger, 1987).
This study explains partly the drastic change in food consumption patterns
in Saudi Arabia. The traditional diet which consisted of dates, milk, rice, bread
and fish has changed to a more diversified diet. Red meat and poultry are
consumed more frequently than marine food, and mutton and lamb are preferred
to beef. Rice is still the most staple cereal and it is eaten almost daily with other
food and camel meat still used. Wheat is mainly consumed as bread or pasta. Milk
and dairy products have become essential items in meals, particularly laban.
Chips,chocolates and sweets are the main foods consumed in between meals as
snacks. Tea is the most popular drink and is consumed sweetened, with or without
milk. Alcoholic drinks are forbidden by law in Saudi Arabia.
A few studies were concerned with nutrient intake in Saudi Arabia, and in
one was on pre-school children (Sawaya et a!, 1985). The impression from the
literature revealed that the Saudi diet is typically high in fat (Sawaya et al, 1985),
high in carbohydrates, particularly complex (Sawaya et al, 1984), and moderate in
protein content (Sawaya et al,1986). In addition, the chemical and nutritional
quality of six Saudi Arabian dishes based on cereals and legumes was investigated
(Al-Jebrin et al, 1985a,b), and 14 Saudi Arabian dishes based on meat, fish or
eggs were investigated for their nutrient composition as well (Sawaya eta!, 1986).
However, these dishes could provide an appropriate amount of protein and energy
to meet the Recommended Dietary Allowances (RDA) if consumed in adequate
quantities.
Half of our male subjects added salts to food, which might explain
previous studies which showed that sodium content was high [> 160 mg/lOOg] in
most dishes, particularly four dishes, and relatively low [<36 mg/bOg] in two
dishes (Al-Jebrin et al, 1985). Added to the salt content is the high use of spices,
especially cumin, coriander leaves and cloves which contain a high amount of
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sodium. Whether these salty dishes have a relation to the high rate of hypertension
that is common in Saudi Arabia [Chapter, 5] would be of interest to investigate.
Rice is second to wheat in global importance as a staple food for man. In
Saudi Arabia rice is the main food followed by bread. However, this study
supports a previous impression that rice is never eaten alone but always consumed
with meat, fish or poultry. This naturally improves the nutritional value of the rice
(Musaiger, 1987). The rice consumed in Saudi Arabia is polished. The practice of
washing and straining leads to the removal of some water soluble nutrients.
Another important factor is cooking the dish at a very high temperature for a long
time, which may enhance or reduce its nutritional value, since overheating of
dishes may render some of amino acids in the protein unavailable and inactivate
vitamins.
Bread, as shown in this study, is consumed less by the inhabitants of the
Saudi Arabia when compared to rice. Nevertheless, it is the main food item for
breakfast and supper. Five main types of bread consumed in Saudi Arabia have
been analysed [white and brown Arabic breads, European, Yemeni and Somali
breads] (Sawaya et a!, 1984). They confirm that the whole wheat flour contains
three times as much dietary fibre as white flour. This gives it a mild laxative
effect.
Increasing prosperity always leads to a more varied diet and a decreasing
consumption of cereals. In this study, almost 30 % ate breakfast cereal
[cornflakes] which is an example of westernization of eating habits.
Honey and jam which contain about 60 % sugar contributed moderately to
the caloric intake in this group.
Care should be taken with regard to snacks which were composed mainly
of confectionery. This comprised up to 70% of carbohydrate and nuts which
mostly have a high content of fat and protein.
Red meats and beans taken in the morning are the two main source of
protein. The protein quality of foods consumed in the Saudi Arabia was also
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investigated previously (Al-Jebrin et al, l985a). Amino acid profiles were found
to be good in Saudi meat-based dishes and in breads when compared with
FAO/WHO [1973] reference protein (Sawaya et al, 1984, 1986).
Attempts have bean made to analyse content of two high cholesterol of
dishes; mutabak ma'lahm (meat paste) and shakshuka (egg omelet). Obviously the
use of eggs in these two dishes has contributed to the high level of cholesterol in
each of them. It was found that most of the Saudi dishes had a high fat content
and a low ratio of polyunsaturated/saturated fatty acids. This may contribute to the
prevalence of atherosclerosis in the country (Sawaya et al, 1985a).
Vegetable oils are relatively newcomers to the diet in Saudi Arabia and
contribute greatly to the total fat and calorie content of the diet. The practice of
pouring melted fat or butter on top of the rice to enhance the flavour before
eating, might increase the amount of fat in the rice.
Milk and dairy products have traditionally been a major contributor to the
protein and calorie content of the diet. The consumption of these foods is still
high although other sources of animal protein are consumed regularly as they are
now freely available.
Humans are not very fond of plain water and prefer flavoured fluids such
as tea, coffee, cocoa, fruit juice, or even synthetic t colas' and 'lemonades'. They
are also a source of energy and a few provide small amounts of micronutrients.
The hot climate in Saudi Arabia encourages people to drink various types of soft
drinks, carbonated beverages being the most common. This study showed that
80% regularly consumed soft drinks. However, most soft drinks are sweetened. If
sugar is used, this may contribute to obesity and the drink is unsuitable for
diabetics.
Adding milk and sugar adds significantly to the dietary energy of some
people. In Saudi Arabia tea was once a rare and expensive commodity in the diet
[the traditional cardomon coffee being previously more popular and taken without
sugar]. Tea is taken sweetened and in large quantities throughout the day,
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contributing greatly to the calorie content of the diet. Coffee is a popular drink
and in moderate amounts a mild cerebral stimulant and diuretic. Alcohol was not
a problem in our community.
However, it is worthwhile mentioning that these dishes are eaten alongside
other foods such as laban, dates, and fresh vegetables which supplement the
nutritional value of the dishes, particularly in some minerals and vitamins, as well
as fibre [which was found to be deficient in the dishes].
Although the reason(s) for dietary modification are not shown here, 10%
of this population practised dietary modification by several means. This indicates
that only a small proportion showed some alterations in dietary habits for one
reason or another.
Several factors are known to have an influence on food consumption
patterns in Saudi Arabia. Increase in income may be one of the most significant
factors responsible for the change in food consumption patterns. Among other
factors are educational level, food prices, beliefs and attitudes,mass media and
household size. Added to this is the availability of fast foods such as beelburgers
and fried chicken which are widely consumed especially by the young generation.
Canned and other processed foods are widely available on the market and have
become an important component of the diet. However, these factors were not
examined specifically in this study.
Another aspect in this study is the relation of diet to glucose tolerance
status. A number of diseases, many of which are common and well-known, are
considered for one or both of two reasons; 1) the nature of the previous diet may
play some part in aetiology which is multiple and complex, and 2) modification
of the usual diet or the provision of a special diet reduces the metabolic burden on
discorded organs, or relieves symptoms and other manifestations of disease.
Among these disorders is diabetes. Dietary factors may increase the risk of an
individual developing diabetes. Thus, diabetes, hypertension and cardiovascular
disease can be linked to diet, at least in relation to obesity (Barrett-Connor, 1985).
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Since subjects with elevated blood glucose levels are at higher risk for
subsequent development of NIDDM (Jarrett et a!, 1979; Chapter 2) another way
of exploring the relation between diet and the onset of diabetes is to study its
relationship to glucose tolerance. In several epidemiological studies no clear
relationship could be demonstrated between dietary factors and the onset of
diabetes (Baird, 1972, Medalie et al, 1975; Lundgren et a!, 1989, Feskens et a!,
1989). However, recent studies have suggested that energy balance and the use of
carbohydrate-rich foods are related to the development of glucose intolerance in
an elderly population (Feskens et al, 1991). The intake of saturated fat and dietary
cholesterol may be detrimental to glucose tolerance, in contrast to the intake of
pectin and mono and disaccharides (Feskens et al, 199(J).
The hypothesis that a low fibre diet contributes to the aetiology of diabetes
has also been proposed, but it is difficult to see how a deficiency of fibre could
cause the disorder (Trowel!, 1975). The hypothesis was based on African
countries where the fibre content of the diet is high and prevalence of diabetes
low. In prosperous communities this relationship tends to be reversed. This is
often considered with the proposed that a large consumption of sugar may
predispose to diabetes although West (1978) lists 21 papers supporting this claim,
but also 22 papers which do not.
However the biggest diet related problem that is prevalent in Saudi Arabia
is obesity [Chapter 5]. Data kept over a 6 month period on diabetic admissions to
Riyadh Armed Forces Hospital (Gibbon, 1988) showed that out of 161 diabetic
males, 52% were more than 10% over IBW and 13 % were more than 30% over
IBW. The results for women were even more significant, 86% of the diabetic
females were more than 10% above IBW and 48% were more than 30% above
IBW. In the past obesity was a status symbol and it is only relatively recently that
the population has started to become aware of the effect on health.
To obtain data on the incidence of diet related disease, Kingdom-wide, is
difficult and it is only possible to extrapolate from the trends seen in this
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population. This study showed no relationship between most commonly used food
items and glucose intolerance in this small group of middle-aged urban men
[Thble 7.11], and favours that dietary factors play no role in the aetiology of
diabetes. In Saudi Arabia this is the product of the adoption of dietary habits
influenced by increased wealth, traditional social habits and very heavy
advertising by western food manufacturers. In the older section of the population
there is very little knowledge of the functioning of the body. To grasp the concept
that food can be harmful proves difficult. It is also difficult to dispel the fatalistic
belief that you cannot control your own health.
However, the population is becoming more aware of the effect bad dietary
habits are having on their health and are showing an interest in helping
themselves. The media used to provide this information must be chosen wisely
bearing in mind the high rate of illiteracy and social and religious influences on
the diet.
Further research in this direction would be of interest particularly a
quantitative-type of study in a large population, but taking into consideration
several factors; 1) the absence of food composition tables for use in Saudi Arabia
which should be established, since currently used tables [USA, RDA;
FAOIWHO] are lacking in many foods and dishes commonly consumed in this
country. Once these tables are available, these should provide useful information,
especially on ingredients, preparation and composition of composite dishes and of
ready-made foods available on the market. Thus, the development of regional
RDAs is required, taking into account body weight, dietary pattern and
bioavailability of nutrients in local foods, 2) the measurement of actual food
intake for each member in the family is difficult to obtain, since Saudi families
often eat together from the same plate. The food is served on a big tray (especially
at lunch) and all the family members surround it, eating the food using their
fingers sometimes. Thus establishing an appropriate technique for collecting
dietary intake, taking into consideration the socio-cultural aspects of the
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community, is highly supported, 3) the lack of qualified and trained staff to collect
dietary information, 4) the difficulty in obtaining actual quantities of ingredients
used in the local composite dishes.
In the meanwhile some practical comments are worthy of mention.
Physician and general practitioners alike should be aware of the dietary habits of
diabetic individuals before instituting a dietary plan and advise, and the present
study should provide some help in this direction. Also the practice of circulating
"translated dietary sheets" from a western designed diet regimen should be
stopped. Failure to observe these suggestions will greatly reduce compliance and
produce a lack of adherence of the diabetic individual to follow the prescribed
diet.
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Title
Table 7.1:
General dietary infonnation:
Meals habits:
-Three meals or more a day 	 88
-Lunch as a main meal	 94
-Taking snacks between meals 	 53
The snack between lunch and dinner 	 74
-Eating at home in general	 86
-Brakfast mainly at 7:30 - 10:30 	 73
Dont take breakfast	 11
-Lunch time mainly at 14:00 -16:00 	 78
-Dinner time mainly at 21:00 - 23:00	 71
Dietary modification:
Subjects [%] state that they:
-Added salt either when not enough or always before eating 	 48
-Changed their diet, 	 10
-Decreased the amount of:
Fat	 10
Sugar	 8
Salt	 4
Bread	 3
Identification ability (%) of brand name(s) or contents for some commonly used food itans
Food item	 Known (%)
-Oilorfat	 98
-Cheese	 92
-Milk	 78
-Yoghurt	 75
-Cream	 33
-Butter	 27
-Milky-made foods	 17
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Table 7.2:
Frequency of eating selected foods as a percentage of those interviewed. These responses indicate
foods that were taken at least once/week.
Dercentae
çarboh1thtes
Rice	 96
White bread	 89
Beans	 78
Tamees [commonly used white floor bread]	 66
Brown bread	 55
Lentils	 52
Pasta	 47
Potatoes	 42
Honey	 43
Jam	 33
Flour-made food	 34
Cornflakes	 31
Soft drinks [all] 	 86
Tea, sweetened with sugar	 92
Coffee, sweetened with sugar 	 28
Dates	 65
Confectionary
Biscuits	 35
Nuts (all types) 	 35
Cakes	 27
Jellies	 24
Chocolates	 20
Ice Cream	 17
Sweets	 15
Veretablesand fiuli
Salad	 98
Cooked Vegetables eg. Akra 	 92
Carrots	 66
Spices eg. pepper	 52
Oranges	 98
Apples	 83
Bananas	 75
Dates	 65
Tinned fniit	 7
142
Proteins	 percentages
Chicken	 94
Lamb
	
93
Fish
	
62
Organs [liver, kidney, heart]	 36
Beef
	
23
Tuna	 23
Meat pies pastries	 13
Camel	 3
Tinned meat	 3
Beans	 78
Eggs more than 7/ week.	 12
Fats and oils
Oil or fat used at home of plant origin	 79
Olives	 60
Cream	 30
Butter, ghee or margarine	 24
Eggs more than 7/ week.	 12
Milk and milk nroducts
Cheese, any kind
	
93
Cheese, > 250 grams per week
	
19
Laban [Yoghurt]	 70
Milk [amount]	 68
-One glass milk or more per day	 78
-None	 22
-Liquid milk
	
54
-Dried milk
	
24
Adding milk or cream with tea or coffee	 41
Milky-made food
	
19
Milk pudding	 11
Beveraaes and drinking habits
Water ^ 3 litre per day	 8
-Increasing water drinking mainly due to kidney problem	 22
Sweetened tea with sugar 	 92
Sweetened coffee with sugar	 28
Soft drinks [all]	 86
-Natural juices	 15
-Fizzy drinks like pepsi and similar	 79
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Table 7.3
Eating habits by glucose tolerance groups [%].
NGT	 IGT	 NIDDM
n (%)	 55 (58)	 25 (26)	 15(16)
General habits:
Main meal as lunch	 91	 100	 93
Thking snacks between meals 	 73	 64	 80
Changed diet	 9	 19	 25
Adding salt	 48	 50	 44
Specific, each food items taken at least once/week:
Rice	 93	 100	 100
Whitebread	 88	 88	 94
Brown bread	 57	 46	 62
Beans	 74	 88	 75
Potatoes (a)	 67	 87	 62
Honey	 43	 50	 31
Jam	 29	 42	 31
More than7eggsperweek 	 10	 12	 19
Milk	 69	 77	 50
-Milk one glass or more 	 79	 81	 69
-Yoghurt	 67	 77	 69
Eating cheese	 93	 96	 88
Cheese amount > 250 glweek	 21	 8	 31
Lamb	 93	 96	 88
Chicken	 98	 88	 88
Salad	 96	 100	 100
Dates	 66	 73	 50
Apples	 84	 85	 75
Bananas	 76	 77	 69
Oranges	 83	 96	 94
Softdrinks	 91	 81	 75
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CHAPTER EIGHT
PHYSICAL ACTWITY ASSESSMENT
CI1AFER CONTENT:
Summary
	
8.1	 Introduction
	
8.2	 Subjects and methods
	
8.3	 Results
	
8.4	 Discussion
"When the population is often obese and sedentary, exercise would be expected to have
beneficial effects both in promoting weight reduction and in improving glucose regulation".
Zinman and Vranic,1985
SUMMARY
In the Jeddah CVD pilot study, 95 of 125 men [76%] aged 20-65 years completed a
questionnaire concerning six aspects of physical activity and had a venous plasma glucose
measurement on a sample taken at 0 h and 2 h after a 75 g glucose load. Au activity score was
calculated by grouping subjects into three broad categories: inactive, moderately active, and
active. The responses revealed an 'inactive community' and there was no significant differences in
the activity score between the three glucose tolerance groups.
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CHAPTER EIGHT:
	 PHYSICAL ACTIVITY ASSESSMENT
8.1 iNTRODUCTION
There are considerable differences in the prevalence of NIDDM both
between and within populations. A putative factor to explain some differences
and/or changes in the frequency of NIDDM is physical activity. Physical
inactivity has been implicated as a risk factor for development of NIDDM (West
et al, 1978). Studies examining the acute and chronic effects of physical activity
on carbohydrate metabolism and glucose tolerance provide evidence for the
biological plausibility for such a relationship. Yet, despite both of these facts,
epidemiological data on the role of physical activity in the aetiology of NIDDM
or in the worsening of glucose tolerance are still scarce. Results from a few recent
cross-sectional studies suggest that physical inactivity may be an independent risk
factor for NIDDM (Taylor et al, 1984; Cederhoim et al, 1985, Lindgarde et al,
1981), whereas two large earlier studies had not found a significant relationship
between glucose tolerance and habitual physical activity (Jarrett et al, 1986;
Montoye et a!, 1977).
The relationship between habitual physical activity and glucose or
NIDDM has been explored in few populations and with inconsistent results
(Montoye et a!, 1977; Taylor Ct a!, 1984, Cederhoim, 1985). Most recently the
Whitehall Study provided the opportunity for a further exploration of the
relationship, with the potential advantage of large numbers and observations
(Jarrett et a!, 1986). Similar observation was also described for Mauritius where
physical inactivity was correlated with the prevalence of NIDDM and IGT
(Dowse et al, 1991). Thus, this study aimed at describing the physical activity
status in an urban male population of Saudi Arabia and exploring differences
between the three glucose tolerance groups.
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8.2 METHODS
Background. Methods of acquiring information on physical activity may involve
(a): questioning or self-recording, (b): some form of measurement of movement,
(C): heart rate recording, or (d): measuring energy expenditure (Durnin, 1990).
Several useful general reviews of these methods have been published (Montoye et
a!, 1984; Wishburn et a!, 1986). The most common technique of assessment is to
measure physical activity by questionnaire or by a diary record. Some
questionnaires require a skilled interviewer and can take up to l'/2 hour, whereas
others can be self-administered and completed in 10-15 mm (Durnin, 1990). In
addition, although other possible measurements are on the horizon, questionnaires
and interviews, still appear to be the most convenient methods for assessing
exercise habits in epidemiological studies at present (Montoye, 1990). Testing the
validity of the different types of questionnaire is difficult and there is still great
uncertainty in this field (Durnin, 1990). Moreover, none of the newly developed
questionnaires and interviews have been validated, mainly because of a lack of an
acceptable criterion (Montoye, 1990). The goal of measuring physical activity as
an essential indicator in the survey is not to measure physical activity as a whole,
but to measure those parts which can be influenced by individual attitudes
(Leparsky et al, 1987).
This study. In this study, therefore, the questionnaire for physical activity
which recommended by the Countrywide Integrated Noncommunicable Diseases
Intervention Programme [CINDI] (Leparsky et a!, 1987) was extended and
applied [Appendix 5]. This contains twenty two questions in six parts which cover
various forms of possible physical activity including : work [Q1-4], household
[Q5-7], leisure-time [Q8-12], sports [Q13-16], recreational walking [Q17-19] and
general[Q20-22]. Subsequently an activity score was calculated by grouping the
subjects into three broad categories: inactive, moderately active, and active
[values 1-3]. The activity score covered four types of activity, i.e home activity,
leisure time activity, sport activity and recreational walking. 'Active' had three or
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more [yes] responses, 'moderately active' had intermediate combination of
responses and 'inactive' had three or more [no] responses. These categories, in
other studies, have shown some relationship with subsequent rates of mortality
(Marmot, 1984). The latter group including those men who participated in
vigorous sporting activities such as swimming and football. The technique used
was direct questioning by the investigator and this section required up to 15
minutes for each subject which was only completed in 76 % [n=95] of the total
subjects screened [n= 125]. Data on other survey measurements was also available
for this cohort [n =95] including age, BMI, WHIR, blood pressure and fasting and
2-h plasma glucose and insulin [Chapter 4].
Statistical approach: Descriptive analysis was shown in percentages for the
whole group. Crosstabulation and X2 was used. Mann-Whitney was used to
compare activity score between groups and to compare variables between active
groups.
8.3 RESULTS
The responses to the physical activity questionnaire, for the whole
population, are shown diagrammatically [Fig 8.1-8.6] where each diagram
represent responses to a single question. Then, the responses to some physical
activity questions and the activity score by glucose tolerance groups are shown
['läble 8.1]. Finally, subject characteristics by activity score groups are presented
['Thble 8.2].
Work related activity [Fig 8.11 responses revealed that only 4 % walked to
and from work and the great majority [95%] use their own cars or public transport
as a means to travel to work. Daily time spent of less than 30 mm walking to and
from work was found in 83 %. All of those interviewed were working and their
types of work were mainly sedentary [62%], since walking while at work of less
than 2 hours was found in [61%].
Household activity questions [Fig 8.2] revealed that one third [33%] of
subjects participated in household work. Half [46%] spent less than 2 hr per week
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doing so and one fifth [21 %] had perspiration and required rest following that
work.
Participation in leisure-time activity [Fig 8.3] was even lower [14%].
Leisure time was rarely spent in walking [8 %], maintaining activity [6%] and
none performed regular training. Of those who were performing activity, the
majority [64%] took exercise up to 2 times per week. Moreover, duration of an
activity episode of less than 30 minutes was found in 64%, and the frequency of
perspired activity of less than once per week was found in 36%.
Participation in sport [Fig 8.4] was also poor [17%]. Swimming [56%] and
football [19%] were the most common types of sport enjoyed in this population.
However, the majority [76%] spent less than 2 hours per week in sports, and 12%
stated that the present sport times was more than previous times.
Participation [56%] in recreational walking [Fig 8.5] was found in rather
more of the population. However, nearly half [45%] walked less than 2 hours per
week.
Finally, the general perception on activity [Fig 8.20-8.22] showed that a
third of subjects [35%] were satisfied with their current physical condition,
although 70% never seriously increased their leisure-time physical activity and
61 % showed no change during the preceding six months in their leisure-time
physical activity.
In general, coding these various aspects of physical activity into three
categories showed that 77% of this population of urban men were
inactive, 10% moderately active and only 13% were active.
Comparisons of some of these aspects of physical activity by glucose
tolerance group are shown in [Thble 8.1]. The inactivity values tended to be
higher in NTDDM, intermediate in IGT and lower for NGI'. This was also clearly
found in the activity score where the inactivity score was highest in NIDDM
[93%], intermediate in IGT [80%] and lowest in those with NGT [70%].
However, no significant differences were found between these glucose tolerance
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groups, perhaps because of small numbers.
Characteristics of the subjects by activity score groups are shown in 'Iäble
[8.2]. Inactivity was 3-fold more prevalent than activity, although both groups had
comparable age ranges. Those found to be inactive tended to have higher values
for most of the examined variables. Thus, the inactive group had higher BMI and
WHR, their lipids values were higher, their fasting glucose and insulin were
greater and they were more resistant to insulin. None of these when compared
showed statistical significance, however.
8.4 DISCUSSION
Diabetes mellitus, like hypertension and other chronic disorders, is
included in the list of so-called lifestyle diseases. Although diabetes is strongly
genetically determined, heredity cannot totally explain the high rates found.
Among the environmental factors that might be implicated in the outburst of
diabetes in a certain population, physical activity superimposed on overnutrition
plays a fundamental role.
At present, epidemiological data on the role of physical activity in the
aetiology of NIDDM or in the worsening of glucose tolerance are still scarce.
Studies are not available in the literature which described physical activity in
relation to diabetes mellitus in Saudi Arabia or in the surrounding Gulf countries
which share a more or less similar environment. Moreover, these prevalence
studies (Fatani a al, 1985; Bacchus Ct a!, 1982; Chapter 3) which suggested that
inactivity might play a role, did not assess it. This was the rationale behind my
intention to assess physical activity in our urban population and to investigate the
relationship of this activity to glucose tolerance group.
In this inactivity has been demonstrated in many physical activity facets
and one can rightly label this community as an 'inactive community'. The
number, although reasonable for a pilot investigation, needs to be larger, perhaps
in the range of thousands, to show significant differences in terms of glucose
tolerance or activity score groups. This study did, however, show that a greater
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number of subjects with NTDDM and JOT did not participate actively in various
lifestyle activities. Moreover, inactivity being lower in NOT [70%], intermediate
in lOT [80%] and higher in NIDDM [93%] provides support that physical
inactivity, at least in this subpopulation, tended to be commoner in subjects with
glucose intolerance.
One direct study relevant to life style is that of 1ylor et al (1984), who
studied males of two ethnic groups - Indian and Melanesian - living in Fiji.
Diabetes prevalence was calculated from known plus newly diagnosed, the latter
comprising men with 2-h plasma glucose levels of 11.1 mmoL Il or more. Physical
activity was classified as sedentary, light, moderate or heavy, based principally
upon occupation. Comparing sedentary/light with moderate/heavy activity
groups, age adjusted 2 h blood glucose levels were higher in the sedentary/light
groups in both populations, but the difference was statistically significant only in
Melanesians [0.4 mmol/l; p = 0.03]. For reasons which are not apparent, the
difference in prevalence of diabetes [higher in the less active groups] was more
evident in the Indians.
Approximately 20 years ago, BjOrntorp and his colleagues suggested that
physical training is associated with lower plasma insulin concentrations and
improved insulin sensitivity (BjOruorp et al, 1972). They found that physically
active middle-aged men who regularly participated in sports had much lower
plasma insulin concentrations both while fasting and after the administration of
glucose than did inactive men matched for age and weight who had similar blood
glucose concentrations. Our study was similar in that we showed relatively,
although not significantly, higher values for fasting insulin and insulin resistance
in the inactive group.
The hypothesis that exercise might provide some protection against the
development of NIDDM rests upon observed reductions in glycaemia and
insulinaemia following acute exercise or exercise programmes and the
substantially increased incidence of NIDDM in populations where life-style,
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including occupational exercise has changed drastically during the 20th century.
Reviewing the experimental studies in NIDDM, Zinman and Vranic (Zinman et
a!, 1985) state "When the population is often obese and sedentary, exercise would
be expected to have beneficial effects both in promoting weight reduction and in
improving glucose regulation. Documentation of improving insulin sensitivity
and glucose tolerance has been shown. However, the effects have not been of
large magnitude and are often of short duration".
The Whitehall study despite the large numbers of observations (Jarrett et
al, 1986) could find no association between estimated leisure time activity or a
surrogate measure of energy expenditure and glucose tolerance as indicated by the
blood glucose level 2-h after an OCTT. Further, although in many fewer subjects,
there were no significant differences in estimated leisure time activity in men with
established or newly diagnosed diabetes compared with non-diabetic subjects.
A similar investigation to the Whitehall Study, although with several
methodological differences, was performed in the Tecumseh Health Study
(Montoye et a!, 1977) in which 1300 men aged 16-64 were classified into three
groups on the basis of their habitual leisure and occupational physical activity [in
the Whitehall Study occupational activity was not considered as most subjects had
sedentary occupations]. There was no significant correlation between glucose
tolerance and physical activity.
Cederhoim and Wibell (Cederhoim et a!, 1985) studied glucose tolerance
and reported leisure time activity in 371 men and 435 women, aged 47-54 years,
derived from the register of the County Council of Uppsala. The subjects were
divided into two groups: low [682] and high [125] activity. After adjustment for
co-variates the mean 2 h blood glucose level was 0.52 mmol/l higher in the less
active group (p <0.001), but when the sexes were compared separately the
difference was only significant in men.
The Whitehall Study and the other studies reviewed above provide little or
no support for the hypothesis that physical activity provides some protection
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against the risk of developing NIDDM. Even when statistically significant,
differences in glucose tolerance between activity groups are trivial in degree.
Moreover, although a role for physical conditioning in the prevention of NIDDM
has been suspected on the basis of population and cross-sectional studies, no
effect of exercise independent of other factors has been identified (Horton, 1991).
It is possible, however, that as these studies were cross-sectional in design that
they may lack power in detecting a putative beneficial effect. Thus, prospective
studies would have a greater chance of detecting an effect, if it exists, but the
logistic problems in mounting a study of adequate size and duration would
provide a considerable deterrent.
A recent long-term study presented convincing evidence that there was an
inverse relation between energy expenditure in leisure-time physical activity and
the development of NIDDM during the subsequent 15 years (Helmrich et al,
1991). This prospective study proved that the protective effect of physical activity
was independent of other risk factors and was particularly strong among men who
participated in vigorous sports, although participation in less vigorous activities
was also protective. Moreover, in a selected high-risk subgroup, habitual physical
activity had the greatest protective effect, decreasing the incidence of diabetes by
24 % from the highest activity group to the lowest. These findings strongly
support the position that persons who are at substantial risk for NIDDM should be
encouraged to maintain a high level of physical activity in their daily lives.
At this point, this advice is of utmost importance to the urban male
population in Saudi Arabia, since the prevalence of both IGT and NTDDM were
found very high. Thus, improving the present style of physical activity might help
in this direction and an a large-scale intervention study would be of interest.
Regular physical exercise has long been considered an important part of
the treatment of NIDDM and is frequently prescribed, along with diet, oral
hypoglycaemic agents, or insulin. In addition to lowering blood glucose levels in
the short term, exercise may improve long-term glucose control, as indicated by
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glycated haemoglobin. Insulin sensitivity is also increased. Other benefits of
exercise extend to several cardiovascular risk factors, such as improvement in
mild-to-moderate hypertension, improved lipid profiles, and more effective
weight reduction (Horton, 1988).
Clearly, regular physical. activity is an important component of a healthy
lifestyle for all of us, but it may be particularly important for those at increased
risk for chronic diseases such as NIDDM, hypertension, and hyperlipidaemia.
In conclusion, physical activity responses revealed a great inactive sector
in this urban community. Encouraging activity by any means should be one of
many advisory practices among not only the high-risk or diabetic population in
particular, but also among the general population as a whole.
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Table 8.1
Physical activity responses and score [%J by glucose tolerance group [n=95]
NGT	 IGT	 NIDDM
n(%)	 55(58)	 25(26)	 15(16)
Don't walk
To and from work	 69	 84	 87
While at working days	 18	 24	 26
Subjects j participating in activity:
Household	 62	 68	 87
Leisure-time	 84	 88	 93
Sport	 78	 84	 100
Recreational walking	 4()	 44
Perception of current physical condition:
Badorverybad	 11	 24	 27
Never increased leisure time activity 	 62	 88	 74
Perceived no change in preceding 6 months activity 54
	 76	 60
The activity score:
Inactive	 70	 80	 93
Moderately active	 15	 4	 7
Active	 15	 16	 0
Statistical comparisons showed no significance.
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Table 8.2
Subjects [n=951 characteristics by activity score.
Inactive
	
Active
n
(%)
Age	 years
(range)
BMI	 h/rn2
WHR
Systolic blood pressure mrnHg
Diastolic blood pressure mmHg
Cholesterol	 inmol/l
Triglyceride	 mmol/l
Fasting glucose	 mmol/l
2-h glucose	 mmol/l
Glucose AUC	 mmol 1 'h
Fasting insulin	 mUll
Insulin ATJC
	
mU 1 th
proinsulin pmol.1/
insulin pmol.l	 molar ratio
ILOMA model assessment of:
a-cell function
Insulin resistance
73
(77)
38 ± 1
(20-55)
28.6 ± 0.5
1.01 ± 0.01
121 ± 2
75 ± 1
4.7 ± 0.1
1.5 ± 0.1
6.1 ± 0.2
8.7 ± 0.6
17.1 ± 0.8
17.8 ± 1.5
147 ± 7
0.13 ± 0.1
169 ± 18
4.9 ± 0.4
22
(23)
36 ± 1
(22-50)
27.4 ± 0.8
1.00 ± 0.01
121 ± 3
74 ± 2
4.5 ± 0.2
1.2 ± 0.1
5.4 ± 0.1
6.7 ± 0.5
14.5 ± 0.6
15.5 ± 2.3
149 ± 15
0.12 ± 0.02
179 ± 32
3.7 ± 0.5
Mean ± SEM. Statistical comparisons showed no significance.
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Ethnicity is one kind of patent difference, and although it is difficult to define it accurately, it does
convey the idea of peculiar characteristics assigned to some group of persons who can be easily
recognizable and can be differentiated from others. 	 G. Alleyne in (Cruickshank ea al, 1989)
SUMMARY
The aim of this chapter is to examine similarities or differences that might existed
between Saudi and non-Saudi citizens. The available variables were carefully examined in this
respect and are presented here.
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CHAPTER NINE:
	
NATIONALS vs NON-NATIONALS
9.1 INTRODUCTION
The estimated total population living in Saudi Arabia was about 12 million
in 1985 (James et al, 199(3). Throughout the centuries, a large proportion of the
population has consisted of Muslims of different national origin, who came for
Hajj and later settled in the Arabian peninsular. In addition, there have been a few
non-Muslims who came for trade, business, work or diplomacy. Since
commercial drilling for oil commenced in Saudi Arabia in 1938, the influx of
expatriate workers from the West and Third World Countries increased
dramatically. The foreign population in the whole Kingdom was estimated to be
28.4 % in 1985 (James et al, 1990). This reached 53 % in Jeddah (Al-Harbi,
1988), perhaps because it is the main west sea-port and the gateway to the Holy
Cities, Makkah and Madinah. This background justifies the main theme of this
chapter which aimed to examine the effects of nationality on different metabolic,
,dietary and physical activity variables.
9.2 SUBJECTS and METHODS
The study subjects [n= 125; 95 for the dietary and physical activity
studies], the questionnaire, the survey physical procedures and blood
measurements, laboratory assaying methods, definitions and cut-off points were
all described in previous chapters. Here for the purpose of nationality differences,
Saudi nationality was defined as those who were holding Saudi Identity Cards,
which almost always indicated that the father [one generation] and or his
offspring were born in Saudi Arabia. All other nationalities, due to the small
number for each, were grouped collectively under non-nationals.
The data were then, analysed with the SPSSPC+ using nationality as a
dichotomous explanatory variable against all the available response variables
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separately. Comparison between the two nationality groups were performed using
the Mann-Whitney U test or X2 test. A p value < 0.05 was taken to be significant.
9.3 RESULTS
The results are shown in Tables [9.1-9.8]. Nationalities are shown in Thble
[9.1]; Saudi were found to be the majority (61%). The non-Saudi constituted 11
nationalities, the majority of them were from Arabic-speaking countries [Egypt,
41 %J and few from non-Arabic-speaking countries such as Afghanistan and
Somalia. The non-nationals originated from four different ethnic groups, namely,
Mediterranean [85 %], African [11 %], and equal percentages from the Indian
subcontinent [2%] and South East Asia [2%].
Socioeconomic and environmental features are shown in Table [9.21.
Saudi Arabia as a place of origin was found in 96% of nationals but, not
surprisingly, in only 14 % of non-nationals. There were, also not surprisingly,
differences between nationals and non-nationals with respect to residency
duration, educational level and income. Thus, 65 % of nationals had lived 15
years or more in Saudi Arabia versus 20 % of non-nationals; higher education was
less in nationals [35%] versus non-nationals [47%], but higher income [ >4500
SR/month] were mote frequent among nationals [77 % vs 12 %]. However,
income class was the only factor which showed a significant difference [p <0.05].
Nationals [65 %] smoked more frequently than non-nationals [55%],
although they had low rates for smoking cigarettes only [40 % vs 53 %], but high
rates of smoking both cigarettes and shisha [10 % vs 6 %J. These and CYD
symptoms were not significant between nationals and non-nationals.
The prevalence rates of glucose intolerance and risk factors by nationality
are shown in Table [9.3]. The rates of diabetes meffitus were not different in
nationals [13.1 %] vs non-nationals [14.3%] in contrast to lOT where rates
approached 30% in the nationals compared with 22.4% in non-nationals. There
were, however, no significant differences in the rates of abnormal glucose
tolerance, due to small numbers. The rates of obesity and increased WHR were
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not significantly higher in nationals compared to non-nationals. Hypertension and
hyperuricaemia rates were slightly lower in nationals. Nationals also had
significantly higher rates of hypercholesterolaemia but no significant differences
in hypertriglyceridaemia compared to non-nationals.
General and anthropometric measurements are shown in Table [9.4]. Both
groups exhibit comparable age and BMI and there was no significant differences
in WHR, systolic or diastolic blood pressure.
Glucose and insulin values during the OGTT, fructosamine and AUC
values are shown in Table [9.5]. fl-cell function and relative insulin resistance
calculated from the HOMA model are also shown. There were no significant
differences in these variables between the two nationality groups. However,
fasting and 2-h plasma glucose values tended to be higher in non-nationals,
although not significantly. Both nationalities had comparable fasting insulin levels
but 2-h insulin values were significantly higher in nationals [p <0.05].
The metabolic-endocrine group of risk factors are shown in Table [9.6].
There were no significant differences between the two nationalities for
cholesterol, triglyceride, uric acid, fasting insulin, proinsulin, proinsulin/insulin
molar ratio or SHBG values.
Selected dietary habits and physical activity score are shown in Table
[9.7]. Taking snacks between meals tended to be greater in nationals [61 %]
versus non-nationals [45 %, ns] and in particular those snacks that were taken
between lunch and dinner [84 % vs 59 %]. No food items showed significant
differences between nationals vs non-nationals except for brown bread [78 % vs
31%] and dates [84 % vs 45%] [Both, p < 0.05]. The nationals, however, had
significantly greater inactivity scores compared to non-nationals [86 % vs 32%, p
<0.05]. Apart from these observations no significant differences existed in the
many variables assessed between nationals and non-nationals.
9.4 DISCUSSION
The concept of 'ethnic origin' is not simple. There are fundamental
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questions of definition of 'ethnicity' to be addressed and any investigation of
ethnic groups requires a method to identify their members. For example, does the
term include solely immigrants, or also those in the 'new' country to parents [or
grandparents] born overseas?. If the latter, is membership of a particular ethnic
group restricted to those with both parents born in the same country; how are
those of mixed parentage to be assigned?. To a great degree the choices to be
made rest upon the requirements and orientation of the researcher (Cruickshank,
1989). In this study, the nationwise difference was the only feasible approach due
to the small size of the group.
The association between ethnic/racial group and disease and the
differences in the frequencies of various diseases among a wide range of ethnic
and racial group is well-known and was discussed comprehensively recently
(Polednak, 1989).
Both diversity and similarity across populations need to be recognised,
whether one is dealing with sociocultural characteristics, biological
characteristics, or risk of disease. Cross-sectional studies of human behaviour,
including those related to dietary habits, and reactions to the stresses of
acculturation and migration, are important from an epidemiologic perspective.
The variability in disease patterns within groups and the opportunity to study the
processes of migration, acculturation, and urbanization has also been amply
demonstrated in diverse groups as South American Indians, Melanesian, and
Polynesians (Polednak, 1989).
This chapter attempted to explore this concept of ethnic differences within
Saudi Arabia, since at least third of its inhabitants are foreigners. Ethnic groups
may differ in sociocultural factors and this was clearly observed in this group with
respect to income where a high socioeconomic class was much more frequent
among nationals, if income was considered as social class indicator. But these
patterns in sociocultural aspects may change rapidly with time as shown in
various migrants groups (Cruickshank, 1989).
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The previous studies on the prevalence of diabetes mellitus in Saudi
Arabia examined ruler/urban differences and were from the central and western
regions [Chapter 3]. However, unfortunately, none of these studies, although their
sample size was large, differentiated between nationals and non-nationals.
The prevalence rate of diabetes in this study was almost the same between
nationals and non-nationals, but that for JOT was higher among nationals.
However none of the risk factors showed any significance differences except
cholesterol where hypercholesterolaemia [^ 5.7 mmolJl, p =0.04] was found three
times more among nationals. However values at cut-off points of ^ 5.2 and 6.5
mmolJl were insignificant. A recent report (Inwn et al, 1991) with larger sample
En =8291] on importance of cholesterol screening in Saudi Arabia found that 38%
had serum total cholesterol concentrations > 5.2 mmol/1 but this report did not
examined etimic differences.
The prevalence of NIDDM varies greatly both among members of the
same ethnic group living in different environments, and among members of
different ethnic groups living in the same environment (King et a!, 1988). These
patterns provide evidence that NIDDM is the result of an interaction between
environmental and genetic determinants. Expatriate Indian communities in many
part of the world have much higher prevalence of diabetes than in most regions
within India itself (A hufa et al, 1979). However, Indians living in an affluent
suburb of New Delhi also had high rates which were similar to those living in
Southall in West London (1&ma et al, 1986). Also, differences have been found
in the prevalence of diabetes among Japanese migrants living in the island of
Hawaii [12.3%] and those within Japan itself living in Hiroshima [6.9%] (Kawate
eta!, 1979).
"The Bedouin diet was limited to milk products, dried fruit and grains
from settled villagers when available. Meat was only eaten when an animal was
slaughtered for special ceremonies. Their diet was, on occasions, supplemented
by raiding from settled villagers (Encyclopaedia Britannica)". This quoted
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statement may not be true for Saudi Arabia today. Moreover, the dishes
consumed in Saudi Arabia are considerably different in their ingredients to those
consumed in other Middle East or Western countries, since the Middle Eastern
diet which depends on cereals and legumes as a source of protein may not apply
to the Saudi diet where the diet is composed of many animal protein foods such
as eggs, meat, fish and poultry (Ml4aiger, 1987).
The traditional diet of Saudi Arabia has regional variations influenced by
climate [which varies from the hot arid desert of the central region to the humid
coastal plains and the cooler mountain regions of the south], availability of fertile
land, the sea and the annual influx of Pilgrims to Makkah. The Hejaz or Mddcah
region has been influenced by Pilgrims and foods of Indian and Indonesian origin
have been incorporated into the diet. The southern region which includes the
Asir mountains and the coastal plain traditionally grew millet, sorghum and wheat
as their staples. The central region had wheat as their staple but production was
limited because of the low and unreliable rainfall.
Social and religious aspects of food are quite peculiar. As is the case in
many traditional societies, food has a great social meaning and it is the tradition in
Saudi Arabia to share food with ones neighbour. Food is offered to all who enter
the home and to refuse is to cause great offence. Food also has religious
connotations particularly during specific times such as Ramadan. Honey is
believed to have health giving properties and therefore has a special place in the
diet as do dates (Quran).
The high percentage of immigrants with various nationalities has led to a
wide range of foods available on the market. This is mainly because of the
different food habits of those immigrants. There were more than 1,900 different
kinds of processed foods available on the market which are imported from 38
countries (Musaiger, 1987). Thus, immigrants have influenced food consumption
by introducing many food habits to the region. For example, the Arab group,
mainly Palestinians, Lebanese, Egyptians and Jordanians, have had an impact on
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food habits. They introduced many popular dishes such as falafel, himmos,
lebeneh, foul moudams, tabbouli, shawarma, bakalawah and knafeh. Indians and
Pakistanis have influenced the food habits. Indian dishes, such as keema, dhal,
biriyani, mutton curry and chapati, are widely consumed in these countries. The
wide usage of spices in cooking and the availability of various kinds of spices on
the market is the most striking example of the influence of the Indian
subcontinent. In Saudi Arabia, the influence of Yemenis was also observed as
several Yemeni foods are consumed such as Yemeni bread, mutabak leham and
mutabak mamuz (Sawaya et al, 1986).
Dates are a good source of non-haem iron and some other minerals in
addition to simple sugars. The habit of eating them was, not surprisingly, found to
be higher among nationals since this was part of their customs. However, a
similar explanation would be unlikely for the higher rates of eating brown bread
among nationals. Although, the differences in dietary habits were confined to
these two food items [and perhaps snacking habits] it would be enough to shed
some light into the importance of ethnic differences in planning dietary advise.
The ethnicity of the group of Nisci men did not seem to affect greatly the
nutrient character of their diet (Tsunehara et a!, 1990). Population or ethnic
differences in CVD risk factors are apparently related largely to differences in
intake of specific dietary constituents such as total fats or specific types of fat,
fibre, and sodium. This study did not show marked ethnic differences in CVD risk
factors although certain, unrelated, dietary constituents were changed.
The differences in activity score can be clearly explained on the basis of
social class differences between nationals and non-nationals. Thus, high inactivity
rate among nationals might be related to the high income rate which facilitates
more lazy albeit luxurious life-style.
Therefore, this study showed certain biological and behavioural
differences on an ethnical basis in a population sharing one environment. It
illustrated differences in insulin responses, in the rate of hypercholesterolaemia, in
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certain socioeconomic and dietary aspects, and in the level of activity. However,
the lack of difference in diabetes and CVD risk factors between nationals and
non-nationals suggests environmental factors are dominant over the genetic
background in these populations or there is some common genetic material.
Thus describing and explaining of associations between ethnic group and
disease has several applications (Polednak, 1989). In clinical practice recognition
of diversity in disease risk by ethnic group among patients can be helpful in
diagnosis and in planning of both prevention and treatment strategies. Also, the
applications of knowledge of ethnic differences in disease for clinicians relates to
decisions about possible diagnostic tests and avoidance of unnecessary tests. In
contrast to misdiagnosis based on lack of awareness of ethnic group as a risk
factor, clinical oversight may occur with regard to diseases not expected to be
found in an ethnic group. Finally, primary care physicians may need to learn to
apply techniques such as goal setting or community group involvement in the
treatment of diabetes, dietary aspects or overweight.
In general, part of effective preventive medicine involves recognition of
modifiable factors involved in disease causation or progression. This recognition
may be aided by the results of studies that consider ethnic group, which may
provide clues to more specific and modifiable risk factors and better prediction of
outcome. The explanation of population differences in rates of disease, which
sometimes follow ethnic lines of demarcation, will require attention to multiple
potential differences including sociocultural and biological factors.
The diversity of nationalities that formed this population in Jeddah is an
index to the actual mixture of ethnic groups that constituted the whole
community. A future work should consider this diversity and a comparative
study, perhaps, between the endogenous and the exogenous population as a whole
or between the two different exogenous ethnic groups, or between a single ethnic
group and its counterpart in the place of origin, would be of future interest.
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9.1:
Population nationalities.
n[%J
All
Saudi
non-Saudi
Components of non-Saudi nationalities:
1. Egypt
2. Sudan
3. South Yemen
4. North Yemen
5. Thnisia
6. Palestinian
7. Jordan
8. Lebanon
9. Pakistan
10. Afghanistan
11. Somalia
125 (100)
76 (61)
49 (39)
20 (41%)
9 (18%)
4 (9%)
3 (6%)
3 (6%)
3 (6%)
2 (4%)
2 (4%)
1 (2%)
1 (2%)
1 (2%)
Total
	
49 [1001
172
47
(49)
14
86
80
20
53
47
88
12
55
8
0
20
0
Table 9.2:
General historical characteristics by nationality [n=9S].
Nationals
n
	 48
(%)	 (51)
Place of origin:
Saudi Arabia	 96
Elsewhere (Mediterranean
Indian, South East Asian,
Africa)	 4
Residence duration in
Saudi Arabia:
upto l5yrs	 35
>15 yrs	 65
Education level:
Up to secondary school 	 65
University or above	 35
1lncome (SR):
Up to 4500	 23
>4500
	 77
Smoking	 65
Symptoms of CYD:
-Pain or discomfort in chest 	 6
-Severe pain across the front of
chest lasting for half an hour
or more
	 4
-Pain in either leg on walking 	 27
-Weakness or loss of strength in
an arm or leg lasting for 24 hrs	 0
1, P < 0.05.
non-Nationals
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Table 9.3:
Prevalence (%) of glucose intolerance and CYD risk factors by nationality in 125 subjects.
Nationals	 non-Nationals
n
	 76
	
49
[%]
	 (61)	 (39)
NOT	 57	 64
lOT	 30	 22
NIDDM
	
13
	
14
Overweight	 BMI ^ 27 km/rn2 51	 57
Obesity	 BMI ^ 30kg/rn2 32	 31
WHR	 > 1.00
	
51
	
49
Hypertension	 WHO, 1978	 4	 6
Hypercholesterolaemia ^ 6.5 mmol/1	 11	 2
'Hypercholesterolaemia ^ 5.7 mrnol/1	 24	 8
Hypercholesterolaemia ^ 5.2 mrnol/1	 32	 24
Hypertriglyceridaemia	 ^ 2.2 mmol/1	 11	 20
Hypertriglyceridaemia	 ^ 1.7 mmol/1	 25	 31
Hyperuricaemia	 ^ 4.2 mmol/1
	
39
	
41
1, P < 0.05.
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Table 9.4:
Clinical characteristics by nationality. Mean ± SEM or range [n=125].
Nationals	 non-Nationals
n
(%)
Age
(yrs)
Weight
(kg)
Height
(m)
BMI
(kg/rn2)
Waist
(cm)
Hip
(cm)
WHR
Systolic BP
(mmllg)
Diastolic BP
(mmHg)
76
(61)
38 ± 8
(20-60)
78 ± 15
1.69 ± 0.1
28 ± 5.0
96.5 ± 11.6
95.8 ± 10.9
1.01 ± 0.03
119 ± 15
74 ± 11
49
(39)
38 ± 7
(27-64)
82 ± 13
1.70 ± 0.1
28 ± 4
98.5 ± 10.5
97.9 ± 10.3
1.01 ± 0.03
120 ± 15
76 ± 10
Statistical compnson showed none significance.
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Table 9.5:
Glucose and insulin during OGTT (75g) , fructosamine and the calculated area under the
response cruve (AUC) for glucose and insulin expressed in mean ± SEM.
Nationals	 non-Nationals
Glucose (mmol/1):
Fasting
1-h
2-h
AUC
(mmol r' h)
Fructosamine
(mmol/l)
Insulin (mU/l):
Fasting
1-h
'2-h
2AUC
(mU 1.1 h)
Pathogenesis:
a-cell function
Insulin resistance
5.6 ± 0.1
10.3 ± 0.4
8.0 ± 0.4
15.9 ± 0.6
2.5 ± 0.04
15.7 ± 1.4
118.8 ± 6.0
108.2 ± 8.2
162 ± 9
166 ± 18
4.0 ± 0.4
6.2 ± 0.3
10.7 ± 0.6
8.3 ± 0.8
16.8 ± 1.1
2.5 ± 0.05
15.8 ± 1.5
103.9 ± 7.2
86.7 ± 7.8
138 ± 10
155 ± 19
4.3 ± 0.4
1,2; P < 0.05
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94.8 ± 9.1
(15-360)
12.0 ± 1.3
(1.9-38.5)
0.14 ± 0.01
(0.05-0.48)
36.9 ± 3.0
(12.7-109)
Table 9.6:
Metabolic-endocrine group of risk factors by nationality. Mean ± SEM and range [n= 125].
Nationals	 non-Nationals
Cholesterol	 4.9 ± 0.1	 4.7 ± 0.1
(mmoIIl)	 (2.9-7.3)	 (3.3-6.9)
Triglyceride	 1.4 ± 0.1	 1.5 ± 0.1
(mmolll)	 (0.5-5.4)	 (0.4-3.1)
Uric acid	 3.8 ± 0.1	 3.9 ± 0.1
(mmol/l)	 (0.7-6.3)	 (0.9-5.6)
Fasting insulin	 94.4 ± 8.6
(pmolIl)	 (12-490)
Proinsulin	 13.2 ± 1.2
(pznol/l)	 (1.6-51.7)
Proinsulin!	 0.16 ± 0.01
insulin molar ratio 	 (0.02-0.45)
SHBG	 33.8 ± 2.5
(nmol/1)	 (10.2-162.5)
Statistical comprison showed none significance.
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Table 9.7
Eating habits and activity score [%] by nationality [n=95].
Nationals	 non-Nationals
n (%)	 48 (51)	 47 (49)
General habits:
Main meal as lunch	 98	 90
Taking snacks between meals 	 61	 45
-Time of snacks between lunch and dinner 84	 59
Specific, each food items taken at least once/week:
More than7eggsperweek	 12	 13
Milk	 66	 69
Lamb	 96	 90
Chicken	 94	 94
Honey	 47	 39
Jam	 39	 26
Beans	 78	 77
White bread	 84	 94
1Brown bread	 78	 31
Rice	 100	 92
Potatoes	 55	 71
Salad	 98	 98
2Dates	 84	 45
Apples	 78	 88
Bananas	 74	 75
Oranges	 88	 88
Soft drinks	 78	 79
Activity score (%):
Inactive	 86	 68
3Active	 14
	 32
Moderately active	 6	 15
Active	 8	 17
1, 2, 3 ; P < 0.05
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SUMMARY
The aim of this chapter is to investigate the differences and/or the similarities between
subjects diagnosed as IGT and NIDDM compared with normals. The emphasis is on some
hormonal and metabolic aspects following an oral stimulus.
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CHAPTER TEN:	 SUBSTRATES and HORMONAL ESTIMATION
10.1 INTRODUCTION
A full account of the subjects with IG was given in Chapter 2 and only a
brief introduction is given here. The redefinition and classification of diabetes
mellitus by the World Health Organization (WHO, 1985) and the National
Diabetes Data Group of USA (NDDG, 1979) introduced the category of Impaired
Glucose Tolerance (1(n). Justification for a group interposed between normal and
frankly diabetic patients was provided by epidemiological data showing that only
a small proportion show worsening to diabetes each year and that they only rarely
develop specific diabetic complications (Jarrett et al, 1979; Fuller et al, 1980).
Nevertheless, identification of these patients was recommended since they have
an increased risk of developing atherosclerosis, but not the microvascular
complications of diabetes (Fuller et al, 1980).
IGT is common in obesity and is associated with abnormalities of
intermediary metabolites both fasting and during the OGTT which suggested
decreased insulin sensitivity not only with regard to glucose, but also in non-
esterifled fatty acid (NEFA) and ketone body metabolism (Robertson et al, 199(J).
Furthermore, IGT in obesity may be associated with reduced insulin clearance and
additional insensitivity to insulin action in hepatic and peripheral glucose
metabolism and fatty acid re-esterification, but that appears not to be the case for
lipolysis or ketogenesis (Robertson et a!, 1991). Those patients with IGT were
mainly recruited from hospital clinics and they were grossly obese (BMI > 45). It
is unclear whether the abnormality of blood glucose in subjects with IGT is
accompanied by other metabolic abnormalities which characterized this group and
might led in some of them to overt diabetes. Thus, the study described in this
chapter sought any hormonal and intermediary metabolites abnormalities during
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fasting and also in the response to an OCTET in non-obese healthy male subjects
with 1(11' recruited in the community. Results are compared with those found in
subjects with N(ff and NIDDM.
10.2 SUBJECTS and METHODS
Subjects :The recruitment procedure for the whole population was described
earlier [Chapter 4]. Those who were found to have either IGT or NIDDM using
WHO screening criteria (WHO, 1985) were given a further confirmatory OGfF
without informing them about their results, in order to establish the diagnosis.
Those who agreed and came for the second OGTT were informed about their
results. They were then asked to agree to a further extended OGTT to look at
their metabolic responses in more detail. An age and weight-matched cohort was
selected from those with normal glucose tolerance [NGI] on screening and acted
as normal controls. Thus, the whole group [n=43] involved in this study consisted
of subjects with IGT [n=17], with NU)DM [n=9] and with NOT [n=17]. All
subjects gave informed, written consent to the protocol before enrolment for the
last OGIT. No subjects were taking any medications including thiazide diuretics,
corticosteroids, and they had no evidence of other disease as was shown by the
questionnaire in the screening phase. The study took place in the 'investigation
room' established by the investigator at the Diabetic and Hypertension Centre
[DHC] of Jeddah, Saudi Arabia.
Protocol: Subjects were asked to eat their normal diet which usually contained a
minimum of 300 g carbohydrate. None of the subjects drank alcohol. No special
instruction was given to avoid vigorous physical activity in the 48 hour prior to
study since the preceding questionniare revealed that the cohort was inactive.
Special instruction was given to the subjects the day before the study day to
abstain from eating or drinldng from 11:00 pm and to come early next morning by
8:30 am to ensure an overnight fast of 10 - 12 h. Those who failed to follow the
instructions were given another appointment [2 subjects]. Throughout the study
subjects remained semi-recumbent and were not smoke. Entertainment was
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provided via educational pamphlets or video-cassettes during the waiting time to
avoid boredom. An 18-gauge Brannula cannula was inserted into an antecubital
vein at least 30 minutes before sampling. After two fasting blood samples [at -15
and 00 minutes] had been taken each subject drank 75 g anhydrous dextrose in
300 ml water over 5 miii. Additional blood samples were taken at 30, 60, 90, and
120 minutes from the start of the glucose drink for insulin, C-peptide, proinsulin,
glucagon, glucose, lactate, pyruvate, alanine, 3-hydroxybutyrate, glycerol and
NEFA. A further two samples were taken for insulin, C-peptide and proinsulin at
10, and 20 minutes. At each sample time at least 10 ml blood was withdrawn after
discarding the initial 0.5 ml: 1 ml was mixed with refrigerated 5 ml perchloric
acid solution and centrifuged immediately to remove the protein precipitate; 2 ml
was placed in lithium heparun tubes for measurement of plasma NEFA, and 2.25
ml in traysolol (0.25 ml) tubes for glucagon. The remainder of the blood was
placed in plain tubes for measurement of serum insulin, C-peptide and pro-insulin.
The perchloric acid extract and separated plasma or serum were stored at - 40 °C
until assay. The detailed analytical methods were described above [Chapter 4].
Statistical analysis. The results have been analysed by calculating the areas
under the responses curves [AUC] of the different variables were calculated using
the trapezoidal role and were compared for the three groups of subjects (Leyland
et al, 1991; Mathews et a!, 1990). As most of the variables studied were not
normally distributed, non-parametric statistical methods have been used.
Comparisons between two groups were performed using the Mann-Whitney U-
test. Comparisons between the three glucose tolerance groups were performed
with Kruskal-Wallis one-way analysis of variance by ranks. A p-value (two-
tailed) less than 0.05 was considered statistically significant. All results are
expressed as mean ± SD and SEM in text and as mean ± SEM in the figures.
10.3 RESULTS
Details of subjects and basic parameters are shown in 'lble 10.1. Age in
those with IGT and NIDDM was almost identical and non-significantly higher
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than those with NGT. Subjects with lOT had slightly (but non-significantly)
higher BMI [29 ± 2] compared to the BMI found in NOT and NIDDM subjects.
Fructosamine values, not surprisingly, were significantly higher in the NIDDM
group compared with those with NOT [p <0.004] or lOT [p < 0.002]. Area under
the response curve [AUC] following OGTT by glucose tolerance groups are
shown also [ilible 10.2].
Hormone concentrations: The mean 1± SEMI concentrations are shown for
serum insulin [Fig 10.1], C-peptide [Fig 10.2], proinsulin [Fig 10.3] and glucagon
[Fig 10.4]. Areas under the curve for insulin [mU/l/h] were higher in NOT [193 ±
23], intermediate in lOT [168 ± 22] and lowest in those NIDDM [86 ± 14] but a
significant difference [p < 0.04] was only shown between JOT vs NIDDM.
Although the basal plasma insulin values tended to be lower for NOT [9.6 ± 1.5]
vs IGT [13 ± 2] and NIDDM [13 ± 3], the incremental values were reversed and
were significantly higher in NOT [111 ± 13] vs lOT [96 ± 13, P = 0.03] and vs
NIDDM [48 ± 8, P = 0.02]. The absolute insulin concentrations were intermediate
throughout in subjects with IGT between the highest values found in NOT and
lowest values found in NI1)DM. The peak insulin concentration occurred at 60-
90 minutes for both lOT and NOT whereas it was at 90-120 minutes in NIDDM.
C-peptide AUCs were similar in subjects with NOT and lOT [3.5 ± 0.03]
but both were higher than in NIDDM [2.7 ± 0.02]. However, no significant
difference was found between the three groups except at 20 mm [JOT vs NIDDM,
P = 0.04] and at 60 minutes [NGT vs NIDDM, P =0.03]. The AIJC for
proinsulin was lowest in NOr [36 ± 4], intermediate in ior [41±4] and highest
in NIDDM [54 ± 14], although these differences did not reach significance.
Similar patterns were found for glucagon values with no significant difference
between the three groups NOT [81 ± 6], lOT [81 ± 5] and NIDDM [107 ± 13].
Substrate concentrations:
The mean concentrations are illustrated for glucose in Fig 10.5, lactate
[Fig 10.6], pyruvate [Fig 10.7], aJ.anine [Fig 10.8], 3-hydroxybutyrate [Fig 10.9],
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NEFA [Fig 10.10], and glycerol [Fig 10.11]. Blood lactate concentrations were
intermediate for IGT between NUT which were the lowest and NIDDM which
were the highest. This was clearly seen in the basal state and at the late time
points. Pyruvate concentration differences broadly followed those of lactate
except that the IGT group were the highest, and those with NIDDM were
intermediate. 3-hydroxybutyrate values were highest in those with JOT while the
values for NOT and NTDDM were almost identical. There were no significant
differences between the three groups for intermediary metabolite concentrations
of lactate, pyruvate, 3-hydroxybutyrate and alanine. However, significant
differences were found for glycerol and NEFA. NEFA concentrations were
significantly higher, compared with NOT, in subjects with IGT [p =0.01] and
NIDDM [p=0.0O6] which was also the case for glycerol [NGT vs JOT, p=O.02;
NGT vs NIDDM, p=O.04] [Fig 10.10, Fig 10.111.
10.4 DISCUSSION
The insulin response to oral glucose, which was significantly lower in the
subjects with IGT, contrasts with the findings of previous studies of 'chemical
diabetes' (Reaven et a!, 1968; Savage et a!, 1975) and the earlier finding of
defects of insulin-stimulated glucose uptake in chemical diabetes (Reaven a a!,
1977; Kolterinan et a!, 1981). This could be due to heterogeneity among subjects
with JUT' which is well known, or selection bias could conceivably have produced
a normal glucose tolerance cohort with high basal insulin values.
The data cannot determine whether, in non-obese subjects with IGT, it is
resistance to insulin-stimulated glucose uptake into muscle or failure of
suppression of hepatic gluconeogenesis which is the more important component
of the hyperglycaemia following oral glucose.
It is of interest to note that in these subjects the early (60 mm) insulin
response is similar in those groups despite subjects with IGT having a
significantly higher blood glucose concentration. An additional component of the
hyperglycaemia might be a degree of impairment or delay in insulin secretion in
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response to oral glucose (Prager et al, 1987). A reduced insulin response was a
strildng finding in the studies of first-degree relatives of Type 2 diabetic patients
(Barnett et al, 1981, 0 'Rahilly et al, 1986). Population and clinical studies
indicate that glucose-stimulated hyperinsulinaemia is associated with deterioration
from normal to ICTF whereas a reduced insulin response is a marker of subsequent
progression to diabetes (Sicreè et al, 1987; Kadowaki et a!, 1984).In this study,
subjects with ICr and NIDDM, abnormalities were present in lipid metabolism
when 1(11' was compared with NG and these were similar in NIDDM. Despite
similar basal insulin concentrations, subjects with IGT had significantly raised
NEFA which were accompanied by higher glycerol concentrations. Plasma
NEFA concentrations were also significantly higher in IGT throughout the OGU
[p < 0.05]. The fmdings for NEFA and glycerol indicate resistance to the action of
insulin in adipocytes.
The results of the comparison of JOT with NOT and NIDDM in non-obese
subjects suggest that JOT is associated with reduced insulin concentrations, a high
insulin: proinsulin ratio, insulin resistance and reduced insulin secretion, in
addition to increased peripheral fatty acid mobilization. Previous studies of insulin
insensitivity in subjects with IGT where insulin receptor binding has been
measured have reached conificting conclusions, with insensitivity attributed solely
to decreased binding (Kolterman et a!, 1981) or purely to post-binding defects
(Nagulesparan et a!, 1980).
Both NIDDM (Banerji et al, 1989) and lesser degrees of glucose
intolerance (Reaven et a!, 1979) were heterogeneous in terms of insulin
insensitivity of glucose metabolism, and it would not be unreasonable to suppose
that this heterogeneity will extend to other aspects of insulin action.
Consequently, generalizations from this cohort of subjects with JOT to other
groups is not possible.
In summary, significant differences in NEFA and glycerol concentration
both fasting and in response to OGTT were observed between non-obese subjects
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with NGT and IGT and also NGT and NIDDM but not between IGT and
NIDDM. Thus, non-obese subjects with IGT have abnormalities of fat
metabolism as well as of carbohydrate metabolism. These findings suggest
resistance to the action of insulin occurs in a number of different tissues, already
in the "prediabetic" state.
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Table 10.1
Subjects characteristics by glucose tolerance group. Mean ± SEM.
NGT	 IGT	 NIDDM
n
Age (yrs)
Weight (kg)
Height (m)
BMI
12Fructosamine
(mmol F')
17
39 ± 2
78 ± 3
1.7 ± 0.02
27 ± 1
2.5 ± 0.1
17
43 ± 3
83 ± 3
1.7 ± 0.01
29 ± 1
2.3 ± 0.1
9
44±3
79 ± 5
1.7 ± 0.03
27 ± 1
3.1 ± 0.2
1, NIDDM vs NGT	 p = 0.004
2, NIDDM vs IGT	 p = 0.002
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168 ± 22 86 ± 14
3.5 ± 0.3
40.8 ± 4.1
81.3 ± 4.9
2.7 ± 0.2
54.4 ± 13.5
106.6 ± 13.0
605 ± 30
59 ± 23
0.58 ± 0.05
72 ± 6
2063 ± 151
138 ± 17
16.4 ± 0.7 21.5 ± 1.5
2125 ± 138
129 ± 15
639 ± 39
35 ± 11
0.63 ± 0.05
59 ± 3
Table 10.2
Area under the curve [AUC] following OGTT by glucose tolerance groups. Mean ± SEM.
NGT	 IGT	 NIDDM
Hormones:
Iiisu1AUC	 193±23
(mU 1.1 h)
C-pepAUC	 3.5 ±0.3
(nmol r' h)
ProinsulinAUC	 36.4 ± 4.5
(jmo1 F1 h)
Glucagon	 80.7 ± 5.6
(pmol F' h)
Substrates
G1uAUC	 13.5 ±0.5
(mniol F' h)
Lac AUC	 2004 ± 168
(junol F1 h)
PyrAIJC	 121±9
(jimol F' h)
AIaAUC	 548±32
(JLmol r' h)
3-HBAUC	 34±9
(imol F1 h)
*NEFA AUC
	 0.41 ± 0.05
(mine! F1 h)
GLyAUC	 51±4
(junol F' h)
* Means presence of significance, see text.
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Fig. 10.1: Serum insulin values; basal and post—glucose.
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Fig. 10.3: Serum proinsulin values; basal and post—glucose.
50 -'
40
0
E 300.
C
0L.
10
o NGT
• IGT
• NIDDM
0 I-
-30 0 30 60 90 120 150
Time (minutes).
Fig. 10.4: Plasma glucagon values; basal and post—glucose.
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Fig. 10.11: Blood glycerol values; basal and post—glucose.
80
60
0
E
:40
0I..
I)
U
20 o NGT
• IGT
• NIDDM
01
—30 0
	
30 60 90 120 150
Time (minutes).
193
GENERAL SUMMARIES
CHAPTER ELEVEN
CONCLUSIONS and FUTURE
CIIAFI'ER CONTENT:
	
11.1	 Conclusions.
	
11.2	 Potential for future studies.
194
CRAFrER ELEVEN: CONCLUSIONS and FUTURE
11.1 CONCLUSIONS
The application of epidemiology to the study of NTDDM is providing new
insights into many aspects of this major public-health problem, including its
natural history, prevalence, incidence, morbidity, and mortality in diverse
populations around the globe. These studies, on epidemiology, are providing
direction for research into the possible molecular defect or defects and
biochemical mechanism or mechanisms underlying NIDDM and important
information on the extrinsic [social, cultural, environmental] risk determinants.
This study is just one example. It highlights the high prevalence of glucose
intolerance and CVD risk factors such as hypertension, dyslipidaemia and
hyperinsulinaemia and demonstratedthe importance of regional adipose tissue
distribution, particularly upper-body obesity and physical inactivity in enhancing
the risk of NIDDM. These fmdings have important implications for the primary
prevention of NII)DM.
There is an increasing prevalence of diabetes mellitus in Saudi Arabia, as
shown here, and perhaps in other Gulf countries (Asfour et al, 1990), and makes a
high demand on the existing health services. Several measures should be taken
into consideration for the control of diabetes in the Saudi Arabian community.
These include proper health education for the public and training medical and
paramedical health workers about diabetes. In many hospitals and health centres
in the region the management of diabetes is insufficient, mainly because of
shortage of physicians or general practitioners interested in diabetes. Moreover,
there is a lack of a team work approach to care including diabetic nurses,
dietitians, chiropodist and ophthalmologists.
This study, also shows the importance of social habits such as smoking.
Cigarette smoking is a major risk factor which is increasing dramatically in Saudi
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Arabia and may partly be responsible for the increased risk of heart disease, since
there was an increase of 47% in imports in one year 1982-1983. Alcohol
consumption, although forbidden has also shown a gradual increase which may be
because of the increased frequency of those travelling outside the country to drink
alcohol.
This study identified several other problems including hypertension, and
hyperlipidaemia. Many people were, perhaps, unaware of their condition, and
there was limited public concern regarding hypertension. A large proportion of
cases did not receive regular treatment and there was a lack of routine
measurements of blood pressure or lipids by the physician in patients attending
the polyclinics.
Another emerging risk factor presented here is obesity which is becoming
one of the most important public health problems in Saudi Arabia. Although it is
more prevalent among middle-aged adults, childhood obesity has also been
reported (Musaiger, 1987). Unfortunately, there has until now been no well-
designed study to determine the prevalence of obesity in this community. Most of
the studies are based on weight and height measurements, which are a less
accurate index, as overweight may be due to an increase in muscle mass or body
fluid or body fat.
There are several factors contributing to the incidence of obesity in Saudi
Arabia. With the greater availability of housemaids, cars, televisions and other
sophisticated household appliances, the physical activity of the people has
significantly diminished. Among women the problem is more serious, as watching
television and eating snacks are the main activities during their leisure time,
especially when the majority of women are unemployed. Their life is more
sedentary even though they do not consume high amounts of food. Also, perhaps,
most of the inhabitants of Saudi Arabia seek easy work and rely on services. In
many cases they rely on sources of revenue other than those derived from
employment and hard work. Recently there has been an interest in physical
196
fitness programmes, but only few people joined such activities.
The attitude towards obesity is another important factor. The traditional
clothing style of Saudi Arabian people also plays a vital role. The long,
comfortable and wide clothes worn by men and women have made them not feel
the gradual gain in weight. This is because these dresses have more space to
absorb weight gain. Once these people change over to western style clothing, they
then realize how much fat they have gained. Many other factors are responsible
for the occurrence of obesity in the Saudi Arabia such as multipregnancies,
shifting from breast to bottle-feeding and environmental factors. A well-designed
study to determine the factors associated with obesity in Saudi Arabia is strongly
supported.
Among all these factors, diet is of key importance in the aetiology of
CHD. The transition to a more westernized diet is likely to result in a high intake
of animal fat and hence saturated fatty acids and dietary cholesterol. The intake of
foods rich in cholesterol such as eggs, red meats and chicken, has increased as
highlighted in this study. The cultural background of the various nationalities and
their food habits are among the factors which influence the control of diabetes in
Saudi Arabia and should be carefully assessed and implemented. Physicians
should be well instructed in the dietary management of diabetes. Information
regarding loss of weight, physical exercises and sound food habits should be a
major component in any health education programme for the public.
Excessive intake of food is also responsible for obesity in the region.
There is good evidence that the energy intake of the people has increased. The
availability and promotion of high carbohydrate snacks such as chocolates, sweets
and biscuits as well as the high-energy content of traditional dishes also
contributes to obesity. However, whether people with glucose intolerance tended
to have different dietary habits compared to normals needs further clarification,
since this study does not prove it.
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In Saudi Arabia the following major barriers of diabetes activities in the
field of nutrition could be encountered. Nutrition is given little or no priority in
health education to the diabetic subjects. The role of sound nutrition in improving
the health status of these subjects is underestimated by the physicians.
This is, perhaps, due to shortage of local qualified personnel specializing in
nutrition or other related fields such as dietetics and food sciences. More studies
are needed to investigate the composition of diets in the region and the role of
these diets in the aetiology of diseases.
Thus, affluence, change in food habits, the prevalence of hypertension,
overweight and diabetes, as well as stress of modern life seem to be largely
prevalent in this urban male community and it may be responsible for the
increasing morbidity and mortality in Saudi Arabia.
Diabetes and CVD risk factors have also affected foreign workers in Saudi
Arabia. Those living in the area, especially those from the north-east Africa and
the Indo-Pakistani subcontinent probably need special consideration. It may be
that the foreign workers in the Saudi Arabia are highly stressed due to a
combination of low pay, overwork, job insecurity, undernutrition, and the
significant factor of being parted from their families for long periods of time.
As shown in different populations, those identified as 1(11' or NIDDM in
this community, were characterised by hyperfunction of the f-cell in IGT,
hypofunction of the a-cell in NIDDM and associated with immature secretion of
proinsulin. The insulin resistance which was profound in NIDDM and
intermediate in IGT was characterised by high glycerol and NEFA which were
suggestive of insulin insensitivity at the level of adipose tissue.
The category of KIT proved to be a valuable epidemiological index when
taken in association with the frequency of diabetes meffitus within populations. It
will probably find increasing use as an indicator to lesser degrees of glucose
intolerance in larger studies of the effects of preventive measures for diabetes
applied in population studies as descriptors.
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Health activities in terms of education and evaluation should be
encouraged. There are already some health activities going on in the health
centres to patients with diabetes or others with NCD, but still few when compared
to the size of the problem. Most if not all the work in health education to the
public is carried out by the Ministries of health, and mainly by the health
education departments. Posters, booklets and leaflets are widely used as a tool for
diabetic education in Saudi Arabia. However, we do not know whether this
method of education is a suitable one in this community which is characterized by
a high percentage of illiteracy and less educated people. The televised health
education programme which is called 'Salametic' (Your Safety), is a very useful
means if used properly and consists of 52 series of 25 mm each for television, and
a message of 2-3 mm daily on the radio. Giving health information does not
guarantee that the dietary habits of the people will change. Unfortunately, there is
no evaluation about the effectiveness of the printed materials on the knowledge,
attitudes and practices of the people in Saudi Arabia.
Preventive measures against diabetes and risk factors should started as
soon as possible. Obesity and atherosclerosis are difficult to treat in adulthood,
and this puts a drain on the health services by providing facilities to treat large
numbers of patients. Physicians often check for diabetes but rarely pay attention
to the associated risk factors. Therefore, more emphasis should be placed on
improvement of the awareness and skills of the physicians towards detecting these
diseases.
Thus, in short:
1). This study shows a high prevalence rates of NTDDM and lOT in an urban male
community. These rates are much higher compared to previous studies.
2). The prevalences of CVD risk factors [smoking, obesity, hypertension,
hypercholesterolaemia and hypertriglyceridaemia] are common.
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3). A single OGTE' is not enough to confirm the diagnosis of diabetes mellitus and
ICT in asymptomatic individuals.
4). The JOT group stands as an independent category and they are more likely to
have a higher prevalence of combination of CHD risk factors as compared to
those with NOT.
5).Physical inactivity and westernised dietary habits are emerging lifestyle
problems. A series of talks should be given to the community regarding their
dietary habits and sedentary life-style.
6). Ethnic difference is of interest.
7). Subjects with JOT are characterised by hyperfunction of the (3-cell, immature
secretion of proinsulin and adipose tissue insulin insensitivity.
WHICH WAY FORWARD?. As shown in chapter 3, data on diabetes
mellitus are still scarce in Saudi Arabia. The general impression from the limited
literature available, no doubt, is that it is an emerging problem in Saudi Arabia,
particularly in urban societies. An increasing prevalence of the disorder may be
related to the changes in social life and dietary pattern as a result of the rapid
economic growth. People are eating foods rich in carbohydrates and fat and
leading sedentary lives. Because of the scarcity of data, the epidemiology of the
disease is not yet fully understood. Many questions concerning the magnitude of
the problem, its distribution, contributing factors, pathogenesis and criteria for
diagnosis still need to be answered. Since, most of the studies carried out, so far,
have been hospital-based dealing with small unrepresentative samples, there is an
urgent need for collective efforts, perhaps via the Saudi Diabetes and Endocrine
Association, from researchers in universities and health service organizations to
conduct more comprehensive and coordinated research work.
For proper control, programmes of health education, early diagnosis and
early treatment should be implemented. Health education should emphasize the
importance of physical activity, balanced diets, the avoidance of being
overweight, excessive worries and intermarriage within diabetic families.
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Modifying lifestyle is probably the biggest challenge.
In short, NIDDM and IGF are very common. Cardiovascular risk factors
should not be ignored during any epidemiological studies. Some features and risk
factors were peculiar to this community. JOT tolerance category stands as its own
as independent category. Prevention should be the target and the aims for this
high diabetic prevalence and further studies are required in that direction and in
other directions of the wide diabetes field research. Since, prevention of diabetes
is the simplest, most rational and generally most economical approach to
treatment, primary prevention is perhaps becoming a reality (Alberti, 1986). The
time, perhaps, is right to start action in populations in which the prevalence of
diabetes is known to have clearly increased recently (Tuomilehto et a!, 1987).
In Saudi Arabia, there is a wealth of research material available but
disappointingly there is not more activity in this area. One of hindering factors
which appeared in this study is the people attitude towards research. As perhaps,
with other developing country the research whic faces and involved the public is
scarce and minimally practised which makes the public less exposed to the
research activity. A well explained and continuous description of any protocol
will be a temporary remedy and makes people appreciate your research work. The
next are some potential thoughts for future work.
11.2 POTENTIAL for FUTURE STUDIES
The continuing health of the diabetic, whether in Saudi Arabia or
elsewhere, depends on both effective health care and related research. Globally,
the past 20 years have seen a major expansion in research related to diabetes.
Techniques currently in use for diabetes research run the entire spectrum from
genetic engineering to psychological testing. The methods in diabetic research
are broadly classified in the areas of basic, clinical and behaviouralleducational
methods. There is no natural division between different aspects of research but
coordination between them is needed to protect the health of those with diabetes.
Many different types of research are potentially required in Saudi Arabia;
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population studies, basic research and clinical research, but all need to be
coordinated to optimize their effect upon the health of diabetics in this region. The
focus of research must include the spectrum from epidemiological studies to basic
investigation. However there are still areas where promising research
developments, health care provision and health sciences are desirable.
Interestingly would be research into preventive aspects investigating the
effects of weight reduction, antidiabetic drugs, dietary manipulation or an increase
in physical activity upon progression from IGT to NIDDM. A carefully planned
large cooperative epidemiological study will assist in the elucidation of the true
causes of diabetes in Saudi Arabia, and thus may provide a rational basis for the
prevention and control of the disease in this geographic location. Such a study
will help to quantify the true contributions of the three major aetiologic
components namely genetics, lifestyle and environment.
1).	 Diabetes mellitus and CVI) survey:
The Saudi Arabian population is approximately 11,542,000 (James et al,
199(J). This constitutes 40.3% [1-12 ys], 8.2% [13-17 years], 20.1% [18-29%],
25.2% [30-59 years] and4.2% [^ 6oyears]. Thereareanequalnumberofmales
and females at different age distribution except at the age of 18-59 years where
the numbers of males are greater by one third than the females. Inhabitants of
Jeddah number approximately 1,000,000. Therefore, a proper urban area
prevalence study in Jeddah would be a logical extension from this study. There
are 40 primary health care centre or more so far in the region of Jeddah city.
Selecting 100 subjects 50 for each sex from each primary health care centre would
be much more representative and give proper risk rates for both diabetes and
CVD risk factors. Those registered in each centre would be selected and the
investigation would move around each centre after prior registration. Known
diabetic and hypertensive patients will be included. This should give an urban
population of 4,000 subjects.
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2). Diabetes and Hypertension Centre at Jeddah [Jeddah DHC]:
The recently established diabetes and hypertension centre [Summer, 1989]
needs to be evaluated. Those registered in this centre reached a number of 5,000
by December 1990. The investigator has gained access to these data and has
requested to start exploring and evaluating the results. Preliminary analysis
showed that males outnumbered females [58% vs 42%]. The majority of them
were middle-aged and the age distribution revealed that 11 % were below 35, 79%
were 35-64 years and 10% ^ 65 years. The BMI distribution showed that 27% had
BMI < 25, 35% had BML of 25-30, 38% of BMI> 30 and 16% had BMI > 35.
This is, so far the largest national centre in term of population and further in-depth
analysis of the available recorded data might reveal an insight into the pattern of
diabetes in this region.
3). Prevalence of hyperglycemia during Haj period:
The ritual gathering of over 1 500 000 Moslem pilgrims while performing
Haj in the Holy places and Jeddah for a period of 2 - 8 weeks creates a unique
situation with particular medical problems. There are many factors that might
contribute to the health problems of these pilgrims including austere living
conditions in tents with deficient water supply, poor sanitation and poor nutrition.
Old age and pre-existing medical illness like diabetes mellitus or hypertension are
also important. Many workers have studied the medical problems that could
afflict these pilgrims and those in their service. Emphasis has been on heat-
induced syndromes (Khogali et al, 1983), and the recently reported different
forms of the 'Diabetic Haj Foot' was interesting ('läwfik et al, 1991).
As an extension to the concept of changing diabetes prevalence between
different nationalities and ethnic groups, it would be of interest to examine this
question in a time where different nationalities are congregated in one place.
Moreover the burden of diabetes problem, although, temporary, could be
investigated. Two stages of this investigation are suggested. The first period
would be in Haj 1412 (July, 1992) during which a 'Diabetes Health Card' should
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be filled in by all pilgrims arriving within 1 month prior to the Haj time at one
place of entry (Jeddah Airport). The Diabetes Health Card should have
information including age, sex, country of origin, known diabetics, duration of
diabetes and type of therapy, diet, OH drugs or insulin, do you carry your diabetic
medicine with you or not, etc. This card will be introduced in three languages
namely Arabic, English and French. The second stage would be during the Haj
1413 (May-June, 1993) during which time the prevalence of hyperglycaemia
would be investigated by capillary blood estimation using a test strip and
Boehringer Mannheim Instrument for example.
4).	 Insulin-dependent diabetes meffitus registry:
Searching the literature of diabetes mellitus in Saudi Arabia reveals no
information about IDDM, although NIDDM in the common form in this area. It
would be important to conduct an appropriate enquiry and to start registering
IDDM.
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SURVEY QUESTIONNAIRE
Appendix 1:
GENERAL Questionnaire:
-Name:
-Address/District: _________________________________
-Primary Health Care Centre (PHCC) No: _________
1-Code No.
2-What is your age in years?.
3-Are your:
4-What is your nationality?.
1 =Saudi.
2=Non-Saudi., please specify:__________
5-What is your ethnic background?.
1 =Arabian.
2= Mediterranean.
3 =Indian.
4=South East Asian.
5 = Negro.
6=Others.
6-How long have you been in Saudi Arabia?.
1=Upto	 5years.
2=Upto	 lOyears.
3=Upto	 15 years.
4=Upto	 2Oyears.
5=More than2O years.
7-What is your level of education?.
1 = illiterate,
2=Writmg and Reading,
3 =Priniaiy,
4=Elementary and Secondary.
5=lJmversity or Above.
S-Are you employed in?.
1 = Goverment.
2=Private firm.
3=Self.
4=Retired.
5 =IJnemployed.
-Questionnaire Date:_/_I_.
-Tel:
Health File No: ________
/ /
1 =Male.2=Female.
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9-What is exactly your occupation or occupation title?.
10-What is approximately your monthly income (SR)?.
1=1500 or less,
2=3000 or less,
3=4500 or less,
4=6000 or less,
5=7500 or less,
6=More.
7=1 don't know.
12-Are you?.
1=Married with one wife.
2=Married with two wives.
3=Smgle.
4=Divorcecj.
13-Is your wife first degree relative to you?.
1=Yes.
2=No.
-How many children do you have?.
14-I have:	 1 2 3 4 5 6 7 8 9 10 boy(s) alive
15-I have:	 1 2 3 4 5 6 7 8 9 10 boy(s) dead
-I don't have boys (99)
16-I have:	 1 2 3 4 5 6 7 8 9 10 girl(s) alive
17-I have:	 1 2 3 4 5 6 7 8 9 10 girl(s) dead
-I don't have girls (99)
18 Do you suffer from diminished sexual desire (impotence)?.
1=Yes.
2=No.
-Have you ever been told by a doctor that you have one of the following?.
19-Diabetes.
1=Yes.
2=No or don't know.
20- High lipids in your blood.
1=Yes.
2=No or don't know.
21- High Blood Pressure.
1= Yes.
2=No or don't know.
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22- Heart diseases.
1=Yes.
2=No or don't know.
23- Stroke.
1=Yes.
2=No or don't know.
24- Are you currently taking any medicine for any reason?.
1=Yes.
2=No or don't know.
25- What is/are the actual name/s of drug/s that you are still using recently?
-Name of drug: _____________________
-Name of drug: _____________________
-Name of drug: ______________________
26-Is your father alive?.
1=Yes.
2=No or don't know.
27-Is your mother alive?
1=iYes.
2=No or don't know.
-How many brothers and sisters do you have?
28-I have:	 1 2 3 4 5 6 7 8 9 10 brother(s) alive
29-I have:	 1 2 3 4 5 6 7 8 9 10 brother(s) dead
-I don't have brothers (99)
30-I have:	 1 2 3 4 5 6 7 8 9 10 sister(s) alive
31-I have:	 1 2 3 4 5 6 7 8 9 10 sister(s) dead
-I don't have sisters (99)
-Is your father suffering from any of the following diseases?.
32-Diabetes.
1=Yes.
2=No or don't know.
33- High Blood Pressure.
1=Yes.
2=No or don't know.
34- Heart diseases.
1=Yes.
2=No or don't know.
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35- Stroke.
1=Yes.
2=No or don't know.
-Is your mother suffering from any of the following diseases?.
36-Diabetes.
1=Yes.
2=No or don't know.
37- High Blood Pressure.
1=Yes.
2=No or don't know.
38- Heart diseases.
1=Yes.
2=No or don't know.
39- Stroke.
1=Yes.
2=No or don't know.
-Are your brothers or sisters suffering from any of the following diseases?.
40-Diabetes.
1 = Yes.
2=No or don't know.
41- High Blood Pressure.
1=Yes.
2=No or don't know.
42- Heart diseases.
1=Yes.
2=No or don't know.
43- Stroke.
1=Yes.
2=No or don't know.
44-Are any of your children suffering from diabetes?.
1=Yes.
2 =No or don't know.
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-At present do you have?
45-Increased urine volume (Polyyria).
1 =Yes
2=No or don't know.
46-Thirst and increased drinking (Polydypsia).
1=Yes
2=No or don't know
47-Hunger and ingestion of large quantities of food (Hyperphagia):
1=Yes
2=No or don't know
48-Weakness and fatigue.
1 =Yes
2= No or don't know
49-Inability to concentrate.
1=Yes
2=No or don't know
50-Do you think that, over the past three month, your weight is?
1= Same.
2= Changed by decreasing.
3 = Changed by increasing.
4= Changes by decreasing and Increasing (ups and downs).
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Appendix 2
1- Have you ever had pam or discomfort in your chest?.
OR
Have you ever had any pressure or heaviness in your chest?.
1=Yes.
2=No or don't know.
2- Have you ever had severe pain across the front of your chest lasting for half an hour or more?
1=Yes.
2=No or don't know.
3- Do you get pain in either leg on walking?.
1=Yes.
2=No or don't know.
4- Have you ever had weakness or loss of strength in an arm or leg lasting for 24 hours?.
1=Yes.
2=No or don't know.
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Appendix 3
SOCIAL HABiTS
CIGARETTES:
1- Do you smoke CIGARETTES now or did you ever smoked CIGARETTES before?
1= Yes, I smoke CIGAREUES NOW.
2= Yes, I used to smoke CIGAREUES but stopped now.
9= No or don't know.
2- Do you consider your smoking habits of CIGARETTES?
1= Regular.
2= Occasional (usually less than one CIGAREUE/day).
9= No, don't smoke.
3- On the average, about how many cigarettes do you now smoke or used to smoke a day?
1= Number :1_I__I.
99= No, don't smoke.
4- For how long have you been smoking CIGARETTES till present or previously?
1= Years	 :111.
(Proper one considered for less than a year or part of the year).
99 = No, don't smoke.
SifiSHA:
5- Do you smoke SifiSHA now or did you ever smoked SHISHA before?
1= Yes, I smoke SHISHA NOW.
2= Yes, I used to smoke SHISHA but stopped now.
9= No or don't know.
6- Do you consider your smoking habits of SHISHA?
1= Regular.
2= Occasional (usually less than one SHISHA/week).
9= No , don't smoke.
7- On the average, about how many SIIJSHA do you now smoke or used to smoke a week?
1= Number :111.
99= No , don't smoke.
8- For flow long have you been smoking SHISHA till present or previously?
1= Years	 :1_I_I.
(Proper one considered for less than a year or part of the year).
99= No , don't smoke.
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PIPE:
9- Do you smoke PIPE now or did you ever smoked PIPE before?
1= Yes,IsmokePIPENOW.
2= Yes, I used to smoke PIPE but stopped now.
9= No or don't know.
CIGARS:
10-Do you smoke CIGARS now or did you ever smoked CIGARS before?
1= Yes, I smoke CIGARS NOW.
2= Yes, I used to smoke CIGARS but stopped now.
9= No or don't know.
ALCOHOL DRINKING:
11-Do you drink ALCOHOL now or have you ever drunk ALCOHOL before?
1= Yes, I drink ALCOHOL NOW.
2= Yes,I had past experience of drinking ALCOHOL but not now.
9 = No or don't know.
QAT EATING (Herbs from Yemen):
12-Do you eat QAT now or have you ever ate QAT before?
1= Yes,IeatQATNOW.
2= Yes, I had past experience of eating QAT but not now.
9= No or don't know.
1 = Means proper	 SMOKER, or DRINKER, or EAX'ER.
2= Means	 EX-SMOKER, or EX-DRINKER, or EX-EATER.
9 or 99 are negative responses.
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Appendix 4
DIETARY QUESTIONNA]1E
DIIECTIONS
The following questions are about your dietary habits and about foods that you usually eats. It
contains two sections. The first set of questions is about your general dietary habits and the second
set of questions will enquire about some food items.
For both sets:
Please ring the ONE most appropriate answer.
For the second set:
For each foods or drinks encircle only ONE answer which is the most applicable to you according
to the following?
1	 2	 3	 4	 5	 6	 7	 M	 R
-If you eat a food every day or seven times a week irrespective of any day,
then ring the:
7
-If you eat a food once or several times a week up to six times, then ring
the appropriate number accordingly:
1	 2	 3	 4	 5	 or	 6
-If you eat a food less than Once a week and once or more than
once a month; for example every 10 days, or forthightly, or every three weeks,
then ring:
M
-If you eat a food less than once a month, for example every two or three months,
or every six months, or yearly, or rarely, or even never, then ring:
R
214
CASE NO :
SECTION ONE
GENERAL QUESTIONS:
1- How many meals do you eat per day?
2- What is usually your main meal?
"When do you usually eat your main meals, please indicate the time in hours?.
3- Breakfast, at: 	 4-Lunch,	 at:	 5-Dinner, at:
6- Do you usually eat anything between your main meals and how often, regardless
times of snack a day?.
7- When do you usually eat your extra-meal , or snacks?
"' Where do you usually eat your main or other meals?.
8- Breakfast, 9- Lunch, 10- Dinner, 11- Snacks (extrameals).
12-How frequent do you eat outside home?
13-Do you suffer from any long-term illnesse (s) ,and if YES what is it?
14-Are you on any special diet as indicated by the following answers?
15-Have you changed your diet for health reasons during the past 1-2 months?
"- If Yes, in what way?
16	 -Is the amount of fat increased or decreased.
17 -Is the type of fat changed.
18 -Is the use of vegetables increased or decreased.
19 -Is the amount of sugar increased or decreased.
20 -Is the amount of salt increased or decreased.
21 -Is the amount of bread consumption increased or decreased.
22 -Others.
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SECTION TWO
SPECIFIC QUESTIONS :Types of food and Frequency.
23- How many whole eggs (boiled fried or cooked) do you usually eat in one week?
24- How many days a week do you drink milk?
25- How much milk do you drink per day either alone , with cereals like cornflakes or in tea
or coffee?
26- What type of milk do you use most?
26a- Can you specify the brand name of the most type of milk you use?
27- How many days a week do you drink yoghurt?
27a- Can you specify the brand name of the most type of yoghurt you use?
28- How many days a week do you use cream?
28a- Can you specify the brand name of the most type of cream you use?
29- How many days a week do you eat some milky-made food items such as Labna,Mesh or
Haloub?
29a- Can you specify the type this milky-made food that you frequently eat?
30- What is the most type of cheese you eat?
30a- Name the cheese you eat most often?
31- How much cheese would you say you ate per week?
32- How many days a week do you eat butter or margarine?
32a- Can you specify the brand name of the butter or margarine you mostly use?
- How many days of the week do you eat the following foods?
33	 -Honey.
34	 -Jam.
35	 -Olives.
36	 -Beans including chickpeas.
37	 -Comfiakes or similar items
38	 -White e.g Shami, Samoli bread.
39	 -Brown e.g Hab bread.
40	 -Tamees bread.
40a	 -Other kind of bread.
41	 -Rice.
42	 -Spaghetti and other pasta.
*..}Iow many days a week do you eat the following kinds of meat?
43	 - Lamb or Cheep.
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44	 -Beef.
45	 -Camel.
46	 - Chicken or other poultry.
47	 - Liver or kidney or heart.
48	 -Meat pies or pasties.
49	 -Tinned meat (all types).
50	 -Fish.
51	 -Tuna, sardines or similar tinned marine items.
52- Green vegetable or salad like tomato, cucumber and lettuce.
53- Carrots or other root vegetables.
54- Potatoes: a)-Boiled, backed or meshed.
55- Potatoes: b)-Chips or fried (cooked at home).
56- Potatoes: c)-Chips or fried ( from shop).
57- Onions (cooked, raw or pickled).
58- Beans including lentils.
59- Vegetables which needs cooking.
60- Spices like pepper.
61- Tinned fruit:
62- Dates.
63- Apples.
64- Oranges.
65- Bananas.
66- Flour-made food.
67	 -Cakes and similar:
68	 -Jellies and similar:
69	 -Milk pudding (e.g. tapioca):
70	 -Biscuits (all types):
71	 -Chocolates:
72	 -Sweets:
73	 -Nuts (all types):
74	 -Ice-cream (all types):
75- What type of oil or fat do you usually use in your home for cooking frying or baking?
1-Plant origin.
2- Animal origin.
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3- Both type.
4-I don't know or the food which is cooked, fried or baked is not made at my home.
75a- Can you specify the brand name of the butter or margarine you mostly use?
76- Do you add salt to your meals at the table?
77- How much water do you usually drink per day over the last three months?
78- Have you been asked to increase drinking water?
79- What was the reason?
80-Do you drink tea?
1-Sweetened tea with sugar.
2-Sweetened tea with agents.
3-Unswetened tea.
4-Both sweetened and unsweetened tea.
5-I don't drink tea at all.
81- How many glass of tea do you usuaiiy have a day?
82- Do you drink coffee?
1-Sweetened coffee with sugar.
2-Sweetened coffee with agents.
3-Unswetened coffee.
4-Both sweetened and unsweetened coffee.
5-I don't drink coffee at all.
83-How many cup of coffee do you usually have a day?
84-Do you use milk or cream in your coffee or tea?
1-No milk or cream added.
2-Milk only.
3-Cream only.
4-Both milk and cream.
85-How many days of the week do you drink soft drinks?
86-What is the type of the soft drinks you mostly used ?
1-Natural juices.
2-Fizzy drinks like Pepsi and similar.
3-I don't drink.
4-Both.
END OF DIETARY QUESTIONS
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Appendix 5
PHYSICAL ACTiVITY QUESTIONNAIRE
WORK-RELATED:
1- How do you usually go to your work?. 	 I-I
1= Using my car, public transport such as buses or taxis.
2 = Using a bicycle or motorcycle.
3= Walking.
4= None of the above means, e.g my workplace is at home.
2- How many minutes a day do you spend walking, on going to
and coming from work?	 I_I
1= Lessthan30minutesaday.
2= More than 30 minutes a day.
9= I don't walk or get physical activity on the way to work.
3- Which of the following describes how much physical activity is
involved in your job?	 I -
Occupations are divided into four groups. If you do not work, mention group 1.
1 = I do not walk much during my work. My work is mainly sitting work.
Examples :Office work at a desk.
2= I walk in quite a lot in my work but! do not have to lift or carry heavy things.
Examples :Office work where one has to move, shop assistant.
3 = I walk and carry a lot in my work or often to climb staircases or go uphill.
Examples :Carpenter, Work in engine-shop or car-repair shop.
4= My work is heavy physical work, where I have to carry or lift heavy things.
Examples :Heavy construction and industrial work.
4- While at work, how many hours per work day do you spend walking
with or without lifting or carrying heavy objects?
1 = Up to 2 hour.
2= 2-4hour.
3= More than 4 hour.
4= I don't walk at work.
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I-I
HOUSEHOLD WORK:
5- Do you spend time doing household work?
1= Yes.
2= No, I don't know.
6- How many hours per week,approximately, do you spend doing household work
such as scrubbing floors, vacuuming, cooking,washing dishes or
clothes , making beds or shopping?
1= Upto2hour.
2=2-4 hour.
3= More than4hour.
9= I don't do household work.
7- When you do these household shores,do you usually work so hard
that you need to take a rest to catch your breath ?.	 I_I
1= Yes.
2= No, I don't know.
9= I don't do household work.
AT LEISURE-TIME:
8- Do you do physical activity during your leisure-time? 	 I - I
1= Yes.
2= No, I don't know.
9- Which of the following best describes the way you spend your leisure time?
If it varies with the seasons, mention one group that best represents the average of the year.
I-I
1 = In my leisure-time I read, watch television and do things which do not need
physical activity.
2=Jn my leisure-time I walk, ride a bicycle or run at least for four hours a week.
In this is included walking; but not including going to and coming from work.
3 = In my leisure-time I have physical activities to maintain my condition such as ball-games
swimming or similar works.
4= I train in my leisure-time regularly for competitions several days a week, running,
ball-games or other physically heavy sports.
10- How many times a week do you do such leisure-time physical activities
you mentioned in the above question ?
	 I_I
1 = Up to 2 times per week.
2=2-4 timesperweek.
3= More than4 times perweek.
9= I don't do physical activity at my leisure-time.
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11- How long do your physical activity episodes last?	 J - I
1= Less than 30 minutes per time.
2= More than 30 minutes per time.
9 = I don't do physical activity at my leisure-time.
12- How often do you do physical activities lasting at least 20-30 minutes
which make you short of breath and perspire? 	 I - I
1= Less than once a week.
2 = Once or more than once a week.
9= I don't do physical activity at my leisure-time.
SPORTS:
13- Do you participate in sports?
	
I-I
1= Yes.
2= No, I don't know.
14- What sort of sport activities do you usually do?
Specify, please:
1= Football.
2= Swimming.
3 = Sweedy.
4= Jogging.
5= Others.
9= I don't participate in sports.
15- Normally, about how many hours per week, do you spend participating in
sports and physical activity exduding walking?	 I_I
1= Upto2hourperweak.
2= 2-4hourperweak.
3= More than4hour per weak.
9= I don't participate in sports.
16- Is the level of activity that you have just described normal for you or
are you usually more or less active? 	 I_I
1 = My activity is usually the same.
2=1 am usually less active than that amount.
3 = I am usually more active than that amount.
4= Idon't know.
9= I don't participate in sports.
RECREATIONAL WALKING:
17- Do you go walking?.	 I-I
1= Yes.
2= No, I don't know.
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18- Normally, about how many hours per week do you usually spend walking
outside of your home or place of employment, which reflect back
overthepastsixmonths?	 I_I
1= Upto2hourperweek.
2= 2-4hourper week.
3= More than4hourper week.
9= Idon't walk.
19- Is the walking that you reported above normal for you or
do you usually walk more, same or less than that amount?
	 II
1 = I usually walk the same amount.
2=1 usually walk less than that amount.
3 = I usually walk more than that amount.
4= Idon'tknow.
9= Idon'twa&.
GENERAL:
20- How do you consider your present physical condition?.	 I	 I
1= Very good.
2= Good.
3= Satisfactory.
4= Bad.
5= Verybad.
21- Have you ever seriously increased your leisure-time physical activity
and if so, when last ?.
	 I_I
1 = Yes, during the last month.
2= Yes, one month to six months.
3 = Yes, more than six months.
4= Never.
22- Has your leisure-time physical activity, changed during last six months?.
1 = Increased very much.
2= Increased a little.
3= No change.
4= Decreased a little.
5 = Decreased very much.
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